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En 2001, la séquence du génome humain a été publiée (Lander et al. 2001) ; un an après nous 
découvrons celle du génome de la souris (Waterston et al. 2002b). La disponibilité des 
séquences nucléotidiques des deux espèces a permis d’effectuer une analyse comparative de 
leur génome. La force des analyses comparatives résident dans leur capacité à révéler les 
similitudes et différences qui font la particularité des espèces analysées. Les similitudes sont 
utilisées pour identifier des éléments qui auront été conservés au cours de l’évolution et qui en 
conséquence sont probablement impliqués dans des mécanismes essentiels pour le 
développement ou fonctionnement de l’organisme. Les différences, quant à elles, permettent 
de révéler des éléments qui pourraient être à l’origine d’acquisitions nouvelles qui font le 
propre de l’espèce qui les contient ou les a perdus.  
Les analyses comparatives offrent l’opportunité de comprendre les différences phénotypiques, 
morphologiques ou comportementales des différentes espèces.  
 
Le travail présenté dans cette thèse a été initié suite à la première analyse comparative faite à 
l’échelle chromosomique. La comparaison des séquences nucléotidiques du chromosome 21 
humain avec les régions en synténie de la souris (chromosomes murin 16, 10 et 17) a révélé 
un grand nombre de séquences conservées (Dermitzakis et al. 2002b). Un total de 3491 
séquences d’une longueur minimale de 100 paires de bases, une homologie minimale de 70% 
entre les espèces comparées et ne présentant aucune discontinuité dans l’alignement ont été 
identifiées. 1229 de ces séquences correspondent à des gènes connus ou des pseudogènes ; les 
2262 séquences restantes sont des séquences non-codantes et non-annotées à ce jour. Cette 
seconde fraction de séquences conservées à travers l’évolution suscite l’intérêt d’une partie de 
la communauté scientifique. D’autres études comparatives faites à l’échelle de génomes, ont 
confirmé la présence de séquences conservées à travers tout le génome. Cinq pourcent du 
génome humain semble être sous sélection purificatrice, i.e. que la sélection agit de façon à 
éliminer des mutations qui pourraient être désavantageuses de ces séquences (Waterston et al. 
2002b). Puisque les gènes ne contribuent à ce taux que par 1.5%, les 3.5% restants doivent 
provenir de séquences fonctionnelles encore inconnues. 
  
Des études bioinformatiques, fonctionnelles et évolutives ont montré que les séquences 
conservées et non-codantes (CNCs) sont : i) uniques dans le génome, ii) distribuées de façon 
inverse par rapport aux gènes, iii) conservées chez tout les mammifères, iv) que leur potentiel 
transcriptionel est limité et v) que leur façon d’évoluer est différente de celui des gènes ou 
d’autres éléments tels que les ARN non-codants. 
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Le sujet d’étude de cette thèse a été d’explorer la fonction potentielle des ces éléments 
conservés avec un intérêt particulier pour les séquences CNCs localisées sur le chromosome 
21 humain. L’intérêt particulier pour ce chromosome est basé sur : i) l’expertise et l’intérêt de 
notre laboratoire pour ce chromosome, ii) le chromosome 21 est un des chromosomes humain 
les mieux annotés et iii) de part ses caractéristiques (contenu en gènes, en GC, etc.) le 
chromosome 21 peut être représentatif du génome humain (Lander et al. 2001).  
 
Au début de ce travail de thèse, les fonctions des CNCs étaient largement inconnues et 
différentes hypothèses ont été proposées ; les CNCs pourraient être des éléments régulateurs, 
des éléments structuraux de la chromatine ainsi que des ARNs non-codants ou avoir une autre 
fonction encore inconnue. Quelques études antérieures au séquençage du génome humain 
avaient montré que certaines de ces séquences conservées pouvaient agir en tant que régions 
régulatrices (Koop and Hood 1994; Loots et al. 2000; Oeltjen et al. 1997). 
Les approches prises pour étudier la fonction des CNCs ont donc été principalement  dédiées 
à des analyses de leur potentiel régulateur.  Trois études, correspondant aux trois chapitres, 
sont présentées dans ce manuscrit :  
- Chapitre 1 : Etude du potentiel régulateur d’un groupe de CNCs du chromosome 21 
- Chapitre 2 : Impact de la conservation phylogénique sur le potentiel régulateur des CNCs du 
chromosome 21. 
- Chapitre 3 : Evaluation de la contribution des CNCs dans une maladie monogénique telle 
que le syndrome de BPES. 
 
! Chapitre 1.  
Le but de cette première partie est d’évaluer de façon non biaisée la capacité 
régulatrice des CNCs. Les méthodes que nous avons choisi pour analyser cette fonction 
potentielle sont les suivantes :  
1.- Evaluation de la capacité des séquences conservées à activer ou inhiber la transcription 
d’un gène rapporteur (luciférase). La séquence analysée est clonée en amont d’un promoteur 
minimal et l’effet de la séquence sur le taux d’expression de la luciferase est analysé par 
transfection dans des lignées cellulaires. Septante et une CNCs choisies au hasard ont été 
étudiées dans deux lignées cellulaires : une lignée rénale humaine (293T) et une lignée 
hépatique humaine (Huh7). 
2.- Evaluation de la structure de la chromatine au niveau de ces séquences par digestion 
enzymatique avec l’endonucléase DNAseI (les régions hypersensibles à la DNAseI sont 
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souvent corrélées à des régions régulatrices). Plus de deux cent CNCs ont été analysées dans 
huit différentes lignées cellulaires humaines (GM06990, K562, CaCo2, HepG2, PANC-1, 
HRE, NCIH-460, SKn-SH). 
 
Les résultats obtenus par les deux approches se rejoignent ; le potentiel cis-régulateur des 
CNCs est limité, moins de 20% des CNCs démontrent une activité régulatrice dans notre 
système.  A l’inverse, trois autres groupes de séquences conservées à fort potentiel régulateur 
contenant: i) 21 séquences (TFBS CNCs) pour lesquelles il a été montré que des facteurs de 
transcription pouvaient s’y lier in vivo, ii) 30 séquences (DHS CNCs) qui démontrent une 
hypersensibilité à la DNAseI, iii) 11 séquences conservées décrites dans la littérature comme 
éléments régulateurs, ont été testées dans les mêmes conditions et montrent une proportion de 
CNCs régulatrices plus élevée que si les CNCs sont choisies au hasard (aucun critère de 
sélection, les CNCs peuvent être intergéniques, introniques, dans une région riche ou pauvre 
en gènes).  
 
Finalement l’analyse de séquences non conservées (par luciférase et DNAseI) démontre 
également que la proportion de CNCs régulatrices n’est pas significativement différente de la 
proportion d’éléments conservateurs dans des régions non-conservées. Ceci pourrait suggérer 
que les régions conservées ne sont pas plus riches en éléments régulateurs que des régions 
non-conservées. 
 
! Chapitre 2.  
La littérature sur la fonction de régulation de l’expression des gènes par les CNCs se 
concentre essentiellement sur des séquences extrêmement conservées en terme de phylogénie 
(Pennacchio et al. 2006b; Shin et al. 2005; Woolfe et al. 2005). Les CNCs analysées dans le 
chapitre précédent sont conservées à travers les mammifères ; cependant, aucune d’entre elles 
n’est également présente dans des espèces plus éloignées telles que le poisson. Dans cette 
deuxième partie, l’impact de la conservation phylogénique sur la fonction régulatrice des 
CNCs est analysé.  
 
En 2004, le génome du poulet est séquencé (Hillier et al. 2004). La position intermédiaire, en 
terme de conservation phylogénique (350 millions d’années) de cet organisme par rapport à la 
souris (75 millions d’années) et le poisson (450 millions d’années) en fait un modèle idéal 
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pour évaluer une possible corrélation entre le degré de conservation et le fonction régulatrices 
des CNCs.  
 
L’analyse des CNCs du chromosome 21 humain dans le génome du poulet démontre 
qu’environ 5-6% sont également présentes dans cette espèce. Le potentiel régulateur de 31 de 
ces séquences ainsi que de 19 séquences contrôles (i.e. non conservées) a été évalué in vivo à 
l’aide d’un gène rapporteur (GFP) par éléctroporation dans la rétine du poulet, suivie d’une 
analyse microscopique. Ce tissu a été choisi parce qu’il dérive du système nerveux central et 
qu’il représente un modèle de cellules non-différenciées à des stades précoces du 
développement. Deux stades ont été analysés ; un stade E3 qui ne contient que des cellules 
précurseurs et un stade E6 où les cellules sont distribuées en fonction de leur stade dans le 
cycle cellulaire. Les résultats obtenus dans ce système et avec des CNCs phylogénétiquement 
plus conservées montrent qu’une proportion (40-60%) plus importante de CNCs peut agir en 
tant qu’élément régulateur. Ces résultats ont été confirmés par une deuxième analyse plus 
quantitative, de cytométrie de flux, qui a permis de mesurer le niveau d’expression du gène 
rapporteur et de démontrer que la proportion de séquences conservées activant la transcription 
du GFP est significativement différente de celle des séquences non-conservées. 
Ces résultats suggèrent que le degré de conservation en terme de phylogénie est un des 
facteurs qui pourraient contribuer à la fonction régulatrice des CNCs. 
 
! Chapitre 3.  
La sélection positive observée sur les CNCs implique que leur fonction est essentielle 
pour l’organisme. Un changement dans la séquence de CNCs est donc potentiellement source 
de dysfonctionnement et pourrait contribuer à certaines maladies humaines. Afin de tester 
cette hypothèse, nous avons évalué la contribution potentielle de séquences conservées dans 
le syndrome de Blepharophimosis/ptosis/epicanthus inversus (BPES). BPES est une maladie 
autosomale dominante (MIM110100), qui est causée par des mutations dans le gène FOXL2 
(Crisponi et al. 2001). Toutefois, il a été montré que la maladie pouvait également résulter de 
translocations chromosomiques ou délétions intergéniques autour du locus de FOXL2 (Beysen 
et al. 2005; Crisponi et al. 2004). Ceci pourrait suggérer que ces réarrangements 
chromosomiques interfèrent avec la fonction de certains régulateurs qui agissent à longue 
distance. Un groupe de patients BPES ont été diagnostiqués avec des délétions intergéniques ; 
ceci a permis de définir une région minimale commune appelée SRO (shortest region of 
deletion overlap). Cette région est donc candidate pour des éléments régulateurs de FOXL2.   
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Nous avons étudié 33 patients BPES pour lesquels aucune mutation intragénique, ni 
translocation, ni délétion intergénique n’a été détectée. Onze ADNs de parents ont également 
été inclus dans l’étude. L’analyse comparative de la région de FOXL2 avec son orthologue 
murin a permis d’identifier 25 séquences conservées. Chacune de ces régions a d’abord été 
séquencées pour d’éventuel variants, puis analysées par PCR quantitative pour identifier 
d’éventuelles insertions ou délétions. Le séquençage des CNCs chez les 33 patients et 11 
parents ont permis d’identifier 14 variants nucléotidiques ; parmi eux, seuls 4 changements 
sont spécifique aux patients et pourraient donc être pathogéniques. L’analyse du nombre de 
copies de CNCs a, quant à elle, mis en évidence 7 régions dans lesquelles un réarrangement 
chromosomique pourrait avoir eu lieu. 
Finalement l’analyse in vitro, par gène rapporteur, de 18/25 CNCs et des 4 variants identifiés 
montre i) qu’une seule de ces séquences a une activité régulatrice dans le système utilisé, ii) 
les variants ne modifient pas le profil de régulation des CNCs.  
En conclusion, nos résultats ne permettent pas d’établir un lien direct entre les CNCs de la 
région SRO et le syndrome de BPES. Cependant d’autres analyses (in vivo) sont nécessaire 
avant d’exclure définitivement un rôle de ces CNCs dans la régulation de FOXL2.  
 
Le travail effectué au cours de cette thèse souligne l’importance de certains aspects des CNCs 
et de leurs fonctions. Nos résultats suggèrent que les séquences conservées spécifiques aux 
mammifères ont un potentiel régulateur réduit. Les séquences conservées jusqu’au poulet, à 
l’inverse semblent être majoritairement impliquées dans la régulation de l’expression des 
gènes. Il semblerait donc que toute les CNCs ne soient pas égales dans leurs propriétés 
(conservation par exemple) et que leurs fonctions pourraient être associées à ces différences.  
 
Finalement, des études ont montré récemment que des CNCs pouvaient être à l’origine du 
dysfonctionnement de l’activité d’un gène et causer la maladie (Emison et al. 2005; Lettice et 
al. 2003). La proportion de CNCs impliquées dans des maladies humaines n’est pas connue, 
mais, ceci souligne l’importance des études fonctionnelles sur les CNCs. 
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The release of the Human and Mouse genomes in 2001 and 2002 respectively, had a major 
impact on the comparative genomics field (Lander et al. 2001; Venter et al. 2001; Waterston 
et al. 2002). The passage from interspecies gene mapping / chromosome painting techniques 
to whole genome alignments between different species has given a central role to comparative 
genomics in the deciphering of functional elements in the Human Genome (Boffelli et al. 
2004; Clark 1999; Pennacchio and Rubin 2003). The continuous release of additional genome 
species situated at strategic nodes of evolution, offers new information to pursue more 
detailed functional annotation of vertebrate genomes (Aparicio et al. 2002; Hillier et al. 2004; 
Mikkelsen et al. 2007). 
 
Small-scale comparative analyses had been performed on targeted regions before the 
availability of the full sequence of the human and mouse genomes and had lead to the 
identification of conserved sequences mapping outside of genes (Frazer et al. 2001; Pletcher 
et al. 2001).  
The work discussed in this thesis, is a follow-up of a similar observation made by Dermitzakis 
and colleagues (Dermitzakis et al. 2002) subsequently to the availability of the human and 
mouse genome sequences. The authors took advantage of the accessibility of the full sequence 
of both genomes to perform the first whole chromosome comparative analysis by aligning 
human chromosome 21 (HSA21) to all its mouse syntenic regions on chromosome 10, 16 and 
17 (MMU10, 16 and 17). The initial aim of the comparative analysis was to identify 
conserved functionally transcribed sequences, such as protein-coding genes and non-coding 
RNA (ncRNA). The analysis resulted in the identification of a large number of conserved 
sequences longer than 100bp, with more than 70% hs-mm homology, and with no gaps in the 
alignment. Among the 3491 sequences identified, 1229 overlapped exons, or pseudogenes, 
while surprisingly, the remaining 2262 sequences corresponded to non-coding unannotated 
regions. Further studies on these so-called Conserved Non-Coding sequences (CNCs, 
previously referred to as Conserved Non-Genic sequences; CNGs) have shown that: these are 
single-copy sequences, they do not share any common motif, their distribution is negatively 
correlated to gene density, they have a low transcriptional potential, are conserved in all 
mammals and evolve in a different way than protein-coding genes and ncRNA (Dermitzakis 
et al. 2004; Dermitzakis et al. 2002; Dermitzakis et al. 2003). All these features clearly 
demonstrate that CNCs are not yet unknown genes but probably functional non-coding 
sequences, with putative functions such as gene expression regulation, involvement in 
chromatin structure and packaging, ncRNAs or have a new unknown function. Since CNCs 
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do not share any common motif and thus cannot be subgrouped, they most probably will be 
involved in more than one of the above mentioned biological mechanisms. 
 
The aim of my thesis has been to investigate the putative function of CNCs, and particularly 
their involvement in gene expression regulation. Mainly three questions have been explored 
during the course of the study (a rational is presented for each of these aspects at the 
beginning of each chapter):  
 
 ! What is the regulatory potential of randomly chosen HSA21q CNCs? (chapter I)  
! What is the impact of phylogenetic conservation on the regulatory potential of HSA21q 
CNCs? (chapter II) 
 ! Do pathogenic mutations in CNCs contribute to a monogenic disorder such as BPES?  
         (chapter III) 
 
Each three aspects have resulted in challenging results, and generated new hypotheses. Our 
results are discussed in the context of other recent studies. 
 
! The regulatory potential of randomly chosen HSA21q CNCs 
 Conserved sequences mapping to HSA21q do not differ substantially from other CNCs. 
We chose to specifically concentrate our attention on these CNCs because of: i) the expertise 
and interest of our laboratory on chromosome 21, ii) HSA21q is one of the best annotated 
human chromosomes and an average human chromosome in terms of gene density and GC 
content (Lander et al. 2001; Venter et al. 2001).  
A few studies had previously reported the overlap of conserved sequences with regulatory 
elements even before the release of the human genome (Frazer et al. 2001; Gottgens et al. 
2000; Koop and Hood 1994; Loots et al. 2000; Oeltjen et al. 1997). We decided to further 
explore this regulatory potential for a subset of HSA21q CNCs. The main difficulty about 
investigating the functions of conserved sequences resides in their large number; a systematic 
study of CNCs requires the design of ‘high throughput’ experiments. We choose two 
approaches to evaluate their cis-regulatory potential:  
i) A luciferase reporter gene assay in which the conserved sequence is tested for its 
ability to drive the expression of the reporter gene in human cell lines.  
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ii) A DNAseI hypersensitivity (DH) assay that assesses the state of the chromatin. 
DH sites (DHS) are regions in open chromatin conformation that have been 
strongly correlated to regulatory elements (Gross and Garrard 1988).  
Both screens were performed in a panel of human cell lines; the use of cells over animal 
models has the advantage to allow for rapid and large screens. Although some concern might 
arise from the use of cells, a large number of studies have now confirm their informativity for 
annotation of functional elements in the human genome (Consortium 2007), further studies 
have demonstrated good consistency of the results obtained in vitro compared to in vivo (Shin 
et al. 2005; Wang et al. 2007).  
 In the first chapter we demonstrate that the investigation of the regulatory potential of a 
set of randomly chosen HSA21q CNCs (n"71) by classical enhancer/silencer assays 
(luciferase, DNAseI hypersensitivity) in human cell lines (n#8), has resulted in a low 
percentage (<20%) of CNCs demonstrating cis-regulatory activity. In addition, the testing of 
single-copy non-conserved sequences (n=21) along with CNCs strongly suggests that 
conserved regions are not enriched in regulatory elements compared to non-conserved 
sequences, both groups exhibit a comparable potential to gene expression regulation.  
These results stand in stark contrast with previous reported observations (Pennacchio et al. 
2006; Shin et al. 2005; Woolfe et al. 2005) and re-question the current ‘conservation – 
regulation’ hypothesis that seems to dominate the comparative field.  
  
! The impact of phylogenetic conservation on the regulatory potential of HSA21q CNCs 
 In order to gain insights into this new facet of the project, we decided to further 
investigate the impact of phylogenetic conservation on the potential regulatory function of 
conserved sequences. It is in fact currently widely accepted that human-fugu conserved 
sequences are mostly developmental regulators (Pennacchio et al. 2006; Woolfe et al. 2005), 
but it is unknown if the high proportion of detected functional CNCs is specific to the 
450Mya separating human to fish, or if an intermediate genome as the chicken (350Mya) 
would provide enough phylogenetic distance to identify CNCs with similar functional 
properties. 
The sequencing of the chicken genome in 2004 (Hillier et al. 2004), allowed us to determine 
the fraction of HSA21q CNCs that were conserved between human and chicken; 
approximately 5-6% of HSA21q-mouse CNCs were also found to be conserved in the chicken 
genome. To assess the impact of deeper phylogenetic conservation on the regulatory potential 
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of conserved sequences, we performed in vivo reporter assays on a subset of HSA21q CNCs 
in the chick retina. Two embryonic stages were investigated, day 3 of embryonic stage (E3) 
and day 6 (E6). In addition to providing a more in vivo model than cell lines, the retina at this 
stages give the opportunity to evaluate a putative function of CNCs in non-differentiated cells 
(E3) and cells starting to be committed (E6).  
The preliminary results we have obtained on 31 CNCs and 19 single-copy non-conserved 
control sequences show that a significant proportion (approximately 40-60%) of CNCs are 
now able to activate transcription, whereas only a minority of non-conserved sequence can. 
These observations strongly suggest that phylogenetic conservation might help in defining 
specific functions for CNCs; deeply conserved sequences would mainly act as developmental 
regulators, while mammalian CNCs would have a yet-unknown roles.  
 
! Pathogenic mutations in CNCs and the BPES monogenic disorder 
 Finally, if evolutionary conservation of CNCs is of functional importance, it is expected 
that CNCs nucleotide variants could result in human pathogenic processes. At the time this 
work was started no such observation had been reported in the literature. We thus took 
advantage of a collaborative project to investigate the contribution of CNCs in the 
blepharophimosis / ptosis / epicanthus inversus Syndrome (BPES), an autosomal dominant 
monogenic disorder (MIM110100). It had been previously reported that a minimal 126kb 
intergenic deletion downstream to the causative gene (FOXL2) could cause the disease 
(Beysen et al. 2005); this region contains a number of CNCs, and we thus decided to 
investigate the contribution of CNCs present in this minimal region in BPES patients negative 
for FOXL2 mutations as well as negative for gross chromosomal rearrangements 
(translocation and intergenic deletions). CNCs sequencing in 33 patients resulted in the 
identification of 14 nucleotide variants among which 4 could be pathogenic, however, only 
one of the putative causative nucleotide substitution mapped to a highly conserved nucleotide. 
CNCs copy-number analysis was also perform to investigate insertions/deletions that could be 
associated to the disease; 9 patients present putative chromosomal abnormalities, however 
further validation experiments would be required to confirm the observation and link these 
variations to BPES. Finally, we tested the putative regulatory activity of 18/25 CNCs with 
luciferase reporter assay in cells; only one conserved sequence exhibits regulatory potential in 
the cell lines analysed. In conclusion, our results could not yet establish a role of CNCs in the 
regulation of the FOXL2 gene. Additional experiments (such as in vivo studies), however, 
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would be required before definitively excluding any link of CNCs variants and the 
pathogenesis of the disease.  
Although our analysis has been unsuccessful in demonstrating the putative involvement of 
CNCs in BPES, several studies have now been able to associate CNC variants to disease 
occurrence, underlying the importance of studying them further (Emison et al. 2005; Lettice 
et al. 2003). 
 
 
The work accomplished during the course of my thesis underscores certain aspects in the field 
of conserved non-coding sequences. It suggests that all CNCs are not equal (degree and 
phylogenetic conservation, nucleotide sequences composition, genomic context, etc.), and that 
their function might in the future be successfully associated to these differences. As 
demonstrated by our results, features such as phylogenetic conservation or genomic 
environment seem to contribute to the definition of several classes of CNCs and thus several 
types of functions. In this view, a unique common function of CNCs in the field of 
comparative genomics might not be appropriate, rather we predict that each ‘subclass’ of 
CNCs will have different biological properties. New strategies and new tools would be 
necessary either to further explore the regulatory activity of some CNCs or to investigate new 
putative functions in particular classes of conserved sequences.  
Currently we do not know the fraction of regulatory CNCs that might be involved in disease 
occurrence neither do we know how non-regulatory CNCs would be related to disease, both 
aspects necessitate further studies to explore the elusive world of evolutionarily conserved 
sequences 
 
 
In addition to the main thesis project, I have been involved in a previously ongoing project 
with Dr. Bernard Conrad. The project was focusing on the mechanism of transcriptional 
interferences. Transcriptional interference had been shown to affect in a negative way the 
transcription of promoters adjacent one to each others (Conte et al. 2002; Ward and Murray 
1979). In our study we have shown, using the HERV-K18 model (human LTR transposon), 
that transcriptional interference can also act positively, thus probably increasing transcriptome 
diversity and complexity (Leupin et al. 2005). The details and results of the study are 
provided in the appendix section but will not be discussed anywhere else in the thesis.    
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I. COMPARATIVE GENOMICS 
 
Comparative genomics is the analysis and comparison of different species’ genomes 
and thus relies mainly on the availability of these. Comparative analyses take advantage of the 
evolutionary properties of the DNA sequences to identify functional elements and to 
understand evolutionary processes. In other words, the analysis and comparison of the DNA 
sequence of different species allows the identification of similarities and differences between 
genomes that are expected to contribute to their annotation and to the understanding of their 
evolutionary history.  
 
 
I.1. Pre- Human Genome era 
 
Comparative genomics experienced a burst of activity after the sequencing of the first 
vertebrate genomes (Lander et al. 2001; Waterston et al. 2002b), however, many previous 
studies aiming to compare the genomes of species had been performed before the large-scale 
sequencing projects were completed. Techniques such as chromosome painting (Scherthan et 
al. 1994) had been used to map karyotypic changes during the evolution of mammals and to 
assess the conservation of syntenic groups between various species; conserved blocks of DNA 
in species as distant as human and fin whales, for example, where identified (Scherthan et al. 
1994; Wienberg and Stanyon 1995).  The main limitation of these FISH-based approaches is 
the limited resolution they provide; genomic regions whose integrity has been maintained 
during evolution can be identified however no detailed information of gene order and content 
could be obtained. This led to the development of parallel techniques such as gene mapping 
(O'Brien et al. 1999), and sequencing of targeted regions of genomes where BAC clones were 
available.  
The initial aim of comparing orthologous sequences in different species was mainly to 
identify new genes or orthologous genes in the Human Genome. The few studies that 
performed targeted BAC sequencing of orthologous regions, revealed that conservation was 
also detected outside coding regions and that these were often overlapping previously known 
regulatory elements (Duret and Bucher 1997; Gottgens et al. 2000; Gottgens et al. 1997; 
Hardison et al. 1997; Koop and Hood 1994; Loots et al. 2000; Oeltjen et al. 1997; Pennacchio 
and Rubin 2001). This suggested that at least a fraction of intergenic DNA might be 
functional. The putative functional importance of these sequences was further suggested by 
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their presence in some human-fugu alignments, thus extending their conservation to about 
450Mya (Aparicio et al. 1995; Miles et al. 1998). 
 
 
I.2. The Human Genome Project (HGP) and the post-genome era  
 
In 1988, the National Research Council voted the launching of the Human Genome 
Project (HGP). The sequencing of the full sequence of the HG was expected by the scientific 
community to contribute to i) the establishment of a complete gene/protein catalogue, ii) the 
understanding of the gene organisation along the chromosomes, iii) provide the basis for 
sequence variations studies in human population (SNPs) that will then contribute to 
understanding human population history, and iv) finally also with the expectation that the 
human genome will provide a reference genome for large-scale comparative analyses that 
would help identifying regulatory conserved sequences mapping to gene neighbourhood 
(Clark 1999; Hardison et al. 1997; Lander et al. 2001; Olson 1993). 
In 2001, the first draft of the Human Genome was released, and although it provided a vast 
amount of information it underscored the requirement of the sequencing of additional 
mammalian and other genomes in order to obtain a comprehensive map of the different 
features and elements composing it.  
 
The release of the Mouse genome in 2002 (Waterston et al. 2002b), allowed the first whole 
genome comparative analysis at the nucleotide level to be performed. The observations 
resulting from this analysis emphasized the power and expectations of the comparative 
genomics approach as a tool for genome annotation and for studying the evolutionary history 
of genomes, by showing for example that about 5% of the genome is under purifying 
selection, meaning mutations in these regions would most probably be deleterious and are 
thus removed from population.  Since protein coding genes contribute to only 1.5% of this 
conservation it suggests that the remaining 3.5% might arise from yet unidentified but most 
likely functional elements. In addition human-mouse comparison has shown that : i) more 
than 90% of both genomes have a corresponding syntenic region, ii) more than 40% of the 
human genome can align at the nucleotide level to that of the mouse one and iii) conservation 
in known regulatory regions although less than in coding sequences is higher than expected 
under neutral evolution.  
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In addition to these new informations, the comparison of the human and mouse whole 
genomes also revealed important considerations for comparative analyses in general. For 
example, inferring the neutral substitution rate of mouse and human highlighted a correlation 
with the generation time (mouse 0.34 and human 0.17 substitutions per site (Waterston et al. 
2002b) and suggested that comparison of two species with short generation time will identify 
a different set of conserved sequences than when less fast-evolving species are aligned. 
Human-mouse comparison has shown also that the mammalian genome has evolved at a non-
uniform rate, with certain regions displaying higher or lower substitution rates than average 
(Gottgens et al. 2001; Hood et al. 1995; Jimenez et al. 1992; Pennacchio and Rubin 2001; 
Waterston et al. 2002b). This then is important for comparative genomics as the strength of 
conservation must always be considered in relation to the background levels of neutral 
substitution for a particular region (Pennacchio and Rubin 2001).  
 
Figure 1. Phylogenetic tree of Mammals. Red arrows points to some of the main nodes that are questioned 
with the some of the released sequenced genomes. Divergence date from the Human is indicated too. 
Reproduced from Nikolaev et al .(Nikolaev et al. 2007). 
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Over the last few years the sequences of genomes positioned at strategic nodes of evolution 
have been completed; for example the Chicken genome, in 2004, with a common ancestor  
with Human 350Mya ago, the Fugu genome, in 2005, which diverged about 450Mya ago, and 
the Opossum genome in 2007, that is distant of about 200Mya (figure 1). 
 
Interesting observations related to the fraction of conserved regions were further highlighted 
by the release of these new genomes. For example, the sequence of the first non-mammalian 
amniote showed that the higher rate of nucleotide substitution between the human and 
chicken resulted in a reduced portion (2.5%) of the genome under purifying selection between 
these two species compared to human-mouse (5%) (Hillier et al. 2004). The distribution of 
these conserved sequences is higher in non-coding regions (Dermitzakis et al. 2002b) since 
44% are in coding genes and 25% and 31% are in intronic and intergenic regions respectively. 
In addition, comparative analysis with the chicken genome demonstrates that only 30-40% of 
known human-mouse regulatory regions are conserved in the chicken, those are mainly 
associated to development and metabolism genes. This observation raises the question of the 
role of the remaining part of the conserved sequences, especially since they show a 
preferential location to gene poor parts of the genome. 
The recent release of the Opossum genome (Mikkelsen et al. 2007) shows that 99% of the 
conserved sequences identified in the chicken are also found in the Opossum. Strikingly 
however, it reveals that 20% of the CNCs found by eutherian-restricted comparisons are 
absent from sister groups like marsupials (opossum) and aves (chicken). Intriguingly, most of 
these eutherian-specific CNCs seem to be correlated to developmental genes which could 
suggest that modifications of regulatory networks have been a major force in the evolution of 
animal diversity (figure 2).  
  
 
 
Figure 2. Acquisition of new CNCs near developmental genes. Densities of CNCs along HSA3 is plotted in a 
1Mb window. Blue line depicts CNCs found in the Opossum, red line show CNCs specific to eutherians. Peaks 
in the distribution often correlates with developmental genes. Reproduced from Mikkelsen et al. (Consortium 
2007; Mikkelsen et al. 2007) 
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I.3. Outcomes of comparative analysis  
 
The outcome of all the comparative studies to date led to one simple and firm 
conclusion: there are many more functional sequences in the human genome than we 
currently know and it is now necessary to couple the computational sequence analysis efforts 
with experimental procedures to understand what the genome consists of (Consortium 2007; 
Paabo 2003).  
Comparative analysis has exposed a high conservation level between human and other 
species. Among the conserved sequences contributing to it, new genes or gene families have 
been identified (Dehal et al. 2001; Nekrutenko et al. 2003; Pennacchio et al. 2001) but an 
unexpected high fraction of conserved sequences seems to be non-coding and have no 
previous available annotation. Many of these conserved sequences might act as regulatory 
elements that determine the spatial and temporal expression of genes (Dermitzakis and Clark 
2002; Elnitski et al. 2003; Hardison 2000), while others might encode ncRNA or be structural 
elements.  The functional analysis of these sequences will improve our understanding of the 
functional elements of the genome and highlight common species mechanisms or species-
specific pathways (Dorus et al. 2004; Pollard et al. 2006) that will help understanding the 
phenotypic, morphological and behavioural similarities and differences between species.  
 
 
II. CONSERVED NON-CODING  SEQUENCES (CNCS) 
 
As discussed above, the sequencing of genomes from multiple species has opened the 
way to comparative sequence analysis and provides new tools for deciphering genome 
function. The comparison of the human and mouse genomes has shown that approximately 
5% of the Human Genome (HG) is under selective constraint (Lander et al. 2001). Protein-
coding genes contribute to this purifying selection with about ~1.5%, the remaining ~3.5% 
must then be conserved owing to the non-coding fraction of the genome (Waterston et al. 
2002b). Interestingly, prior to the release of the HG, analyses on specific loci had already 
revealed the existence of some conserved sequences (Hardison et al. 1993; Koop and Hood 
1994; Miles et al. 1998; Oeltjen et al. 1997; Pennacchio et al. 2001; Tagle et al. 1988). In 
some cases, these sequences were shown to overlap or behave as regulatory elements 
(Aparicio et al. 1995; Gottgens et al. 2000; Koop and Hood 1994; Lecine et al. 1996; Loots et 
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al. 2000; Oeltjen et al. 1997; Pennacchio et al. 2001) (Gottgens et al. 2002). The occurrence 
of these conserved non-coding sequences in the HG was further demonstrated by large scale 
comparative analyses; for example, the comparison of the entire human chromosome 21 
sequence with its mouse syntenic regions led to the identification of more than 2260 CNCs 
(Dermitzakis et al. 2002b) whereas subsequent whole genome comparisons revealed the 
existence of more than 327’000 (Dermitzakis et al. 2005) to 700’000 CNCs (Bejerano et al. 
2004a). 
 
Conserved Non-Coding sequences (CNCs) are DNA sequences that are under purifying 
selection. The length of the sequences and their conservation strength (percentage identity and 
phylogenetic extend) vary according to the method used to detect them (discussed in the 
“computational approach” section). 
 
 
II.1. Computational strategies for CNCs detection 
 
Initial strategies for comparative analyses relied on simple pairwise comparisons of 
orthologuous regions of the human and mouse genomes. Classical criteria applied to detect 
conserved sequences were the following ones: minimum length of 100bp, 70% minimum 
homology between the species, and no gaps (figure 3) (Dermitzakis et al. 2002b; Nobrega et 
al. 2003). Although these criteria seem arbitrary they are above the level of neutral 
substitution between the human and mouse, and they had been shown to be informative for 
the identification of functional sequences in previous pairwise comparisons (DeSilva et al. 
2002; Duret and Bucher 1997; Loots et al. 2000).  
 
Following the release of new draft genomes, novel whole-genome pairwise comparisons such 
as human-teleost fish (Fugu) or human-cartilaginous fish (elephant shark) were also shown to 
be successful at detecting more deeply conserved non-coding sequences (Miles et al. 1998; 
Venkatesh et al. 2006; Woolfe et al. 2005).Whole-genome pairwise comparison have recently 
also been used to explore conserved non-coding sequences in non-vertebrates organisms such 
as worms and insects (Glazov et al. 2005; Vavouri et al. 2007). 
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Figure 3. Pairwise alignment.  Top panel: Example of human-mouse pairwise alignment using the Pipmaker 
Browser (http://pipmaker.bx.psu.edu/pipmaker/). Dot denotes conservation above 50%; pink boxes highlight 
regions of "100bp, "70% identity. Bottom panel: example of conserved sequence pairwise alignment.  
 
In conclusion several studies rely on pairwise comparison for the detection of putative 
functional conserved sequences. Pairwise alignments however, have a number of limitations 
for the identification of conserved sequences. For example, their efficiency to recognize 
conserved sequences is dependent on the separation time from the last common ancestor of 
the two species. Too closely related species might result in a signal-to-noise ratio too low to 
be specific for purifying selection, and too distant species might result in the identification of 
sequences involved exclusively in ancient pathways (figure 4).  
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Figure 4. Comparative genomics limitations. (A) Human-mouse comparison detects a high amount of 
conserved sequences (strong sensitivity), however the functional relevance of these sequences seem to be less 
evident (low specificity). On the other hand, human-fugu comparison results in the identification of a reduced 
number of conserved sequences (low sensitivity) that, however, have strong functional evidences (strong 
specificity). (B) Known heart enhancers and their phylogenetic conservation. This panel illustrates first that deep 
phylogenetic conservation does not detect all functional conserved sequences, and second that the choice of the 
aligned species, in the case of MCS detection for example, is critical. Reproduced from Visel et al. 2007 (Visel 
et al. 2007) 
 
The progressive release of new genomes and the specific sequencing of orthologuous regions 
in a high number of species drove the development of several new computational approaches 
to identify conserved sequences (Boffelli et al. 2003; Boffelli et al. 2004b; Cooper et al. 2005; 
Margulies et al. 2003; Thomas et al. 2003). Simple pairwise comparisons evolved into 
sophisticated algorithms that take into consideration factors such as phylogenetic distance 
between species, general variation in the sequence conservation, rate of neutral substitution, 
etc. Importantly, different programs give different weight to these factors; the set of retrieved 
conserved sequences might thus vary substantially (Couronne et al. 2003); for example 
human-mouse pairwise comparison detected 327’000 CNCs (Dermitzakis et al. 2005) and 
human-mouse-rat multialignement resulted in 700’000 CNCs (Bejerano et al. 2004). The 
application of a particular approach might also differ depending on factors such as the number 
of species analysed, their phylogenetic relationships and more simply depending on the aim of 
the analysis. As examples of such variations, an overview of selected recently-developed 
approaches are discussed below: 
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! Multi-species Conserved Sequences (MCS) (Margulies et al. 2003; Thomas et al. 2003) 
 Multi-species alignments have been developed to overcome the limitation of pairwise 
comparisons; as discussed previously the choice of the species in a simple pairwise alignment 
is critical (Portnoy et al. 2005). The MCS approach relies on two methods; the binomial-based 
and the parsimony-based methods. Essentially the first approach scores the conservation in 
relation to the contributing species, i.e. a conserved nucleotide will have more weight if it is 
conserved through more distantly related species than if it is specific to more closely-related 
species (takes into account the phylogenetic distance). The second method reflects the 
minimal number of substitutions needed along the branches of a given phylogenetic tree to 
explain the observed conservation level (takes into account the neutral substitution rate). 
In terms of application, multi-species alignments favour the identification of sequences that 
have been under constraint in all the studied species, changing the combination of species 
might then results in the identification of MCS with different properties (Boffelli et al. 
2004a). For example, including primates seems not to improve the detection of MCS, while 
including rodents seems to results in detection of greater number of MCS without biased 
towards conserved coding regions as observed when including fish and to a lesser extend 
chicken (Margulies et al. 2003; Thomas et al. 2003). The preferential detection of MCS 
conserved in all species will also result in a loss of detection of sequences that would have 
changed function in one or the other lineage (figure 4B).  
 
! Phylogenetic Shadowing of Primates (Boffelli et al. 2003) 
 Phylogenetic Shadowing has been developed to compare closely related species by 
making use of the branch lengths of the phylogeny, allowing for multiple substitutions per site 
on single branches of the tree and considering the pattern of substitutions. The method thus 
take into account the phylogenetic relationship of the species compared by giving more power 
to substitutions occuring in closely related species than in distant ones. In terms of application 
Phylogenetic Shadowing is used to differentiate sequences conserved due to insufficient time 
of divergence (mutations have not had enough time to accumulate) or due to specific 
purifying selection. The efficacy of the method had been partially proven with the comparison 
and the successful identification of conserved primate-specific regulatory sequence of the 
apolipoprotein locus using apes (6-14Mya), Old World Monkeys (25Mya), New World 
Monkeys (40Mya) and human sequences. Recently, further support has been provided by the 
analysis of eight additional loci in one human, six primates and one lemur (Wang et al. 2007). 
In this case, six primate-specific conserved sequences were identified using a new algorithm 
 42
named Gumby (Prabhakar et al. 2006). Experimental analyses confirmed that 50% of the 
detected conserved sequences are functional. Importantly, in the two studies the primate-
specific functional conserved sequences would have been missed by alignment with more 
distantly related species (mouse for example). 
 
! Genomic Evolutionary Rate Profiling (GERP) (Cooper et al. 2005) 
 Regions under purifying selection show a reduce rate of substitution compared to 
neutrally evolving regions. The principle of the GERP strategy is to find constraint regions by 
estimating the degree of purifying selection on each base of the alignment compared to the 
neutral substitution rates related to the species under consideration. The main particularity of 
this approach is that conserved regions selected in this way depend on the force of the 
selective pressure rather than on the degree of phylogenetic conservation.  
 
! PhastCons (Siepel et al. 2005) 
 This new program is designed to identify conserved elements in multiple aligned 
sequences. Similar to MCS method, PhastCons considers the phylogenetic relationship 
between the species studied but in addition it implements a statistical model that considers 
both the process by which nucleotide substitutions occur at each site in a genome and how 
this process changes from one site to the next.  
The original paper presents the detection of Highly Conserved Elements (HCE) for 
vertebrates (5 species studied), insects (4 species), Caenorhabditis (2 species) and 
Saccharomyces (7 species). The average length of the predicted conserved sequences is about 
100-200bp for all groups except worms were the elements are slightly longer (270bp). In all 
species however their length ranges from 5bp to thousands of baisepairs. Other features of 
HCE diverge depending on the species aligned, for example 93% of insects, worms and yeast 
HCE correspond to exons, while 42% do in the vertebrates. The remaining portion of 
conserved sequences in vertebrates map to 3’UTRs and gene deserts. Interestingly, there 
seems to be an association between specific features of the conserved sequences and their 
putative functions, thus the longer HCEs map to the 3’UTRs and could suggest a role in post-
transcriptional regulation (for example miRNA binding regions). 
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! Gumby (Prabhakar et al. 2006) 
 Gumby is a recently developped computational approach that detects conserved non-
coding sequences in alignements of phylogenetically close or distant species and of any size. 
Interestingly, for each alignement Gumby provides a P-value that allows the ranking of CNCs 
from extremely conserved to more shallow conservation. The comparisons of human-mouse-
rat / human-mouse-chicken / human-mouse-frog and human-mouse-fish CNCs, resulted in 
two main conclusions: i) the size of the conserved sequences decreases with evolutionary 
distance, ii) the longest and more conserved (based on the P-value) sequences are also 
conserved in more distant species. In term of probabilites, for example, the most conserved 
human-rodent CNCs have 86% of chance to be conserved in the chicken, while the lowest 
conserved ones have less than 4%.   
In term of application, the method has been developed to assess the merits of phylogenetic 
conservation in the identification of functional elements; for example human-rodent 
extremely conserved sequences were overlapped with previously known enhancers, or 
assayed by LacZ mice transgenesis in comparison to human-fish CNCs. The results obtained 
by Prabhakar and colleagues suggest that close conservation is sufficient to identify human 
regulatory elements and that comparison of more distantly related species results in a loss of 
sensitivity.   
 
! Intraspecies comparisons (Boffelli et al. 2004b) 
 Currently, most of the methods developed for CNCs detection are based on multispecies 
comparisons. Recently, however, functional conserved sequences have successfully been 
identified by intraspecies comparisons too. The work of Boffelli et al. (Boffelli et al. 2004b) 
on the sea squirt Ciona intestinalis demonstrated that intraspecies comparisons can be use to 
detect functional DNA elements responsible for biological traits that are unique to the species. 
The strategy however is limited since it requires a high rate of allelic polymorphism in the 
specie investigated or the collection of a large sample of members of the species. C. 
intestinalis has a high rate of intraspecies sequence polymorphism, consequently, 30 
individuals were sufficient to determine the rate of mutations of targeted regions and identify 
the low mutations rate regions that mark putative functional conserved sequences. 
Experimental analyses of these slow evolving regions confirm their functional role.  
Similar analyses in humans will require few thousands of individuals due to the complexity of 
the human population, its dynamic and haplotype structure.  
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As pointed out previously, each approach has its own particularities and thus results in the 
identification of specific set of conserved sequences. Although there is probably a substantial 
overlap in the sequences identified (for the multispecies comparisons), it is important to keep 
in mind the features of the detection method used as it might, in the future, help defining 
specific functional groups within CNCs. An example to support this idea is provided by 
studies on human-fish conserved sequences that seem to correlate the phylogenetic 
conservation with regulatory elements implicated in development (Nobrega et al. 2003; Shin 
et al. 2005; Woolfe et al. 2005). It will be interesting to see if functional analyses on the 
different types of conserved sequences will reveal specific functional categories. 
 
II.2. Conserved sequences, subfamilies 
 
Evolutionarily conserved sequences, as discussed in the previous section, have been identified 
in various ways. This has generated a large number of acronyms for conserved sequences; in 
some cases different names designate similar conserved sequences (in terms of number and 
type of species compared, minimal length of the sequence, minimal percentage of identity, 
etc.), while for others it defines a very specific ‘group’ of elements. Because it seems that all 
conserved sequences are not identical in their properties and in their putative functions, the 
principal ‘terminology’ will be presented in this section.  
 
! Conserved Non-Coding sequences (CNCs)   
 Conserved Non-Coding sequences in the literature is a widespread term that mainly 
designates evolutionarily conserved sequences that are "70-100bp and share "70% homology 
between the species investigated (figure 5). Most of the comparisons to identify them are 
based on an initial pairwise human-mouse alignment of the region of interest, to which 
additional species might be added (mostly other mammals) (Dermitzakis et al. 2002b; Frazer 
et al. 2004; Liu and Francke 2006; Loots et al. 2000; Nobrega et al. 2003; Nobrega et al. 
2004). Other acronyms related to similar kind of conserved sequences are: CNG (Conserved 
Non-Genic sequences) (Dermitzakis et al. 2002b; Dubchak et al. 2000), CNSs (Conserved 
Non-coding Sequences) (Baroukh et al. 2005; Dubchak et al. 2000), ECRs (Evolutionarily 
Conserved Regions) (Loots et al. 2005), etc. 
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Figure 5. Conserved Sequences. Examples of two conserved sequences alignment among mammals, these 
examples illustrate the different ‘patterns’ of conservation observed (A) Strong conservation along the whole 
sequence, among all species. (B) More variability is observed among the conserved sequences, but some 
domains seem to be under stronger purifying selection and might denote the functional domains.  
 
CNCs are single-copy sequences which main properties are: i) preferential mapping to gene 
poor regions (Dermitzakis et al. 2002b), ii) low transcriptional potential (Dermitzakis et al. 
2002b), iii) conservation in all mammals (Dermitzakis et al. 2003b). In addition their pattern 
of substitutions support that they are under stronger purifying selection than protein coding 
genes or ncRNA and highlight some clustering of substitutions that could define functional 
domains (Dermitzakis et al. 2003b). Finally no correlation is observed between their length 
and their distance from genes, this is also true for the degree of constraint and genomic 
distribution (Dermitzakis et al. 2004; Mural et al. 2002).   
 
Given that CNCs and especially HSA21q CNCs are at the centre of this work, all these 
properties are detailed in the “HSA21q CNCs” introductory chapter.  
 
! UltraConserved elements (UCs) (Bejerano et al. 2004c) 
Ultraconserved elements have been defined as sequences conserved in human, mouse 
and rat and that align over " 200bp and share 100% homology between the three species (no 
insertion or deletion are allowed). Following these criteria, 481 UC elements have been 
mapped on the Human Genome, interestingly UCs are absent from two chromosomes; 
HSA21 and HSAY (figure 6). Further exploration of UCs has shown that almost all (97-99%) 
of them align in chicken and dog, and a high proportion (67%) are also found in the fish 
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genome. The quality of the alignment is extremely high since it approaches 100% in chicken 
and dog, and 76% for the fish. The extreme conservation of UC suggests that they have been 
under strong purifying selection for around 450Mya. In addition some UCs seem to originate 
from transposition events (Bejerano et al. 2006; Nishihara et al. 2006). 
Ultraconserved elements falls into three main categories: i) exonic UC; 111/481 UC overlap 
protein coding genes, ii) non-exonic UC; 256/481 present no evidence of transcription and iii) 
possibly exonic; evidence of transcription is not conclusive for 114/481. Interestingly exonic 
UC and non-exonic UC are associated to different genes families, the first are enriched for 
RNA binding and regulation of splicing genes while the second are enriched for 
developmental, transcription regulation and DNA binding genes.  
 
Recently, non-vertebrate Ultraconserved sequences have been identified by comparative 
analysis between Drosophila melanogaster, Drosophila pseudoobscura and Anopheles 
gambiae. In this case, UCs are identical non-gapped matches that are at least 50bp long. 
Overall their phylogenetic conservation is almost similar to the vertebrates UCs, since the last 
common ancestor between all three species is around 330Mya (Glazov et al. 2005).  
  
In addition to the original study, a few other papers have referred to Ultraconserved elements 
although with somewhat different criteria with respect to the original report; for example 
Sandelin et al. reported the identification of 3583 Ultraconserved regions identified by 
human-mouse comparison (at least 50bp long and 95% homology) intersected with human-
fugu conserved sequences  (Lareau et al. 2007; Sandelin et al. 2004).  
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Figure 6. Mapping of the 481 UC in the human genome. Exonic elements are depicted as thin blue bar above 
the chromosome, non-exonic element are shown as thin green bars below the chromosome and possibly exonic 
are shown as black bars centered on the chromosome. Chromosome centromeres are represented by purple 
boxes. 89 clusters of UC (mapping within less than 675kb from each others) have been identified, there are all 
boxed and named correspondingly to the prominent gene or gene family located nearby. Interestingly, non-
exonic elements exhibit a significant enrichment for developmental genes; this could suggest non-exonic UC 
might act as long range enhancer for these genes. Reproduced from Bejerano et al. (Bejerano et al. 2004c) 
 
! highly Conserved Non-coding Elements (CNEs) (Woolfe et al. 2005) 
CNEs refer specifically to human-fugu conserved sequences (Abbasi et al. 2007; 
Woolfe et al. 2005). Whole-genome human-fugu alignment resulted in the identification of 
1373 highly conserved non-coding elements ranging from 93 to 740bp with an average mean 
of conservation of 84%. These highly Conserved Non-coding Elements are usually found in 
clusters, with the vast majority of them (93%) lying within 500kb of genes mainly involved in 
transcriptional regulation and development (figure 7). These results are consistent with the 
previous report of clustering of highly conserved sequences near developmental genes and 
might suggest a specific role for this class of conserved sequences (Sandelin et al. 2004)  
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Figure 7. CNE mapping in the human genome. CNEs locate preferentially near genes involved in 
transcription regulation and development (trans-dev genes). This scheme highlights all trans-dev genes that are 
within 500kb of CNE clusters. Each CNE cluster is represented by a green arrow head. Gene names in bold 
script indicate gene lying next to cluster of "10CNEs. Reproduced from Woolfe et al. (Woolfe et al. 2005) 
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CNEs are also enriched in A+T content compared to the region where they are located, with 
their flanking regions exhibiting a marked drop of AT content (Walter et al. 2005). The higher 
A+T content of the CNEs could favour a structural role (like Matrix Attached Regions, 
MARs), interestingly however ‘enhancer’ assays in zebrafish have shown that 23/25 of the 
tested sequences could drive tissue specific transcription of a reporter gene. 
 
As for the UC elements, CNEs are conserved in additional genomes (mouse, rat, chicken and 
zebrafish) and are absent from HSA21 and HSAY. Interestingly, despite the existing 
similarities shared by UCs and CNEs only 42% (109/256) of the non-coding UC elements 
overlap with CNEs. 
 
Related to CNEs are the Non-Coding Evolutionarily Conserved Regions (NCECRs) that have 
been identified by Human-Zebrafish alignments, and that show an important overlap with 
CNEs (Shin et al. 2005). 
 
Similarly to UCs, a class of non-vertebrates CNE has been reported recently in nematodes 
(Vavouri et al. 2007). Comparison of the Caenorhabditis elegans and Caenorhabditis 
briggsae (divergence time, 80-100Mya) resulted in the identification of 3061 elements of at 
least 30bp (without gap) named worm CNEs (wCNEs). Surprisingly, although wCNE are 
shorter than their vertebrate homologues the distribution of intergenic wCNEs in the genome 
is similar in terms of A+T content defining their boundaries and in terms of preferential 
association to developmental genes. This last observation prompted the authors to suggest that 
vertebrate and non-vertebrate CNEs evolved in parallel to regulate the expression of a core set 
of regulatory genes that they suppose could define animal body plan.  
Intronic wCNE, mostly map within the 1st alternative exon of alternatively splice forms, this 
could favour a cis-regulatory role on the alternative form (figure 8).  
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Figure 8. Significant wCNEs mapping to 1st alternative exons and known enhancers. Schematic of the ser-2 
gene and its alternative forms in C.elegans. Strikingly all wCNEs mapping to the ser-2 locus overlap previously 
characterized enhancers, and when located into introns a significant localization to alternative transcription start 
sites is observed.  wCNE are shown as red boxes. Yellow boxes depict previously known enhancer, with tissue 
specific activity. Reproduced from Vavouri et al. (Vavouri et al. 2007) 
 
! Ancient Noncoding elements (Venkatesh et al. 2006) 
The common ancestor between cartilaginous fish and humans has been placed about 
530Mya ago. The draft sequence of the elephant shark (Venkatesh et al. 2007) was aligned to 
the human sequence and resulted in the identification of 4782 conserved sequences associated 
to more than 1000 genes mostly involved in transcription, DNA binding, and transcription 
factor activity. This number is however predicted to reach about 6300 when a more complete 
sequence of the elephant shark genome will be released. The mean length of these so-called 
ancient noncoding elements is 210bp, with 71-98% identity. Interestingly, human and 
cartilaginous fish share a higher number of evolutionary conserved sequences than human and 
fugu / zebrafish. Since human and fugu diverged from each other more recently than with the 
cartilaginous fish, this could mark a more rapid divergence of regulatory regions in the 
terminal branches of human and fugu. 
 
II.3. Origins of Conserved sequences 
 
Exploring the phylogenetic origin of conserved sequences will certainly contribute to 
the understanding of evolutionary processes and unravelling their function role (correlation 
between CNCs acquisition or loss with new morphological features for example).  
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A small fraction of conserved sequences (>0.1%) has been detected in ancient genomes such 
as the fish (450Mya), however none of these can be identified in non-vertebrate species 
(Bejerano et al. 2004c; Woolfe et al. 2005). It has been reported that a fraction of CNCs could 
be mapped within ancient genome duplications, however out of the 2300 mammalian CNCs 
conserved in the pufferfish, only 124 related families of CNCs with no more than 5 members 
each has been identified (i.e. a maximum of 620 CNCs could have arisen from duplication 
events) (McEwen et al. 2006). This suggests that genome duplication is probably not the 
major contributor to the large number of conserved sequences mapping to the human genome. 
Recently another mechanism has been proposed to contribute to the occurrence of a subset of 
CNCs; several investigations have shown that a fraction of CNCs could have been introduced 
by mobile element insertions such as ancestral repeats and transposons (Bejerano et al. 2006; 
Gentles et al. 2007; Kamal et al. 2006; Lowe et al. 2007; Nishihara et al. 2006; Xie et al. 
2006). These observations were unexpected since conserved sequences had been shown to 
lack any common motif and also because repeated DNA has often been considered as mostly 
non-functional. 
 
Initially, four major families of conserved sequences (named MER121 (Kamal et al. 2006), 
LF-SINE (Bejerano et al. 2006), HsSINE3 (Xie et al. 2006) and AmnSINE3 (Nishihara et al. 
2006) have been shown to arise from either ancestral repeats or SINE-related families. Two 
additional studies have now reported that all classes of transposons (LINE, SINE, LTR and 
DNA transposons) were contributing to the transmission/acquisition of a small fraction (~2%) 
of conserved sequences (Gentles et al. 2007; Lowe et al. 2007). That mobile elements can 
experience purifying selection strongly support that these sequences have acquired important 
functions (a phenomenon that is called exaptation).  
 
A brief overview of the reported CNC families is given below: 
 
! MER121 family (Kamal et al. 2006) 
 About 0.2% of all conserved sequences of the human genome (~700’000 CNCs described 
in the HG (Bejerano et al. 2004a) belong to the MER121 Ancestral Repeats (AR) family. The 
conserved sequences arising from MER121 show considerable sequence variation among 
them but a striking conservation in orthologuous location across human, dog, mouse and rat 
species. Their presence in marsupials and absence in aves suggest that they originated by 
transposition ~200Mya ago (human-marsupial time divergence $180Mya) (figure 9D). The 
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precise function of these elements is still unknown, but computational analyses suggest that 
they are neither protein coding nor ncRNA genes. Interestingly, MER121 derived CNCs 
locate preferentially in gene poor regions or regions of lower exon density. This is 
reminiscent of the general distribution of conserved non-coding sequences (Dermitzakis et al. 
2005; Hillier et al. 2004). 
 
! Lobe-finned fishes SINE (LF-SINE) (Bejerano et al. 2006) 
 LF-SINE is a new family of retroposons that has been identified following the 
characterization of one of the most evolutionary constrained regions in mammals (UC338) 
(figure 9A). The identification of an homologue of this sequence in Coelacanth revealed a 
481bp region exhibiting features (serine tRNA-like domain, A and B boxes of PolIII promoter 
and 3’end polyA region) typical of SINEs. Interestingly, the high frequency of similar 
sequences in the Coelacanth genome and their low divergence suggests that LF-SINE is part 
of a recently active SINE family that has been conserved from more than 400Mya. Copies of 
LF-SINE are detected in tetrapodes and species related to coelacanth but are absent in 
invertebrates genomes (figure 9D). They contribute to approximately 0.035% of all conserved 
sequences mapping to the human genome (245 copies detected/700’000 CNCs).  
In human, LF-SINEs are mainly intergenic (66%) but can also be intronic (28%) or 
overlapping exons (6%). The functional analysis of two conserved LF-SINE regions, an 
intergenic and an exonic one, show that these can act as long-range enhancers and as 
alternatively splice exons respectively (Bejerano et al. 2006). 
 
! SINE3 family (Xie et al. 2006) 
 Alignment of all human-mouse syntenic conserved sequences with all known vertebrate 
transposable elements exposed an additional family of conserved sequences arising from 
SINE3 transposition (figure 9B). One-hundred and twenty four matches (HsSINE3) are 
present in the human genome which accounts for ~0.018% of all mammalian CNCs; 85% of 
them are retained in their orthologuous position with a high sequence identity (74%) across 
mammals. HsSINE3 conserved sequences are also found in the chicken (GalSINE3) although 
not at orthologuous positions. This suggests HsSINE3 and GalSINE3 originated from a 
common ancestor, but that different copies have been retained in the two genomes. Finally, 
these elements are also related to the active SINE3 repeat in the zebrafish and to a SINE 
element in coelacanth (figure 9D). 
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Figure 9. Structure and phylogenetic conservation of SINE derived conserved sequences. (A) Top panel: 
Schematic of LF-SINE and its relation to an exapted distal enhancer near ISL1, and the ultraconserved exon of 
PCBP2, exonized from the reverse strand. Bottom panel: Alignment of multiple species instances of the PCBP2 
exonized element, and ISL1 proximal LF-SINE enhancer, with the reconstructed coelacanth SINE. Filled squares 
(matches) and white spaces (tetrapodal inserts) are with respect to the coelacanth sequence. (B) Comparison of 
the zebrafish DrSINE3 transposable element and HsSINE3-1 as well as the orthologous conservation of 
HsSINE3-1 across various mammals. Related portions are shown in the same color. Most of the similarity 
between the human sequence and DrSINE3 lies within the central core region (shown in blue and labeled "B"); 
the best aligning portion of 162 bp in humans is indicated by the rectangle and shown as a pairwise alignment. 
For conservation across HDMR, colors are as follows: red, identical 4-way; black, nonidentical 4-way; gray, <4 
bases align. The corresponding orthologous sequence in additional mammals is shown as a multiple alignment in 
red. (C) Top panel: Schematic representation of AmnSINE and the active SINE3 repeat in zebrafish (SINE3) and 
coelacanth (LmeSINE). Green boxes represent common sequences among all deuterostomian (Deu-domain), 
yellow and red boxes represent promoter regions derived from tRNA and 5S rRNA respectively, blue boxes 
represent 3’-tail of SINE that are similar to that of zebrafish. Bottom panel: Example of conserved AmnSINE1 
locus on HSA15 conserved in all mammals obtained from UCSC Genome Browser. (D) Phylogeny of genomes 
searched for SINE-derived conserved sequences. Thick; copies of SINE element found in the draft genome, 
cross; no copies found, n.i.; no indication are provided in the reference study. Modified from (Bejerano et al. 
2006; Nishihara et al. 2006; Xie et al. 2006). 
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! AmnSINE (Nishihara et al. 2006) 
 AmnSINE have been discovered following the identification of a new SINE family in 
coelacanth. They are conserved both in mammals and chicken which supports evolutionary 
conservation over more than 350Mya (figure 9D). They are characterized by a central highly 
conserved region and 5’/3’ ends that are more degenerated (figure 9C). One-hundred and five 
AmnSINE copies phylogenetically conserved among mammals have been identified and at 
least a portion of them overlap with previously described evolutionarily conserved sequences 
(representing about 0.015% of CNCs) (Bejerano et al. 2004c; Siepel et al. 2005).  
 
! Transposable elements in the short-tailed opossum (Gentles et al. 2007) 
 The sequencing of the Monodelphis domestica genome identified 83 families of repetitive 
sequences present in mammals and in chicken; none is present in the fish (figure 9D). The 83 
families are present in 18’290 copies in the human genome (Gentles et al. 2007). Among 
these repeated elements, 3512 (19%) overlap previously described conserved elements (Siepel 
et al. 2005). This would account for approximately 0.5% of all CNCs in the HG. MER131 
SINE elements are one of the families shown to overlap with conserved sequences. Further 
investigations of this specific repeats family lead to two main observations: first, MER131 
elements exhibit a higher interspecies syntenic conservation than intraspecies conservation 
(i.e. hs-marsupial versus marsupial alone) which confirms that those elements are under 
purifying selection and suggests that transposition occurred before exaptation. Second, the 
repeat elements within conserved sequences overlap significantly with the Cis-Regulatory 
Module database (Wang et al. 2006) suggestive of a cis-regulatory potential. 
 
! Pan-boreutherian CNCs from repetitive origins (Lowe et al. 2007) 
 Lowe et al. have reported the identification of 10’402 pan-boreutherian (primate-rodent-
dog) conserved non-exonic sequences from repetitive origins. Although conserved sequences 
originate from all repeats families, the main contributors are again LINE and SINE repeated 
elements (figure 10). Additional properties of the sequences are: i) conserved non-exonic 
sequences harbour ‘subregions’ that are under stronger constraint; this might define functional 
domains in the conserved sequence, ii) a preferential mapping to gene desert regions is also 
observed for exapted elements and iii) cluster of exapted sequences are preferentially 
associated to development and cell adhesion related genes.  
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Pan-boreuterian constrained non-exonic sequences cover less than 1.5% of the human 
genome, thus despite the large number of identified sequences of repetitive origins, the 
overall proportion is still very low. 
 
 
Figure 10. Contribution of repeat classes 
and families. Autonomous LINEs and the 
non-autonomous SINE mobile elements are 
the major contributors to novel functional 
DNA. DNA transposons and LTR, however, 
also contribute substantially. The unknown 
class is made entirely of MER121 instances 
(Kamal et al. 2006). Reproduced from Lowe 
et al. (Lowe et al. 2007). 
 
 
 
In conclusion, transposable elements seem to play a major role in shaping the genome through 
the dispersion of sequences that will potentially acquire new functions and consequently be 
submitted to purifying selection. Currently, repeated elements seem to have contributed to the 
appearance of only a small subset of conserved elements (approximately 2% if we assume the 
700’000 CNCs map to the HG (Bejerano et al. 2004a). However, this might be an 
underestimation since extended evolutionary time divergence would provide sufficient time 
for neutral substitution to accumulate in the transposable sequences and make them no longer 
recognizable. 
 
 
II.4. Function of CNCs 
 
The strong conservation and pattern of evolution of conserved sequences strongly argues for a 
functional role. Several different functions have been proposed for conserved sequences; 
among them, it has been suggested that they could act as cis- or trans- regulatory elements, 
have a structural role, be involved in chromatin packaging, or have other yet-unknown 
function. Intronic conserved sequences could in addition be involved in alternative splicing or 
in other post-transcriptional regulation mechanisms. 
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One of the main challenges for the elucidation of the functional roles of CNCs is the design of 
meaningful large-scale experiments that could provide significant information on their 
different putative functions. To overcome this difficulty, some of the potential roles of CNCs 
have first been investigated by bio-computational approaches.  
 
! Matrix Attached Regions (MARs) 
MARs are non-coding DNA eukaryotic regions that are involved in the attachment of 
chromatin to the nuclear membrane, as well as to chromatin remodelling and transcription 
regulation (Laemmli et al. 1992). The binding affinity of MARs to the nuclear matrix seems 
to be correlated with AT rich motifs. A recent computational study investigating the 
contribution of conserved non-coding sequences to MARs has shown that 11% of human-
mouse conserved sequences with higher A+T content (~50%) are associated to confirmed or 
predicted matrix-scaffold attachment regions (MARs) (Glazko et al. 2003). Interestingly, the 
predicted conserved MARs fall in intergenic regions that are all associated to divergently 
transcribed genes, suggesting an involvement in transcriptional initiation (Glazko et al. 2003). 
Further supporting such role for a portion of CNCs, a previous study on the Wilm’s Tumor 
gene had identified a conserved DNAseI hypersensitive region that showed evidence of 
matrix attachment sequence (Scholz et al. 1997). 
 
! Alternative Splicing 
Another computational analysis has focused on the contribution of intronic conserved 
sequences to alternative splicing (Sorek and Ast 2003). Indeed the bioinformatics analyses 
show that 77% of human-mouse conserved alternatively spliced exons are flanked by 
conserved sequences compared to 17% for constitutive spliced exons. They also observed that 
introns flanking alternative exons are more conserved (figure11A). This observation has been 
subsequently used as a tool to identify putative alternative exons and led to the experimental 
confirmation that conserved sequences contribute to alternative splicing (figure 11B) 
(Philipps et al. 2004). Additional support has been provided by the work of Glazov and 
colleagues on Ultraconserved elements in insect species; first by confirming the occurrence of 
UC regions at intron-exon junctions and second by experimentally demonstrating that the 
homothorax intronic UC is associated to intron retention in the pre-mRNA transcript (Glazov 
et al. 2005). The striking question about the involvement of a fraction of CNCs in alternative 
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splicing is the absence of any common motif, which might suggest that each conserved 
sequence has been acquired independently. 
 
 
Figure 11. Conserved sequences promote alternative splicing. (A-B) Vista pairwise alignment between 
Drosophila melanogaster and D. pseudoobscura. Blue blocks represent exons and pink blocks show conserved 
sequences (with more than 75% identity). Each graph relates to a specific gene. Splicing forms are shown under 
each graph (in black and red). Reproduced from Philipps et al. (Philipps et al. 2004) (A) Alternatively spliced 
exons are flanked by highly conserved sequences. (B) A fraction of CNCs map to alternatively spliced exons. 
(C) Shown are two examples of conserved sequences inclusion leading to premature stop codon in SR proteins. 
Graphs show human-mouse percent identity over the gene; reference exons are shown in blue, highly conserved 
non-coding sequences are shown in yellow and regions associated with alternative splicing are shown as red bar 
above the graph. Indicated as 2 and 3, are the known human and mouse transcripts; above the exon structure the 
reference splicing form is draw while the alternative one with the intron inclusion (yellow box) is below the exon 
structure. Reference stop codons are above and premature stop codons are below the exon structure and are 
shown as red circle. Reproduced from Lareau et al. (Lareau et al. 2007) 
 
A related role has been observed recently in the SR protein family; SR proteins are involved 
at different steps of pre-mRNA splicing (Lareau et al. 2007). Surprisingly, the authors 
observed that every member of the human SR gene family contains a highly conserved 
sequence that is alternatively spliced (figure 11C). Curiously, this leads to the inclusion of the 
conserved sequence that will in turn, introduce a premature stop codon and result in the 
production of an abortive transcript. Thus in this example, the conserved sequence seems to 
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be involved in a negative feedback loop that controls the level of expression of the wild-type 
and degenerative transcripts. 
 
! Non-coding RNA (ncRNA) 
In addition to a role in alternative transcript, the study of Feng et al. (Feng et al. 2006) 
provided evidence that conserved sequences can also be transcribed and produce ncRNA. 
Their study on the regulation of the Dlx5/6 locus reveals that a previously ultraconserved 
enhancer activates transcription by means of the interaction of its own ncRNA with its target 
gene. This trans-regulation highlights a cooperative action of the ncRNA-target protein (in 
this case Dlx2) to regulate the expression of the target gene as well as nearby genes (in this 
case Dlx5 & 6). 
The study of Shnyreva et al., also correlates intergenic transcription of conserved sequences 
with IFN%  gene transcription activation (Shnyreva et al. 2004). 
 
! Enhancer / Silencer (cis-regulatory function) 
Except the few examples presented earlier almost all other computational and 
experimental studies on conserved sequences have focused on their cis-regulatory potential. 
This is probably related to the fact that conserved sequences serving as regulatory elements 
had been described before the release of the first vertebrate genomes, and thus before the 
emergence of comparative analysis and conserved sequences (Griffin et al. 2002; Koop and 
Hood 1994; Oeltjen et al. 1997). The subsequent release of the Human and Mouse genomes 
showed that about 5% of the genome is under purifying selection; along with previous 
experimental studies on conservation this has led to the widespread notion that most 
conserved regions could mark regulatory elements. Supporting this hypothesis, several 
bioinformatic approaches have been developed and have successfully detected regulatory 
sequences mostly by combining conservation (Kellis et al. 2003; Xie et al. 2007) with 
putative ‘marks’ of regulatory function such as Regulatory Potential (Kolbe et al. 2004), 
TFBS frequency (Wang et al. 2006) or Gene tissue-specific expression variation (Pennacchio 
et al. 2007) (figure 12).  
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Figure 12. Computational cis-regulatory elements prediction based on conservation. The cis-regulatory 
function of CNCs is supported by the positive results retrieved by computational studies aiming at mapping 
regulatory elements on the bases of conservation. (A) Wang et al. (Wang et al. 2006) developed a method to 
identify mammalian erythroid cis-regulatory modules. Their strategy mainly consists in finding erythroid 
differentially expressed genes, map the conserved sequences within or around these gene and select as candidate 
conserved sequences with high Regulatory Potential (RP) and GATA-1 binding site matches. (B) Pennacchio et 
al. (Pennacchio et al. 2007) used a similar approach in order to identify all tissue-specific enhancers in the 
human genome. They also identified differentially expressed genes, assigned them conserved sequences and 
selected candidate CNCs by transcription factor binding site (TFBS) mapping with them. They score the CNCs 
based on TFBS weight calculation. Both studies report significant positive results and highlight the relationship 
between conservation and cis-regulatory activity.   
 
Until recently the majority of the studies aimed at identifying or understanding the role of 
CNCs within or lying around a specific gene, this could shed some concern regarding the 
conservation-regulation hypothesis. The specific genomic landscapes might increase the 
probability of detecting regulatory CNCs compared to the analysis of CNCs chosen randomly. 
Thus currently, much uncertainty still remains on the regulatory potential of CNCs at large.  
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Table 1 lists the main studies that have been performed on the cis-regulatory function of 
CNCs and highlight the variability in their regulatory activity. A careful overview of the 
existing CNCs literature also gives some insights in the features that could contribute to this 
variability and that might be used to identify regulatory or non-regulatory CNCs: 
 
Degree of conservation. Two types of conservation are considered here; first the 
degree of identity between specific alignments (e.g. 50% or 70% or 100% identity between 
specific species) and second, the depth of phylogenetic conservation (i.e. estimated age of the 
common ancestor of the genomes compared).  
The degree of homology does not seem to be related to the regulatory potential of the 
conserved sequence, this is supported by several studies that show that the identified 
functional conserved sequences are within the less conserved sequences analysed (Fabbro et 
al. 2005; Martin et al. 2004). On the other hand, it seems that phylogenetic conservation 
might help in identifying regulatory conserved sequences. This would not be related to the 
number of species in which the sequence is conserved (Frazer et al. 2004) but rather on the 
time of divergence among the compared species. Although there is no systematic summary of 
the regulatory data on conserved sequences, it is widely believed that the deeply conserved 
elements (i.e. conserved down to fish) are mainly developmental regulators. Based on the 
studies reported in Table1, an average of 60% of conserved elements in fish and 40% in 
tetrapods exhibit a cis-regulatory potential (calculations made on the analysed studies of 
Table 1). It is however not clear how far in the evolution one should go to have sufficient 
signal-to-noise ratio to detect functionally conserved sequences. For example, would an 
intermediate genome such as the chicken be distant enough to detect conserved regulatory 
sequences (hs-fugu: 450Mya, hs-chicken: 350Mya)?  
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Table 1.  Regulatory potential of CNCs based on past reports 
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Deep phylogenetic conservation might however not be sufficient to detect all regulatory 
elements, since this might favour the detection of conserved sequences involved in ancient 
functional modules such as those related to development. Controversy on the impact of 
phylogenetic distance on the detection of conserved sequences is also underscored by the 
study of Prabhakar et al. (Prabhakar et al. 2006). Their work highlights the limited success 
rate of distant species comparisons to detect previously characterized regulatory elements 
(figure 13) (Prabhakar et al. 2006). In addition it has also been reported that human-primate 
conservation (~100Mya versus 450Mya human-fugu) could also be sufficient to detect 
regulatory sequences that would in fact have been missed by use of more distantly related 
species (Boffelli et al. 2003; Wang et al. 2007). In conclusion, although it seems that 
phylogenetic conservation is very useful to detect regulatory potential, it looks likely that 
other factors (e.g. genomic context) should be also considered. It would be interesting to see if 
in the future the degree of phylogenetic conservation might help defining different categories 
of cis-regulatory elements. 
 
Genomic landscape. Given that conservation has become a mark for transcriptional 
regulatory activity, a plethora of studies investigating the regulation of a specific gene (or 
gene family) have reported the identification of functional conserved sequences located 
around or within them. These analyses tend to support the regulatory function of CNCs 
independently of their degree of conservation, however, these results might not be 
representative of the majority of CNCs. In fact, it is known that CNCs preferentially map to 
gene poor regions, thus before concluding that the majority of CNCs are regulatory elements 
it is essential to investigate their function in a non biased way. As suggested in Table 1, very 
few studies have attempted to explore CNCs at random, or in gene desert regions, however 
the results obtained in these investigations do not necessarily support a widespread regulatory 
function for all CNCs (see for example in Prabhakar et al. CNCs lying outside or within a 
developmental loci) (Nobrega et al. 2004; Pennacchio et al. 2006b; Prabhakar et al. 2006). Of 
interest, these studies strongly indicate that genomic position and phylogenetic conservation 
should both be taken in account when studying CNCs and making conclusions about their 
function (figure 13).  
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Figure 13. Phylogenetic conservation and genomic landscape influence the cis-regulatory function of 
CNCs. (A) In this study the authors concentrated on the DACH locus and the human-fugu conserved sequences 
mapping within it. LacZ enhancer reporter assays in mouse embryos successfully confirmed that a large 
proportion (77%) of CNCs act as enhancers (Nobrega et al. 2003). Reproduced from Boffelli et al. (Boffelli et al. 
2004a) (B) In order to evaluate the impact of phylogenetic conservation on the identification of functional 
conserved sequences, the authors screened the DACH locus for human-rodent conserved sequences.  Five CNCs 
were selected for LacZ reporter assays in embryos. Interestingly, despite the reduce conservation of sequences 
compared to panel A, a high number of conserved regulatory elements are still detected (50%) (Prabhakar et al. 
2006). Reproduced from Prabhakar et al. (C) Functional assays on conserved sequences mapping to gene desert 
regions (MMU3 and MMU19), and with different level of conservation. LacZ assays in embryos showed that 
only 1 of the most conserved activates transcription (Nobrega et al. 2004). This suggests that both conservation 
and chromatin context contribute to the functional determination of a CNC. Modified from Nobrega et al. 
(Nobrega et al. 2003; Nobrega et al. 2004). 
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Independent of the concerns discussed above, interesting observations have been discussed on 
the fraction of CNCs that function as transcriptional regulators: 
Conservation of a CNC is not always homogenous, but can harbour ‘highly’ conserved 
regions embedded into ‘less’ conserved regions. In the study of Poulin et al. a UC element is 
shown to act as enhancer. Interestingly this UC harbours a core region of 144bp sharing 100% 
identity with hs-mm-Galgal-zebrafish-fugu; when the whole UC region was assayed it 
showed enhancer activity, however when the 144bp core region was deleted from the UC or 
was tested alone the enhancer activity was lost. This suggests that this core region is 
necessary but not sufficient for the enhancer activity (figure 14A) (Poulin et al. 2005). In a 
recent study on CNCs regulating GLI3, a similar observation has been made on several 
sequences harbouring highly conserved core regions (human-fugu) embedded in human-
mouse conserved sequences. Deletion of the core elements reduces considerably the 
expression of the reporter gene while if the flanking sequences are deleted the activating 
potential is lost; again suggesting that the deeply conserved sequence is necessary but not 
sufficient for the regulatory activity (figure 14B) (Abbasi et al. 2007).  
Interestingly a synergetic action between ‘low’ and ‘high’ conserved regions within the same 
evolutionarily conserved sequence has been also highlighted in CNCs of the Iroquois cluster 
(de la Calle-Mustienes et al. 2005). Mammalian Irx genes are organised in two clusters, IrxA 
and IrxB, originated from a duplication event. Two UCs have been identified per cluster, 
interestingly these four UCs share a core region that is highly conserved and that exhibits 
identical pattern of expression when tested alone. However when each one is assayed along 
with its flanking regions, modulation of the expression pattern can be observed with some 
CNCs. This could point out to the different properties of vertebrate versus mammalian CNCs, 
and suggests that CNCs are under the dual action of both purifying and positive selection. 
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Figure 14. The core region of conserved sequences is necessary but not sufficient for expression. (A) 
Functional analysis of the DACH1 enhancer, DC2. The 424bp Ultraconserved region contains a core sequence of 
144 bp which show 100% identity with fugu. Deletion constructs on the regulatory sequence and its flanking 
regions, show that the full UC region activates LacZ reporter gene in mouse embryos. When only the 144bp core 
sequence is tested no activity is detected anymore, the same is observed when only the flanking regions are 
assayed. This suggests a cooperative activity between the highly conserved sequence and its surrounding regions 
(Poulin et al. 2005). Modified from Poulin et al. (B) Regulatory conserved region for Gli3 gene (Abbasi et al. 
2007). The alignment of the whole conserved region in human-mouse-chick-frog and fugu highlights the 
presence of a core conserved fragment of 125bp, to which many TFBS are predicted to map. WT and deletion 
constructs assayed for transcriptional activation of a reporter gene in cells, show that deletion of the core region 
(red bar) reduces considerably the level of expression. However when the 125bp core region is assayed alone, 
the regulatory activity is absent. The core region is then necessary but not sufficient for correct expression. 
Modified from Abbasi et al. (Abbasi et al. 2007) 
 
 An intriguing observation is the substantial fraction of experimentally detected 
regulatory conserved sequences that act in the Central Nervous System (CNS) or derived 
tissues or cell lines (Bailey et al. 2006; Frazer et al. 2004; Grice et al. 2005; Nobrega et al. 
2003; Pennacchio et al. 2006b). A contributing factor to this observation is the large number 
of studies focusing on genes involved or expressed in neural system and derivatives. 
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However, other factors might include extended phylogenetic conservation; in Pennacchio et 
al. fifty-seven sequences conserved down to fish and enhancing transcription show a 
reproducible pattern of expression in the CNS (Pennacchio et al. 2006b) (figure 15). The work 
of Bailey et al. raises interesting additional observations on the involvement of UC regions in 
the genomic transcriptional code of the CNS (Bailey et al. 2006). Their analysis on the 
relationship between UC and homeodomain genes showed that: (i) each of these well known 
developmental regulators was associated to a UC, (ii) computational analysis on the 
associated UCs revealed an over-representation of TFBS for Sox (S), POU (P) and 
Homeodomain (H) proteins in 30% of them.  
A subsequent investigation on the pattern of expression of genes linked to UCs enriched in 
SPH TFBS showed that 83% (142/172) were expressed in the CNS versus 36% of control 
genes. These observations were validated by functional studies in which TFBS were 
mutagenized resulting in significant reductions in the activating activity of the UCs. 
Intriguingly, the transcription factors Sox and POU are described as transcriptional activators 
in the literature, while Homeodomain proteins are repressors. The combination of these 
factors on CNCs could define the pattern of expression of their ‘target’ genes; SOX and POU 
would activate transcription in non-expressing H protein tissues while H proteins will have a 
dominant role in expressing tissues (Bailey et al. 2006). 
 
Figure 15. Expression pattern of regulatory CNCs. 167 conserved regions were assayed for enhancer activity 
using LacZ reporter gene in mouse embryos. 75/167 regions resulted in reproducible LacZ activation. The 
pattern of expression drove by these elements is indicated in the graph, with the number of elements positive for 
the tissue (number in the column). Underlined in red, are all tissues derived from neural system.  All tested 
constructs are active in at least one of these tissues. Reproduced from Pennacchio et al. (Pennacchio et al. 
2006b). 
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Strikingly, some studies have described CNCs active in neuronal cell lines or in neural tissues 
that show a repressing activity in non-neural tissues (Grice et al. 2005; Pennacchio et al. 
2006b). Recent studies suggest that CNS genes are very tightly regulated, and associated 
conserved elements could have the additional function of fine-tuning their expression by 
strictly silencing them in non-neuronal tissues 
 
Except for CNCs characterised in the frame of studies dissecting the transcriptional regulation 
of specific genes (Fabbro et al. 2005; Gottgens et al. 2000; Grice et al. 2005; Komatsu et al. 
2002; Loots et al. 2000; Mortlock et al. 2003), it has been generally difficult to associate 
functional conserved sequences to particular genes. Genome wide screens can identify 
regulatory CNCs but generally cannot define CNC-target gene(s) associations. Difficulties 
relating to this observation include: (i) enhancer elements can activate genes over 1Mb 
distance (Lettice et al. 2003) ;(ii) regulatory elements can act in trans (Ling et al. 2006; 
Spilianakis and Flavell 2004). One of the next challenges to dissect the regulatory function of 
CNCs will be to design high-throughput methodologies that will screen for CNCs-gene 
associations. Currently, bioinformatics studies evaluate the potential of using duplicated 
blocks or block of synteny (McEwen et al. 2006) to define minimal target regions, however 
these strategies do not take into account newly acquired regulatory functions.  
 
II. 5. Importance of studying CNCs 
 
Comparative genomics has revealed the presence of highly conserved sequences present 
throughout genomes. Subsequent computational and experimental studies have demonstrated 
the role of purifying selection in the evolution of these sequences and their functional 
potential as matrix attachment regions, splicing regulators and mostly transcriptional 
regulatory elements. Further exploring the role of conserved sequences is critical for many 
reasons:  
1) Protein coding genes account for about 1-2% of the HG and probably represent the 
best studied fraction of the genome. Consequently the role of the vast majority of the HG is 
unknown. Further exploration of conserved sequences will help in gaining insights into the 
‘genomic code’ (Margulies et al. 2007).  
2) Tracking the conserved sequences through vertebrates and non-vertebrates species 
and understanding their origins will contribute to the elucidation of genome reorganization 
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mechanisms (Gentles et al. 2007; Lowe et al. 2007) and give insights into the evolutionary 
story of species (Nikolaev et al. 2007).  
3) Further dissecting the cis-regulatory potential of conserved sequences might reveal 
a role for them in the evolution of phenotypes (McGregor et al. 2007; Wray 2007); as 
mentioned previously the cis-regulatory activity of conserved sequences can be modulated by 
sequence variations and can result in different expression pattern/levels of genes (de la Calle-
Mustienes et al. 2005).  According to this hypothesis, a significant number of SNP have been 
found in ‘accelerated CNC’ (i.e. CNCs with higher lineage-substitutions rate than expected 
under neutrality) and have been correlated to gene expression variation (Bird et al. 2007).  
Nucleotide substitutions in conserved sequences might thus contribute to the evolution of 
quantitative traits and explain morphological, physiological or behavioural changes among 
species.   
4) Sequences undergoing strong purifying selection are probably maintained because 
of their essential function. Consequently, mutations in conserved elements are expected to 
have a considerable effect and might be at origin of an important fraction of human diseases 
(Dermitzakis et al. 2005). This expectation has been supported by the work of Lettice et al. in 
2003 (Lettice et al. 2003). In their screen to identify regulatory elements responsible for the 
initiation and spatial expression of the Sonic Hedgehog (SHH) protein, they identified a 
conserved sequence mapping approximately 1Mb away from it that controls its expression. In 
addition, they demonstrate that nucleotide changes in this evolutionarily conserved enhancer 
disrupts SHH expression and leads to the congenital preaxial polydactyly limbs malformation 
(figure 16) (Lettice et al. 2003; Lettice and Hill 2005). Similarly, Emison et al. have identified 
a susceptibility variant for the Hirschsprung disease. The common non-coding variant 
identified map to a conserved sequence and makes a 20-fold greater contribution to risk than 
rare alleles; this could be explain by its reduced enhancer activity when tested in vitro 
(Emison et al. 2005). Additional CNCs potentially involved in human disease have been 
identified by Loots et al. on the Van Buchem (VB) bone density disease: a minimal intergenic 
deletion in a set of patients negative for null coding mutations in the causative gene (SOST) 
has been identified. This deletion was shown to contain a set of evolutionarily conserved 
sequences some of which can act as enhancers on a reporter gene mimicking the expression 
patter of SOST (Loots et al. 2005).  
In conclusion, nucleotide changes in evolutionarily conserved sequences might be a common 
cause for disease in human populations. However, nucleotide substitutions in conserved 
sequences have not always been successfully linked to dysfunction of the conserved 
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sequences (Bottani et al. 2007; Donfack et al. 2005). Further studies are thus required to 
define the contribution of CNCs to human disease.  
 
 
 
Figure 16. Mutations in the conserved Shh enhancer modify its activity and lead to preaxial polydactyly. 
(A) Conservation profile of the Lmbr1-Shh locus. Lmbr1 and Shh genes lie 1Mb from each other; conserved 
sequences between human-mouse (yellow bars), human-mouse-chicken (green bar) and human-mouse-chicken-
fugu (red bars) within the region are mapped. With increase phylogenetic distance the number of conserved 
sequences decrease considerably, in the human-fugu comparison only two conserved sequences are detected, 
both map to introns of Lmbr1 gene (red bars). The ZRS enhancer is a long range enhancer that regulates Shh. Its 
sequence is detailed: green highlights correspond to nucleotides conserved in human-mouse-chicken, red 
highlights mark nucleotide variants that have been identified in human patients and shown to disrupt the normal 
expression of Shh and lead to preaxial polydactyly (Lettice et al. 2003) (B) Preaxial polydactyly (PPD). Shh 
expression (depicted in blue) starts in the posterior margin of the limb bud in the Zone of Polarising Activity 
(ZPA) which is under the control of the ZRS enhancer element. Previous studies on mutant strain (like Ssq) have 
shown that preaxial polydactyly is caused by the extopic expression of Shh in the anterior margin of the limb 
bud. Mutations in ZRS cause the ectopic anterior expression of Shh, which then allow the limb to continue 
developing and result in additional preaxial fingers (shown in PPD in human and in Ssq mutant mouse) (Lettice 
et al. 2003).Reproduced from Lettice et al. (Lettice and Hill 2005) 
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5) Finally, polymorphic variation in conserved sequences could also account for gene 
expression variation among ethnic groups or individuals (Bird et al. 2007; Stranger et al. 
2007). It would be interesting to identify positively selected signals within CNCs, whereby 
specific alleles might have increased in population frequency as result of conferring a 
selective advantage in response to environmental changes or disease.  
 
 
III. HUMAN CHROMOSOME 21 (HSA21) 
 
The work discussed in this thesis is centred around conserved sequences that map on 
HSA21q. There are two main reasons for this choice: first, following the release of the first 
vertebrate genomes (Lander et al. 2001; Venter et al. 2001; Waterston et al. 2002b) our 
laboratory was involved in the comparative analysis of HSA21q with its mouse syntenic 
regions as a means of improving chromosome annotation. This led to the observation of 
previously unknown conserved sequences the investigation of which became the main topic 
of this thesis. Second, HSA21 which our laboratory has worked on for the last 20 years, is 
probably one of the best annotated human chromosomes; and has been in the past used as a 
model for functional genomics. 
 
In this introductive chapter I will essentially focus on some aspects that are of direct interest 
for the work accomplished: i) description of HSA21, ii) sequencing of HSA21 and gene 
content, iii) comparative analysis with the mouse genome and the identification of conserved 
sequences, iv) functional annotation of HSA21 and v) Down Syndrome and putative 
contribution of CNCs. 
 
III.1. Description 
 
Human chromosome 21 is the smallest acrocentric human autosome. The length of its long 
arm is estimated to be approximately ~33.6Mb (Hattori et al. 2000) which represents around 
1% of the length of the haploid genome.  
In 1959, Jerôme Lejeune identified an extra-copy of HSA21 in Down Syndrome patients 
(Jacobs et al. 1959; Lejeune et al. 1959). Down Syndrome is the most common genetic cause 
of mental retardation in the human population; because of its medical interest and also as a 
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result of its size, human chromosome 21 has been one of the best characterized regions of the 
human genome (Frazer et al. 2003; Frazer et al. 2001; Hattori et al. 2000; Patil et al. 2001).   
 
In 1989 and 1992, high quality genetic (Warren et al. 1989) and physical (Chumakov et al. 
1992) maps were available, while in 2000 the almost complete sequence of the chromosome 
was released (Hattori et al. 2000).  A large number of pilot studies on HSA21 and HSA22 
have also contributed to: i) the establishment of a comprehensive catalogue of HSA21 genes 
(Gardiner et al. 2002; Reymond et al. 2002a), ii) the analysis of the pattern of expression of 
HSA21 genes (Gitton et al. 2002; Reymond et al. 2002b), iii) the mapping of all 
transcriptional units (Kampa et al. 2004; Kapranov et al. 2002), iv) the identification of all 
genetic variations and LD maps (Patil et al. 2001), v) the mapping of transcriptional factor 
binding sites (Cawley et al. 2004) and of vi) evolutionarily conserved sequences (Dermitzakis 
et al. 2002b).  
Insights from all those studies make HSA21 a model chromosome of the whole genome.  
 
 
III.2. HSA21 sequence and gene content 
 
In May 2000, the almost complete sequence of HSA21q was published as part as an 
international effort (Hattori et al. 2000). Using previously mapped BAC and cosmid clones a 
high quality sequence with only 3 small clone gaps and 7 sequencing gaps (100kb of missing 
sequence) was obtained. The analysis of the 33’546’361bp of HSA21q for i) gene content, ii) 
repeats content and iii) chromosomal rearrangements such as duplication events, suggested 
that ~3% of the sequence encodes proteins, ~40% is composed of interspersed repeats (SINE, 
LINE,…) and the remaining portion corresponds to intergenic DNA of unknown function. In 
addition, two duplications were reported, a 10kb duplication in the pericentric region of the 
long and short arm and another 200kb duplication mapping to the proximal and distal 
locations of HSA21q. Currently, 38 additional copy number variant associated to structural 
variation of more than 1kb have mapped to HSA21 (http://projects.tcag.ca/variation).   
 
The number of genes mapping to HSA21q was initially estimated to be approximately 225. 
Among them 127 were known genes, 98 were predicted and 59 were pseudogenes (Hattori et 
al. 2000). The definitive number of genes mapping to HSA21q is however still not conclusive 
although extensive bioinformatics and experimental annotation efforts have been carried out 
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(for example (Gardiner et al. 2002; Reymond et al. 2002a). The recent comparative analysis 
of HSA21q with its chimpanzee orthologous chromosome suggests that 284 genes and 98 
pseudogenes map to the long arm of the chromosome (Watanabe et al. 2004).  
The gene density throughout the length of HSA21q is not uniform but displays a preferential 
localization to more telomeric regions. Consequently, more gene poor regions map to the 
centromeric part of the chromosome. Figure 17 gives an overview of HSA21 features based 
on the last hg assembly (hg18).  
 
 
Figure  17. HSA21 UCSC genome browser view (hg18). A schematic view of the whole HSA21 is displayed. 
Gaps & Coverage; HSA21p is mostly unsequenced, only 280kb were obtained during the initial sequencing. One 
out of the three clone gaps of HSA21q has now been filled. UCSC Gene predictions; include known genes and 
gene prediction based on RefSeq, GenBank, UniProt and comparative genomics. CpG islands; Island of <300bp 
are shown in light green. The repeats content is also displayed (SINE, LINE, etc.). The preferential distribution 
of gene in the telomeric part of the long arm of the chromosome can be observed. GC content correlates with the 
gene content, as suggested in this figure.  
 
 
III.3. Comparative analyses and identification of conserved non-coding sequences 
 
 The release of the HSA21 sequence in 2000 and the following studies contributing to its 
annotation provided the required material (physical maps or draft contigs sequences) to 
perform the first ‘small-scale’ comparative analyses (Frazer et al. 2001; Pletcher et al. 2001; 
Toyoda et al. 2002) and to report the presence of conserved sequences not overlapping known 
genes.  
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For example, comparative analysis of 22.5Mb of the HSA21q, by use of HSA21q high-
density oligonucleotide arrays with mouse and dog orthologuous regions, identified 3398 
conserved regions of at least 30bp with more than 60% homology. Interestingly, 
approximately 40% of the sequences that are under apparent purifying selection were shown 
to map outside of known exons. These non-genic conserved elements were hypothesized to 
correspond either to new genes or sequences involved in processes such as gene regulation, 
replication or chromosome pairing (Frazer et al. 2001). 
 
Following the release of the human and mouse genome, in 2001 and 2002, the first 
chromosome wide comparative analysis was performed on HSA21 and its mouse syntenic 
regions located on MMU10, 16 and 17 (Dermitzakis et al. 2002b). The aim of the 
comparative analysis was to identify functionally transcribed sequences such as new genes or 
ncRNAs. The parameters used to identify such sequences were a sequence length of at least 
100bp with greater than 70% homology and no gaps, these are criteria that had been 
successfully applied in previous comparative studies to identify functionally important 
sequences (DeSilva et al. 2002; Loots et al. 2000). The comparative analysis highlighted the 
presence of a large amount of conserved sequences on HSA21, further investigation on the 
identity of the sequences revealed that 1229 out of 3491 (35.2%) conserved sequences were 
exons of previously known genes or pseudogenes, while unexpectedly 2262 out of the 3491 
(64.8%) were unannotated regions of unknown function that mapped to both intergenic (80%) 
and intronic (20%) regions (figure 18). These were at first named CNGs and later renamed 
CNCs. This set of conserved sequences is at the basis of the work presented here, and are 
discussed in more details here following.  
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Figure 18. HSA21 comparative analysis and identification of large proportion of CNCs. (A) Comparative 
analysis was performed on the long arm of chromosome 21 (33.5Mb) with its mouse syntenic regions on 
chromosome 16 (green blocks), 10 (pink blocks) and 17 (blue blocks). (B) Distribution of the 1229 known 
conserved sequences and 2262 unknown conserved sequences (CNCs) along HSA21q. Reproduced from 
Dermitzakis et al. 2002 (Dermitzakis et al. 2002b). 
 
The main features of the HSA21q CNCs include:  
1.   CNCs are single copy sequences that do not share significant sequence similarity when 
compared to each other (Dermitzakis et al. 2002b). 
2. Their distribution along HSA21q is negatively correlated to the density of genes, 
suggesting they are enriched in gene poor regions of the chromosome (Figure 19A) 
(Dermitzakis et al. 2002b).  
3. CNCs are not previously unknown genes or ncRNA. Extensive computational analyses on 
their coding potential predicted 123 gene models; functional analyses (RT-PCR on 20 human 
tissues) confirmed only 2 of the 123 models (1.7%). In addition, examination of the 
substitution pattern of CNCs compared to coding regions demonstrates that CNCs do not 
exhibit the expected nucleotide substitution periodicity that is specific of coding sequences 
(the distance between consecutive nucleotide substitutions are usually multiple of three due to 
the degeneracy of the genetic code) (figure 19C). Finally, bioinformatics approaches as well s 
integration of previous studies such as the mapping of all cytoplasmic polyA+ RNA of 
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HSA21 (Kapranov et al. 2002) suggested that the majority of these elements were not 
transcribed (figure 19B) (Dermitzakis et al. 2002b).  
4. Experimental analyses on 10% of HSA21 CNCs have revealed that they are conserved in 
all placental mammals (figure 19D), which extend their conservation to ~200Mya 
(Dermitzakis et al. 2003b). In addition, within the set of HSA21q CNCs, approximately 5-6% 
(n=110-140) are also conserved in chicken ("100bp, "70% identity) (personal data) and less 
than 0.15% CNCs have matches in fugu ("50bp, 70% identity) 
5. CNCs are selectively constrained and evolve differently than protein-coding genes and 
ncRNAs. Quantification of the level of conservation by calculation of sequence change per 
million years (Mya) for CNCs, protein coding genes and ncRNA show that CNCs are under 
stronger selective pressure (Dermitzakis et al. 2003b). The distribution of substitutions within 
these sequences also showed that CNCs have a significant clustering of their substitutions that 
could suggest the presence of functional domains within CNCs. Interestingly, intergenic and 
intronic CNCs show the same level of significance in substitution clustering suggesting they 
might have similar role (Dermitzakis et al. 2004). No significant clustering is observed in 
coding regions (figure 20A). 
6. CNC constraints are independent of their genic environment. As revealed by calculations 
of the distance of intergenic CNCs to the nearest genes and subsequent normalization for the 
intergenic length, CNCs do not cluster preferentially near genes but exhibit a uniform 
distribution in the intergenic space. Similarly, no correlation is observed between the level of 
constrain and the distance from genes (figure 20B) (Dermitzakis et al. 2004). 
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Figure 19. Features of CNCs. (A) Plot showing the negative correlation between CNCs distribution and exons 
in 1Mb window of the whole HG. (B) Colour coded panel illustrating the low transcriptional potential of CNCs. 
Each CNCs is depicted as a squares, and squares are ordered from centromere to telomere along HSA21q (left to 
right and from up to down). Arrows indicate the position of the last block on the chromosome. Transcription 
potential is based on computational (GrailExp, GenomeScan, human and mouse EST, QRNA) and experimental 
criteria (microarray (Kapranov et al. 2002)). (C) Frequency substitutions of the distance between consecutive 
nucleotide change in known (upper graph) and unknown (lower graph) conserved sequences. The n=3 
periodicity in exons reflects the frequent nucleotide change in the 3d base of the codon. (D) Conservation of 
CNCs among all placental mammals. The graph shows the number of CNCs successfully amplified in each of 
the denoted species. Blue fractions, correspond to the number of CNCs amplified with primer originally 
designed primers (hs-mm), red bars show the proportion of CNCs that can be amplified by an additional pair of 
the primers. Reproduced from Dermitzakis et al. 2002, 2003 & 2005 (Dermitzakis et al. 2003a; Dermitzakis et 
al. 2005; Dermitzakis et al. 2002b). 
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Figure 20. Evolutionary properties of CNCs. (A) CNCs evolve differently than coding regions (COD) or 
ncRNA. Plots of confidence intervals showing: i) in the top panel: CNCs are more constrain than COD or 
ncRNA. Y-axis; sequence change per million years and X-axis; analyses performed on 191 CNCs (CNC-all), 63 
CNCs conserved among all mammals (CNC-high), 57 COD, 14ncRNA (ncRNA-all) and 5ncRNA with high 
alignment coverage (ncRNA-high) (Dermitzakis et al. 2003b). ii) in the middle panel: clustering of substitutions 
is more significant in CNCs than in COD, this can suggest that some domains are more constrain in CNCs and 
that those one could be the functional ones. Y-axis; P values of the clustering of substitutions and X-axis as for 
the top panel. iii) in the lower panel: intergenic and intronic CNCs show comparable clustering of substitutions. 
This could suggest both groups of CNCs might have similar functions. Y-axis; as in the middle panel and X-
axis; type of element investigated. (B) Top panel: plot showing the relative distribution of CNCs in intergenic 
regions. CNCs do not show preferential mapping near genes. Lower panel: shown is the degree of divergence in 
the human lineage in relation to the distance from the closest gene. No correlation is observed, this means that 
CNCs near gene are not under stronger constrain than CNCs far from gene (and vice-versa). Reproduced from 
Dermitzakis et al. 2003, 2004 (Dermitzakis et al. 2004; Dermitzakis et al. 2003b). 
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Although the analyses were initially performed on the set of HSA21 CNCs they can be 
extended to the whole–genome. A total of 327’000 CNCs (~1% of the genome) with "100bp, 
"70% human-mouse homology and no gaps were initially detected in the human genome, 
however, the selection of ungapped sequences biased towards the identification/inclusion of 
an excess of coding sequences (reading frame maintained) and probably underestimate the 
total number of CNCs in the genome. Accordingly, more than 700’000 CNCs have been 
reported by Bejerano et al. (Bejerano et al. 2004a). 
 
III.4. Functional annotation 
 
Many pilote studies have taken HSA21 as a model. The rich and diverse functional annotation 
of the chromosome might serve, among other things, as a tool for (functional) characterization 
of new elements such as conserved non-coding sequences or miRNA that map within it. An 
overview of the main studies and how they have contributed to CNCs annotation is provided 
below:  
 
! HSA21q transcription profile (Kampa et al. 2004; Kapranov et al. 2002) 
 The overall transcriptional activity of HSA21 and HSA22 was studied.  The main aim 
was to build an empirical transcription map of these two chromosomes in order to compare 
the results to previous annotation. To achieve this goal, cytoplasmic polyadenylated RNAs 
were extracted from 11 different tumour or foetal cell lines and reverse transcribed. The 
resulting cDNA was subsequently hybridised to HSA21 and HSA22 tiling-arrays. Such arrays 
are composed of 25-mer probes that are spaced each 35bp and they interrogate the non-
repetitive fraction of the chromosomes.  
The identification of all transcripts mapping to HSA21 contributes to: i) the identification of 
new regions of transcription not previously detected, ii) identification of new exons or 
alternative spliced form of known genes, iii) identification of novel non-coding RNAs. The 
transcriptional profile obtained shows a positive correlation with the density of exons, 
however most of the signals are outside of the exons (59.4%-65.9%). Of these approximately 
50% locate within 300bp from the nearest exon. The study thus reveals that a significant large 
portion of the genome is transcribed and transported as mature cytoplasmic polyA+ RNA.  
This observation was further supported in a subsequent analysis; 49% of polyA+ detected 
transcripts do not map to annotated genes, mRNA or EST. In addition even if the overall 
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number of Transfrag (fragments of transcribed sequences) does not vary significantly from 
one cell lines to the other a significant fraction of them exhibit cell type specific ‘expression’.  
 
In the case of HSA21q CNCs, the mapping of all polyA+ transcripts along HSA21 showed 
that only a minority of CNCs (approximately 20%) were transcribed (Dermitzakis et al. 
2002b).  
 
! Gene expression profile (Gitton et al. 2002; Reymond et al. 2002b) 
Spatio-temporal expression of the large majority of HSA21 genes was assessed by two 
independent studies; RNA in situ hybridization, RT-PCR and EST mining resulted in a high-
resolution expression atlas of 160 orthologuous genes at multiple stages of development 
(E9.5-E14.5) (figure 21). These studies resulted in the identification of candidates genes for 
Down Syndrome and HSA21-related monogenic disorders. 
 
A known property of non-coding conserved sequences is their preferential mapping to gene 
poor regions. Regulatory (conserved) sequences within these regions would then function as 
long distance regulators; the identification of the gene regulated by these elements is still 
challenging. Currently, strategies such as defining conserved block of synteny among several 
species (Ahituv et al. 2005) or searching for CNCs associated to paralogous genes (paralogy 
mapping) (Vavouri et al. 2006) are used to define the minimal region within which the 
regulatory sequences could act. The classification of the assayed HSA21 genes according to 
their expression profile has revealed clusters of co-silenced or co-expressed genes that map to 
the same block of synteny (Reymond et al. 2002b); this could help in characterising putative 
long-range (conserved) regulatory elements.   
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Figure 21. Representative in situ hybridisation profiles obtained at E.10.5 (whole mounts) and E14.5 
stages (sections). Reproduced from Reymond et al. (Reymond et al. 2002b) 
 
! Protein complexes mapping (Cawley et al. 2004) 
 Annotation of functional-genomic elements can be provided by the identification of 
protein complexes such as those of transcription factors (TFs). Cawley et al. have used the 
chromatin immunoprecipitation (ChIP) technique in combination with genome arrays (ChIP 
on chip) to map the binding sites of three transcription factors (Sp1, cMyc and p53) on 
HSA21 using a repeat-masked tiling array. The approach allowed the identification of 353, 
756 and 48 potential Transcription Factors Binding Sites (TFBS) for cMyc, Sp1 and p53 
respectively.  
Overall the authors observed that the binding sites are enriched in CpG islands, at the 5’end of 
genes, and within probes containing previously described TFBS. An unexpected high portion 
(36%) of TFBS map within the 3’ ends of known genes. This could favour a role such as 
distal regulators or mark a transcript that would initiate in vicinity (alternative or anti-sense 
transcripts). Further analyses (strand specific RT-PCR or EST database mining) confirmed the 
occurrence of anti-sense transcripts nearby the TFBS; a fraction them are regulated in 
response to cell differentiation to retinoic acid.   
An additional group of TFBS are located at long distance of annotated genes and could act as 
long-range enhancers or be promoter of unknown transcripts.  
TFBS are degenerated stretches of 6-8nt. Conserved regulatory sequences are believed to be 
composed of intricate TFBS that would impose the high purifying selection observed.  
 82
Experimental mapping of TFBS will be useful to evaluate their occurrence in conserved 
sequences and contribute to their functional annotation. Approximately two hundred TFBS 
for Sp1, cMyc and p53 have been mapped on HSA21q; coordinates overlap with the 2262 
HSA21q CNCs results in 23 TFBS CNCs (personal data). TFBS were identified in Jurkat 
cells and HCT116 cells, our evaluation of the regulatory potential of this subset of TFBS 
CNCs in different cell types succeeded in demonstrating a regulatory activity for a substantial 
fraction of them (further detailed in chapter I).   
 
! SNP mapping (Patil et al. 2001) 
 By use of somatic cell hybrids, Patil et al., separated 20 independent copies of HSA21 
from three ethnic groups (African, Asian and Caucasian). The re-sequencing of all 
independent chromosomes by high-density oligonucleotide arrays identified 35’989 Single 
Nucleotide Polymorphisms (SNPs) uniformly distributed along HSA21. The identification of 
these SNPs allowed the definition of 4135 blocks of LD that would be a useful tool to design 
of association studies. 
  
The strong purifying selection of conserved sequences suggests that nucleotidic variation in 
the CNCs might result in abnormal function. Specifically, variation in regulatory CNCs might 
modify the expression of the regulated genes and be at the origin of gene expression variation 
among individuals or be involved in disease pathogenesis. The establishment of a complete 
catalogue of SNPs and LD blocks will help to identify potentially interesting SNPs within 
CNCs and assess their association to phenotypes such as disease susceptibility.   
 
III.5. Down Syndrome and HSA21 related Monogenic disorders 
 
Down Syndrome or Trisomy 21 is the most common genetic cause for mental retardation with 
an incidence of approximately 1/700 live births. It is a complex disorder in which multiple 
tissues and organs are involved and for which a high range of traits and variability exists; in 
addition to mental retardation the extra-copy of HSA21 is also associated to facial 
characteristics, congenital heart disease, early onset Alzheimer’s disease, increased childhood 
leukaemia and immunological deficiencies (Holtzman and Epstein 1992). The major factor 
risk for the disease is the maternal age, at 30 years old the probability is 1/1000 and at 40 it 
rises to 9/1000.  
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In 1959, Jerôme Lejeune and others detected an extra-copy of HSA21 in somatic cells of 
Down Syndrome patients (Lejeune et al. 1959). It was the first time that a chromosomal 
abnormality was associated to a human disorder.  
 
The mechanisms, at the molecular level, that are involved in the disease are still largely 
unknown. Several hypotheses can however be considered: 
1) All HSA21 genes are not equal:  some genes will be dosage sensitive and thus contribute to 
the phenotype, while others will be dosage insensitive and not contribute to the phenotype.  
2) The dosage effect of some genes could be allele-specific: the effect of the combination of 
alleles can be qualitative (alleles with amino acid variations) or quantitative (alleles with 
variation in gene expression level). 
3) The effect of dosage sensitive genes can be direct or indirect: the indirect effect might be 
due to the interaction of HSA21 genes or gene products with non-HSA21 genes or gene-
products. This could also be allele specific. 
4) Triplication of functionally important sequences such as CNCs could be involved. 
However this would be determined after functional characterisation of CNCs.  
 
In addition to Down Syndrome, HSA21 genes are also associated to other monogenic 
disorders, for example; APP is associated to Alzheimer’s diseases (Goate et al. 1991), CSTB 
to progressive myoclonus epilepsy (Pennacchio and Myers 1996), TMPRSS3 to deafness 
(Scott et al. 2001) and COL18A1 for Knobloch syndrome (Sertie et al. 2000). 
It would be interesting to evaluate the contribution of the 2262 CNCs mapping on HSA21 to 
HSA21 related disorders.  
 
The initial characterization of HSA21q CNCs is the main aim of this work.  
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 95
 RATIONALE 
 
The discovery of a large number of evolutionary conserved sequences in the human genome 
gave rise to a massive enthusiasm in the scientific community. At that time, few studies had 
already shown that evolutionary conserved sequences could overlapped regulatory elements 
(Gottgens et al. 2000; Koop and Hood 1994; Loots et al. 2000; Oeltjen et al. 1997), and might 
thus be use as a tool for the identification of regulatory sequences throughout the genome. 
   
A puzzling feature of CNCs is their negative correlation to gene density and thus their 
tendency to map to gene desert regions. This property could either suggest that most CNCs 
act as long-range regulatory elements or rather have a major role in chromatin structure.  
 
In this chapter, we decided to further investigate the putative regulatory role of CNCs by 
examining their global contribution to gene expression regulation. Contrarily, to previous 
studies we decided to perform a systematic analysis of the regulatory function of CNCs. At 
the time this work began, most of the previous studies on conserved sequences had focused on 
the analysis of CNCs within a specific gene landscape. The observations on the regulatory 
potential of CNCs was thus resulting from the testing of a targeted ‘population’ of CNCs 
(Gottgens et al. 2002; Samaras et al. 2002; Sasak et al. 2002; Thornton et al. 2002). 
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ABSTRACT 
 
The global contribution of conserved non-coding sequences (CNCs) to the regulation of 
human genes is unknown. Deeply conserved CNCs shared between human and teleost 
fish predominantly flank genes active during morphogenesis, where they play a 
significant role in transcriptional regulation (Pennacchio et al. 2006a; Shin et al. 2005; 
Woolfe et al. 2005). However, such elements account for <1% of the CNCs in the human 
genome, which are predominantly shared amongst mammals (Woolfe et al. 2005). Here 
we address systematically the regulatory potential of a large sample of mammalian 
CNCs using a variety of classical assays for enhancer/repressor, promoter, and 
chromatin remodelling activity. We find that only a minority (<20%) of mammalian 
CNCs exhibit evidence of regulatory potential when tested across diverse model human 
cell types. Within any given cell type, the fraction of regulatory CNCs is even lower 
(<10%). The results indicate that the substantial majority of mammalian CNCs do not 
encode canonical cis-regulatory activities, and that human genes are predominantly 
under control of non-CNC regulatory elements. 
 
The manuscript includes 1 Supplementary figure and 4 Supplementary Tables in which all 
sequence coordinates are provided. 
 
INTRODUCTION 
 
Identification of non-coding sequences that regulate the timing, magnitude, and 
environmental responsiveness of human gene expression is a major goal of modern genetics. 
Comparison of the human genome with those of other mammalian species has revealed the 
existence of >250,000 non-protein-coding sequences that appear to have been conserved 
through purifying natural selection (Miller et al. 2004). Such conserved non-coding sequences 
(CNCs) are widely believed to harbor not only the majority of human non-coding nucleotides 
under selection (Dermitzakis et al. 2005; Waterston et al. 2002a) but also the preponderance 
of cis-regulatory sequences important for control of human genes (Boffelli et al. 2004a). 
Currently, a gene regulatory role has been assigned to only a very small fraction of human 
CNCs, largely on the basis of experimentation using a restricted set of loci (Frazer et al. 2004; 
Grice et al. 2005; Kleinjan et al. 2004; Mortlock et al. 2003; Nobrega et al. 2003). 
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Interestingly, the majority of enhancers identified in transgenic studies of CNCs belong to the 
small fraction of CNCs that are also conserved in non-mammalian amniotes (Dodou et al. 
2003) and in fish (Shin et al. 2005; Woolfe et al. 2005). A few of these studies have 
investigated the regulatory potential of CNCs at large; the debate however, regarding the cis-
regulatory potential is still open (Supplementary Table I.1.). The debate on the regulatory 
potential of CNCs is particularly true for the fraction of mammalian-specific CNCs, most 
notably those studied in an unbiased fashion.  
 A puzzling feature of CNCs is their concentration in gene-poor regions of the genome 
(Dermitzakis et al. 2005), where large regions harboring hundreds of CNCs are frequently 
found up to several megabases from the nearest annotated genes. This general trend is present 
on chromosome 21 as well, where CNCs and genes cluster at opposite ends of the 
chromosome(Dermitzakis et al. 2005). Recently, deletion of one such region comprised of 
>1,200 CNCs spanning ~2 Mb of the mouse genome was found to yield a normal adult 
phenotype (Nobrega et al. 2004). While some distal enhancers and Locus Control Regions 
(LCRs) are capable of operating over long distances (Lettice et al. 2002; Merla et al. 2006; 
Spitz et al. 2003), the vast majority of classical cis-regulatory elements appear to be located 
proximal to their cognate genes. Indeed, numerous reports indicate that cis-acting elements 
are subject to a strong distance effect, whereby their potency is markedly diminished with 
increasing distance from their substrate promoter(s) (Kmita et al. 2002). Moreover, known 
distal regulatory sequences are usually found either in isolation or in small clusters of 2-5 
elements well-separated from the nearest functional genomic feature.  
 
Here we address the regulatory potential of CNCs in diverse human cell types using a variety 
of standard functional assays. In marked contrast to findings from pan-vertebrate CNCs in the 
context of developmental genes, we find that only a small fraction of mammalian CNCs 
display regulatory potential in model cell types. Combined with an unusual genomic 
distribution favoring gene-poor regions, the results indicate that most CNCs in the human 
genome are not involved in classical transcriptional regulation, suggesting a novel role in 
genome function. 
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RESULTS 
 
Previously we described 2,262 CNCs on human chromosome 21 defined by strong human-
mouse sequence identity ("70% over "100bp with no gaps) and the absence of evidence of 
transcription across a wide range of human tissues (Dermitzakis et al. 2002a). Although 
defined originally on the basis of homology with the mouse, the vast majority of these CNCs 
are conserved across mammals (Dermitzakis et al. 2003b). The features of this particular set 
of HSA21 CNCs do not differ from the CNCs mapping on the rest of the genome 
(Dermitzakis et al. 2005).  
We began by randomly selecting 71 HSA21 CNCs with high ("80% over "100bp with 
no gaps) human-mouse sequence identity (Figure I.1 and Supplementary Table I.2). The 
genomic characteristics of the selected sequences are shown in Table I.1. Briefly, they do not 
differ significantly from the overall set of highly conserved CNCs in key parameters 
including genomic distribution relative to annotated genes and G+C content. For comparison, 
we randomly selected 21 non-CNC single-copy HSA21 sequences as controls (Figure I.1 and 
Supplementary Table II.2); control sequences did not differ significantly from CNCs in 
length, G+C content, and genomic distribution (Table I.1). 
 
Table I.1.Characteristics of CNCs and controls 
 
 
Number Lenght 
Hs-mm 
homology 
G+C content 
Intergenic/Intronic 
distribution 
Random 
CNCs 
71 
254.7 & 
73.8bp 
89% 
[80%-98%] 
37.7% 
[28.1%-63.1%] 
73.2% / 26.8% 
Control 
sequences 
21 236 & 56.7bp 
58% 
[49%-63%] 
41.5% 
[25%-60%] 
47.6% / 52.4% 
TFBS CNCs  23 
148.4 & 
53.5bp 
78% 
[70%-90%] 
52.3% 
[39.5%-73.7%] 
47.8% / 52.2% 
DHS CNCs  30 
233.4 & 
110bp 
85% 
[74%-97%] 
44.2% 
[30.9%-73.3%] 
66.7% / 33.3% 
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Figure I.1. HSA21 CNCs and control sequences. Shown are the mapping locations of the human chromosome 
21 CNCs and control non-genic non-transcribed sequences used in this study relative to known HSA21 genes. 
(a) 2262 CNCs described in Dermitzakis et al. (Dermitzakis et al. 2002a). (b) 71 CNCs selected randomly. (c) 21 
control single-copy sequences chosen randomly along HSA21. (d) 23 CNCs from Dermitzakis et al. coinciding 
with Sp1/Myc/p53 binding sites determined by Cawley et al. (Cawley et al. 2004). (e) 30 DHS CNCs from 
Dermitzakis et al. identified as hypersensitive to DNaseI [(Crawford et al. 2004) and this work]. (f) 38 putative 
promoter CNCs. 
 
The ability to potentiate or repress expression of a linked minimal promoter element is 
a widely exploited property of enhancer and silencer elements. We therefore tested both CNC 
and control sequences for their potential to activate or repress a minimal promoter driving a 
luciferase reporter gene (Supplementary Figure I.1a). We separately cloned 71 CNC and 21 
control sequences upstream of the TK minimal promoter and then measured luciferase 
activity in human embryonic kidney cells (293T) and hepatic carcinoma cells (Huh7). To 
control for transfection efficiency, we co-transfected a renilla reporter and computed the 
firefly:renilla luciferase ratio (see Materials and Methods section). For each of the 92 
constructs we performed three experiments with three biological replicates each (828 total 
data points). Figure I.2a and Figure I.2e show the resulting normalized luciferase results for 
each CNC construct expressed as the fold change relative to the mean of the 21 control 
sequences. We considered increases and decreases of >2-fold relative to the mean of the 
control sequences, and with significant P-value (P<0.05, one sample T-test), to constitute 
presumptive evidence of regulatory potential. Of 71 CNCs, only 9 elements (12.7%) met this 
criterion in either cell type, suggesting that CNCs at large were not significantly enriched for 
cis-regulatory sequences. We found no correlation between the ability to modulate 
transcription of the reporter gene and either CNC length or degree of conservation; nor is this 
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ability related to CNC position along HSA21; nor CNC position in intergenic vs. intronic 
space (P>0.05 for all, Spearman correlation). These results stand in stark contrast to studies 
reporting a high proportion of enhancer activities when CNCs – particularly the most highly 
conserved elements (Supplementary Table I.1) (Pennacchio et al. 2006a; Shin et al. 2005; 
Woolfe et al. 2005) – are tested in cell lines or mouse models (Grice et al. 2005; Mortlock et 
al. 2003; Pennacchio et al. 2006a; Poulin et al. 2005). 
We next considered whether a lack of evident regulatory potential was due to (i) the 
orientation of the CNC with respect to the TK promoter; (ii) the inability of the assay 
generally to identify positive events, and (iii) whether the cell types we studied were not 
particularly fertile ground. To address orientation-dependence, we re-cloned 16 CNCs 
selected randomly in the opposite orientation and assayed for luciferase activity in 293T cells. 
Of these, only 2 (12.5%) showed a significant polarity-dependent transcriptional 
activation/repression (data not shown) showing that orientation could not explain the 
observed lack of regulatory potential. 
 
To address the general permissiveness of the assay to positive events, we examined 
CNCs for which independent high-throughput assays carried out in different cellular 
environments had suggested regulatory potential. Cawley et al. described mapping of binding 
sites for two promiscuous (Sp1, cMyc) and one more specialized (p53) transcriptional 
regulatory factors along the entirety of HSA21 in T-lymphocytes (Jurkat) and colonic 
adenocarcinoma (HCT116) cells (Cawley et al. 2004). Of 305 total binding sites mapped 
across both cell types, 23 (7.5%) coincide with HSA21 CNCs (~1% of CNCs). Since many 
cis-regulatory elements show activity across a range of cell types (particularly in the context 
of transient transfection studies), and since Sp1 and cMyc are ubiquitous activating factors 
(Cawley et al. 2004), we reasoned that this set of independently ascertained CNCs with 
regulatory potential should be enriched in enhancer elements detectable in our assay. We 
therefore subcloned and assayed this first positive control set of 23 CNCs in 293T and Huh7 
cells (Figure I.2b,f). These elements displayed a considerable higher mean level of luciferase 
activity in both 293T cells and Huh7 cells, and a correspondingly higher proportion of 
elements with significant elevations (P<0.05) vs. random CNCs (17.4% vs. 5.6% in 293T and 
21.7% vs. 7% in Huh7) (Figure I.2i, j). 
We next tested 30 CNCs overlapping DNaseI hypersensitive sites (DHSs) from one or 
more cell types, which define chromatin regions accessible to the regulatory machinery and 
are well-known to be associated with diverse cis-regulatory elements. Indeed, DHS CNCs 
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displayed considerably higher proportional activity than random CNCs (16.6% vs 5.6% in 
293T and 13.3% vs 7% in Huh7) (figure I.2c,g). 
 
 
 
Figure I.2. Enhancer/repressor assay of CNCs. Bar graphs show the fold change of luciferase activity 
compared to the control sequence set for 71 selected CNCs (a,e), 23 TFBS CNCs (b,f), 30 DHS CNCs (c,g), and 
11 previously characterized CNCs (d,h) in 293T and Huh7 cell lines respectively. Red lines show &2 fold change 
threshold. Asteriks denote statistically significant change (one sample T-test). (i,j) show the distribution of the 
luciferase activity for each subset of sequences in 293T and Huh7 cell lines respectively. The proportion of 
putative regulatory elements of each subgroup is indicated at the bottom of both graphs. 
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Next we considered whether combining current gene annotation information with 
CNCs might systematically expose a particular class of cis-regulatory sequences such as 
transcriptional promoters. Previous studies suggest that the majority of human promoters 
overlap evolutionarily conserved sequences (Kim et al. 2005a; Kim et al. 2005b). We 
therefore identified HSA21 CNCs that lie within 1kb from the annotated 5’end of a known 
gene. This revealed a total of 38 CNCs (excluding the keratin gene cluster region), of which 
18 were contained within closely spaced clusters of 2 or more CNCs. 
To test the potential of these proximal CNCs to function as transcriptional promoters, 
we subcloned 14 singleton CNCs and 3 CNC clusters in their native orientation upstream of a 
luciferase gene in an episomal vector(Liu et al. 2001) (Supplementary Figure I.1c) and 
assayed luciferase activity following transfection into 293T cells (Figure I.3a). We observed 
a significant activation of the luciferase transcription by 7/17 (41%) of the tested constructs; 
no luciferase transcription was driven by the vector only or by CNCs mapping >1kb from 
known genes (n=3). While evincing a higher success rate than the enhancer assay, the results 
suggest that, overall, only a small fraction of HSA21 CNCs function as transcriptional 
promoters (7/2262=0.3%). Those results are consistent with the low fraction of conserved 
tissue specific promoters identified in a previous computational study (Pennacchio et al. 
2007). Moreover, it is noticeable that all of the sequences testing positive for promoter 
activity were mapping to evolutionarily conserved CpG islands (Kim et al. 2005b; Koyanagi 
et al. 2005). An additional feature of CpG island promoter regions is their high prevalence in 
bidirectional promoters (Adachi and Lieber 2002; Qvist et al. 1998; Trinklein et al. 2004), 
which prompted us to analyze the bidirectional potential of the putative CNC promoters. All 
the putative promoter CNCs tested in the reverse orientation (n=6) were shown to be able to 
drive the expression of the reporter gene independently of the strand they were cloned into, 
suggesting that these are indeed bidirectional promoters (Figure I.3a). For comparison none 
of the 7 CNC constructs negative in the first test for promoter activity were able to drive 
expression of the luciferase reporter when cloned in the opposite orientation. In summary only 
19.5% of the randomly assayed CNC were positive in either the enhancer/repressor or the 
promoter assays (Figure I.3b). 
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Figure I.3. Assay of putative CNC promoters. (a) Bar graph show the normalized luciferase activity of 
putative promoter CNCs in an episomal vector without minimal promoter. Bidirectionality was tested by cloning 
the sequences in the native or reverse orientation. Broken bars show values that are off scale. (b) Pie chart 
showing the proportion of random sequences with enhancer, silencing, promoter or no activity. 
 
We next considered the possibility that CNCs encode cis-regulatory elements that do 
not function in the context of our assay, such as insulators or LCR-like elements (Li et al. 
2005), both of which require a chromatin context for their activity. Additionally, some 
enhancer, silencer or even promoter elements may similarly require assembly into chromatin 
(Liu et al. 2001). We therefore sought to address the question of CNC regulatory potential 
using a generic assay that exploits a common feature of all known classes of human cis-
regulatory elements – namely, their ability to remodel local chromatin architecture, resulting 
in markedly increased physical accessibility. This generic structural accessibility is classically 
assayed by determining chromatin sensitivity to the non-specific endonuclease DNaseI. 
DNaseI hypersensitivity has the possibility not only to detect active elements, but also those, 
which are potentially active or ‘poised’ in their cognate tissues (Gross and Garrard 1988). 
Furthermore, many elements that are active mainly in one tissue or developmental stage tend 
to retain chromatin remodeling and DNaseI hypersensitivity in related tissues or subsequent 
 105
stages when they are not functionally critical (Tuan et al. 1985). These features make DNaseI 
hypersensitivity an outstanding screening test for the cis-regulatory potential of CNCs.  
The advent of high-throughput real-time PCR-based methods for assaying DNaseI 
sensitivity and hypersensitivity (Dorschner et al. 2004; McArthur et al. 2001) renders feasible 
the directed and efficient interrogation of a large collection of CNCs. The observed lack of 
correlation between sequence conservation and regulatory potential in enhancer/silencer and 
promoter assays (Figure I.3b) caused us to examine CNCs more broadly. We randomly 
selected 192 elements from the set of CNCs defined using our original criteria ("70% over 
"100bp with no gaps) and assayed these for DNaseI hypersensitivity in eight diverse human 
cell types (Figure I.4 and Supplementary Table I.3). This revealed that approximately 13% 
(25/192) of CNCs formed DNaseI hypersensitive sites (DHSs) in one or more cell types. Of 
these, 14 DHS CNCs were cell type-specific, while 11 CNCs formed DHSs in 2-8 cell types. 
The proportion of CNCs forming DHSs in any given cell type ranged from 1.6%-4.7% (3-
9/192). However, when CNCs forming DHSs in more than one cell type are excluded (to 
avoid double-counting between tissues), the number of additional CNC DHSs discovered with 
each additional tissue drops dramatically. For example, of the 15 CNC DHSs detected in 
colonic (CACO2), pancreatic (PANC1), and neural (SK-N-SH) cells, 13 were detected in 
other cell types. This suggests that adding progressively larger cell / tissue panels is unlikely 
to increase markedly the proportion of CNC DHSs. 
 
 
Figure I.4. Multi-tissue DNaseI hypersensivity patterns of CNCs. Shown are the locations of HSA21 CNCs 
(top row, black vertical marks), 192 CNCs tested for DHSs potential (second row, black vertical marks), and 
CNCs encoding DHSs in one or more cell types (colored vertical marks). Absence of a colored vertical mark 
beneath a CNC from row 2 indicates lack of DHS potential in the tissue tested. 
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We also considered whether the aforementioned results might be due to biased 
selection of CNCs. We aimed to estimate the degree to which the results differ from random 
expectation given the distribution of both DHSs and CNCs. To address this in an unbiased 
fashion, we mapped DNaseI hypersensitive sites in a continuous fashion across 2.2Mb of 
HSA21 in multiple cell types using quantitative chromatin profiling (Dorschner et al. 2004). 
We examined two large continous regions: a 1.7Mb tract (chr21:32,668,237-34,364,221, 
ENCODE region #ENm005) containing 32 genes and 95 CNCs, and a 500kb tract 
(chr21:39,244,467-39,744,466, ENCODE region #ENr133) containing 7 genes and 9 CNCs. 
We designed 7,211 PCR amplicons (avg. length ~225bp) tiling end-to-end across these 
regions, achieving gross genomic coverage of 86%. All CNCs in these regions were covered 
by the tiling path. We then quantified DNaseI sensitivity and mapped DNaseI hypersensitive 
sites in four diverse cell types: immortalized human primary b-lymphoblastoid cells (line 
GM06990; Coriell); colonic adenocarcinoma cells (CACO2; ATCC); HeLa cells; and SKnSH 
neuroblastoma cells (ATCC) differentiated with retinoic acid to form neuroblasts. Four 
replicates were performed for each amplicon and tissue and non-DNaseI-treated control (total 
242,176 measurements). Overall, we mapped 595 DHSs within these regions, of which 416 
were distinct and 179 were present in two or more tissues (Table I.2 and Supplementary 
Table I.4). Results of DHS mapping and the relationship of DHSs to CNCs across a 1.7Mb 
region of HSA21 is shown in Figure I.5a. Of 568 distinct DHSs, 15 (3.6%) overlapped a 
CNC (Table I.2). The fraction of CNC DHSs (15/104; 14.4%) is similar to that from the 
multi-tissue testing described above. To determine the degree to which CNCs were enriched 
in DHSs over random expectation we used a permutation approach. We generated 1,000 
random samples (restricted to the tiling path) equal to the number and size of DHSs, and 
computed the overlap with CNCs (Figure I.5b). When DHSs from all four tissues are 
considered collectively, CNCs are not significantly enriched in DHSs; indeed, the overlap 
between the two is squarely within the realm of random expectation. 
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Table I.2. Unbiased mapping of DHS-CNC overlap 
Tissue  # DHSs CNC-DHSs 
CACO2   148      9  
GM06990   134         7 
HeLa    179        12 
SKnSH   134        5 
All    416*        18** 
 
*Note: 179 DHSs were present at the same genomic location in two or more tissues. 
**One DHS overlapped contained three smaller CNCs thus there are 18 CNCs 
overlapping DHSs. 
 
 
Figure I.5. Unbiased mapping of DHSs and DHS:CNC overlaps. (a) Shown for a 1.7Mb region of HSA21 are 
locations of CNCs (top row, vertical red marks); locations of known genes and annotated transcripts; and maps 
of DNaseI hypersensitivity in intestinal (CACO2), lymphoid (GM06990), cervical (HeLa), and neural (SKnSH) 
cell types. A total of 416 distinct DHSs map to this region. (b) Results from 1000 random trials of sample 
size=416 and corresponding overlap with CNCs. Vertical arrow indicates actual result, which is within random 
expectation 
 
Finally, we considered an important caveat to the aforementioned functional assays, 
namely, that they did not assay CNCs shown previously to function as enhancers or repressors 
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in cell and transgenic systems (Grice et al. 2005; Pennacchio et al. 2006a). We therefore 
examined 11 pan-vertebrate CNCs that function as developmental enhancers in vivo or in 
vitro (Grice et al. 2005; Pennacchio et al. 2006a). Four multi-species conserved sequences 
from the RET locus (MCS1-3, MCS-32, MCS-8.7, MCS+9.7)(Grice et al. 2005) and seven 
pan-vertebrate conserved elements shown to function as developmental enhancers in 
transgenic mice (UCE1, 52, 74, 76, 260, 359 and DC2) (Pennacchio et al. 2006a) were cloned 
and assayed for activity in 293T and Huh7 cells. Collectively, we found that 46% (5/11) of 
the constructs exhibited enhancer or repressor activity in at least one cell line (figure I.2d,h). 
We also tested the elements for DNaseI hypersensitivity in five cell types: CACO2 
(intestinal), GM06990 (lymphoblastoid), HeLa (cervical), and HL60 (myeloid). Of 11 
elements, 82% (9/11) were DNaseI hypersensitive in at least one cell type sites (Table I.3). 
We conclude that both the transfection and DNaseI assays are readily capable of detecting the 
cis-regulatory potential of CNCs in adult-stage cells. 
Taken together, our results from multiple assay types across a range of human cell 
lines argue strongly that the majority of mammalian CNCs do not fulfill a classical cis-
regulatory role in differentiated human cells. 
 
Table I.3. Tests of known CNC functional elements 
Element Reference   Functional role* DNaseI hypersensitivity 
E1  [Pennacchio, 2006]  enhancer HeLa, GM06990 
E52  [Pennacchio, 2006]  repressor HL60 
E74  [Pennacchio, 2006]  -   - 
E76 [Pennacchio, 2006]  - CACO2, GM06990, HeLa, HL60 
E260 [Pennacchio, 2006]  repressor CACO2, GM06990 
E359  [Pennacchio, 2006]  enhancer CACO2, GM06990, HL60 
DC2  [Pennacchio, 2006]  - - 
MCS-1.3 [Grice, 2005]  repressor HeLa, HL60 
MCS-8.7 [Grice, 2005]  repressor CACO2, HL60 
MCS-32 [Grice, 2005]  - HL60 
MCS+9.7 [Grice, 2005]  - CACO2, GM06990 
 
*Functional roles correspond to results of transfection assays shown in Figure I.2. Cell types 
listed are those in which the element produced a DNaseI hypersensitive site. The genomic 
coordinates of each element are shown in Supplemental Table I.2. 
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DISCUSSION 
 
The global contribution of CNCs to the regulation of human genes has heretofore not been 
defined. A number of studies have reported the potential of CNCs to function as enhancer 
sequences in the context of specific gene systems (Bejerano et al. 2004b; Delabesse et al. 
2005; Frazer et al. 2004; Grice et al. 2005; Kleinjan et al. 2004; Loots et al. 2005; Mortlock et 
al. 2003). It is notable that the CNCs employed in prior studies were highly ascertained. For 
example, CNCs that are conserved between humans and fish are dramatically overrepresented 
(or, in some cases, targeted exclusively (Pennacchio et al. 2006a; Shin et al. 2005; Woolfe et 
al. 2005)), though they account for <1% of all CNCs. Human-fish CNCs are highly 
concentrated around approximately 150 genes involved in early developmental processes 
(Woolfe et al. 2005). 
Our study focused on mammalian (and specifically on human-mouse) CNCs, which 
account for the vast majority of the conserved non-coding elements in the human genome. 
Our results suggest that the proportion of CNCs exhibiting classical cis-regulatory potential in 
model human cell types is low – on the order of ~20%. Within any given cell type, the 
proportion of these CNCs is even lower, around ~5%. On an absolute level, this suggests that 
the average adult-stage cell contains ~10,000 CNCs with active regulatory potential. Even if 
CNCs were distributed uniformly in the genome, this equates to <1 CNC per active gene. 
However, the marked clustering of CNCs (combined with their concentration in large gene 
deserts), implies that the effective ratio is far lower. Most genes are believed to be under 
control of multiple simultaneously active cis-regulatory sequences. As such, the global 
proportion of transcriptional regulatory activity of human genes accounted for by CNCs is 
likely to be very low. 
Some caveats attend our conclusions. First, it is probable that sampling additional cell 
types will disclose additional CNCs coinciding with DHSs or exhibiting activity in reporter 
assays, boosting the overall proportion of CNCs with regulatory potential. However, because 
many CNCs show regulatory potential in more than one cell type, expanding the tissue 
spectrum has a diminishing rate of return. It is therefore unlikely that the majority of CNCs in 
the human genome will ultimately be found to harbor classical cis-regulatory activity. Since 
CNCs are under selection in humans, the results highlight the possibility that these elements 
play a role in genome structure or function that departs significantly from current concepts of 
gene regulation.  
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Second, it may be argued that the proper models or functional assays were not 
employed. Conserved sequences (specially conserved to fish) have often been studied in vivo 
and results from this approach suggest that they behave as tissue-specific enhancers 
(Pennacchio et al. 2006a).There are three arguments to address the concern of non-detecting  
these specific regulatory sequences: i) our assay on 11 of those sequences shows we can 
detect a majority of them, ii) several studies on CNCs currently utilize in vitro and in vivo 
approaches and show that the results obtain from both approaches are mostly consistent 
(Abbasi et al. 2007; Baroukh et al. 2005; Loots et al. 2005; Wang et al. 2007), iii) most of the 
discoveries and understanding of the complexity of gene regulation  is based exclusively on 
cell lines models (Bernstein et al. 2005; Consortium 2007; Heintzman et al. 2007; Kim et al. 
2005b).  
In addition to classical transcriptional cis-regulation (i.e., regulation of the rate of 
transcription and its spatial and temporal distribution), CNCs have been proposed to function 
in regulation of alternative splicing (Glazov et al. 2005; Lareau et al. 2007; Sorek and Ast 
2003); the general modulation of chromatin structure (Glazko et al. 2003); and as 
unconventional ncRNA species (Pedersen et al. 2006; Washietl et al. 2005). The last is less 
likely since we specifically excluded CNCs that showed evidence of transcription. Since 80% 
of the CNCs we studied were in the intergenic space, they are unlikely to function in 
regulation of splicing. If CNCs had a direct role in modulating chromatin structure as, e.g., an 
insulator or boundary element, this would have been detected in our DNaseI studies since 
such elements coincide with DHSs. However, the possibility remains that CNCs may function 
indirectly in chromatin structure by serving as the substrate for as-yet-undescribed chromatin 
modifying factors that do not give rise to localized chromatin remodeling and altered 
accessibility. The localization of CNCs in gene poor regions makes them attractive targets for 
involvement in the process of large-scale genome repression. 
It is also possible that the CNCs we tested lacked certain conserved features important 
for cis-regulatory activity, which are present in more deeply conserved elements. Pan-
vertebrate CNCs (i.e., those exhibiting conservation from human to avians and fishes) are 
rare. Consequently, of the HSA21 CNCs we selected for study, it is not surprising that none 
exhibit conservation beyond marsupial and monotreme mammals. In view of our results 
testing known pan-vertebrate CNC enhancers, it is possible that this class generally would 
have been considerably more active in our functional assays. However, even if all deeply 
conserved CNCs were ultimately found to be transcriptional regulatory elements, this does 
not account for the vast majority of CNCs clearly under selection in mammals.  
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Importantly, the high proportion of silencers we detected in our assay (for enhancer sequences 
previously tested in whole mouse assay) is of considerable interest. In fact, a putative down-
regulatory function has already been suggested for a few sequences in the original publication 
(Pennacchio et al. 2006a). Our results could actually suggest a model in which highly 
conserved sequences that mainly serve as specific neuronal enhancers could be negative 
regulators in non-neuronal tissues. 
 In summary, we have presented a systematic assessment of the regulatory potential of 
CNCs in human cells. The lack of findings in a series of classical cis-regulatory assays, 
coupled with the peculiar distribution of CNCs in the human genome, points to an 
unconventional role for most CNCs in genome function. Thus CNCs cannot be assumed to 
comprise the dominant mediators of cis-regulatory function in definitive human cells. Our 
results therefore highlight both the need to investigate further the role of CNCs in genome 
function, and the continued requirement for direct interrogation of the genome using 
biochemical and other functional assays. 
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MATERIAL AND METHODS 
 
Enhancer assays. 293T and Huh7 cell lines were cultured in DMEM Glutamax 
supplemented with 10% FCS, 1% streptomycin-penicillin. Each CNC was amplified by PCR 
from human genomic DNA with primers with SalI overhangs (primer sequences available 
upon request). The restriction digested and purified PCR products were then cloned non-
directionally into the XhoI site of the luciferase reporter vector (pTAL-Luc, Clontech). All 
constructs were verified by direct sequencing.  
Transfections were performed with Fugene reagent as described by the manufacturer protocol 
(Roche). Briefly, 1x104 293T cells/well and 1.5x104 Huh7 cells/well were grown into 96 well 
plates (Promega), and transiently transfected with 100ng of each pTAL-Luc CNC construct, 
along with 8ng of control plasmid expressing the renilla gene (pRL-SV40, Promega). Each 
construct was assayed in triplicate in three independent experiments. Firefly and renilla 
luciferase activities were measured using the Dual-GloTM Luciferase Assay System (Promega) 
and a LumiCountTM microplate luminometer (Packard). 
We determined the luciferase activity driven by each construct by first measuring the firefly 
to renilla luciferase ratio for each transfection. In a second step, the signal was normalized to 
the control ratio (pTAL-Luc / pRL-SV40) included on each plate. The strength of the putative 
regulatory element is then assessed by comparison to the mean activity of the set of controls. 
This normalization to the mean activity of the controls gives us the fold change in luciferase 
activity plotted in figure I.2 (a-h). Two-fold change significance is assessed by the one sample 
T-test statistic test.  
 
Promoter assays. Coordinates of the 5’ end of all known and Refseq HSA21 genes were 
downloaded from the UCSC Genome Browser (http://genome.ucsc.edu/) and intersect with  
the 2262 HSA21 CNCs (Dermitzakis et al. 2002a) using Galaxy Browser 
(http://main.g2.psu.edu/). CNCs mapping within 1kb from the transcription start site were 
retained in the “potential promoter” pool. As above CNC or CNC-clusters were amplified 
directly from human genomic DNA and cloned in their native orientation into the pREP4-Luc 
episomal vector (Liu et al. 2001) (See online supplementary materials for sequences of 
primers, Table I.S1). To test for bidirectional promoter 13 out of the 17 constructs were also 
cloned anti-orientationnally. Transfections of cells with 100ng of the experimental vector 
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(CNC-pREP4) along with 16ng of the internal control vector (pREP7-Luc, renilla) per well 
were performed as described above. 
 
DNase I hypersensitivity. We performed DNaseI hypersensitivity testing as described in 
Dorschner et al. (Dorschner et al. 2004), and Sabo et al. (Sabo et al. 2004). We cultured the 
following cell types in humidified incubators at 30-37°C and 5% CO2 in air, using RPMI 
medium 1640 (Invitrogen, Carlsbad CA) supplemented with 7.5% FBS and Penn Strep : 
GM06990 (Coriell Institute, Camden NJ) ; HeLaS3 (ATCC) ; SKnSH (ATCC); PANC1 
(ATCC); NCI-H460 (ATCC); K562 (ATCC); and HepG2 (ATCC). SKnSH cells were 
differentiated into neuroblasts by adding 6uM all trans retinoic acid (ATRA) at ~50% 
confluency for 48 hours prior to harvest.  Primary human renal epithelial cells (HRE) were 
obtained from Cambrex Biosciences (Baltimore, MD) and cultured according to the supplier’s 
protocol.  To remove background introduced from actively dividing cells, we used a standard 
approach for synchronizing cells in G1 by sequential temperature shifts. DNaseI treatments 
were performed as described previously (Dorschner et al. 2004). DNaseI hypersensitive sites 
were identified as clusters (1 or more) contiguous amplicons) with DNaseI sensitivity ratios 
(copies in DNaseI treated vs. control) that exceeded the 95% confidence bound on outliers 
relative to the moving DNaseI sensitivity baseline determined by a LOESS approach as 
described (Dorschner et al. 2004). 
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SUPPLEMENTARY FIGURES 
 
Supplementary figure SI.1. Vectors used in enhancer and promoter studies. (a) CNCs were cloned upstream 
of a minimal TK promoter in a non-directional orientation, 16 CNCs were accumulated in both orientation. (b) 
pRL-SV40 was transfected along with the pTAL-luc experimental vector to control for transfection efficiency in 
the enhancer /repressor assay. (c) putative promoter CNCs (single or clustered) were cloned upstream of the 
luciferase reporter gene in their native orientation, 13 were obtained in the reverse orientation too. (d) pREP7 luc 
was transfected along with the pREP4 luc, as an internal control for transfection efficiency. 
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SUPPLEMENTARY TABLES 
 
Except the first table, supplementary tables 2-4 are Excel Files that list CNCs coordinates or 
DNAseI hypersensitive sites coordinates. I do not include these tables in this thesis 
manuscript but the data are available upon demand.  
 
 
Supplementary Table I.1. Regulatory potential of CNCs based on published work. 
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Supplementary Table I.2. Coordinates of CNCs and controls for cell transfection assays. 
 
Supplementary Table  I. 3. Direct DNaseI hypersensitivity testing of random CNCs. (a) CNC-DHSs by 
tissue type. (b) All 192 randomly-selected CNCs tested for DNaseI hypersensitivity across cell types. 
 
Supplementary Table I.4. Unbiased mapping of DNaseI hypersensitive sites across 2.2Mb of HSA21. 
Coordinates of DNaseI hypersensitive sites by tissue. 
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RATIONALE 
 
Most of the studies on the putative role of CNCs have focused on their regulatory potential. 
The results obtained support a substantial contribution of conserved sequences in the 
regulation of gene expression (Pennacchio et al. 2006; Shin et al. 2005; Woolfe et al. 2005). 
Conversely, our investigation on the regulatory activity of a set of HSA21q CNCs suggests 
that only a fraction of the conserved sequences behave as regulators (Chapter I), and thus the 
results we obtained are in contrast with the widespread notion that evolutionary conservation 
might be a mark for regulatory elements. Our work differs from the other published studies 
because: i) the majority of CNCs in our set are conserved in mammals only (as opposed to 
human-fugu conservation in many studies), ii) the assayed sequences are not biased toward a 
specific genomic region, they map both in intronic or intergenic regions that lie either in gene 
rich or gene poor region of the chromosome. 
 
In this chapter, we have addressed the putative impact of extended phylogenetic conservation 
on the detection of regulatory CNCs. 
  
As mentioned previously, none of the HSA21q CNCs is conserved down to fish. In December 
2004, the genome of the chicken (Gallus gallus) was completed (Hillier et al. 2004), and we 
took advantage of its availability to estimate the proportion of HSA21q CNCs conserved in 
this species and to evaluate their regulatory potential. The chicken genome is an 
“intermediate” genome in terms of phylogenetic distance since it diverged from human 
approximately 350Mya (human-mouse: 75Mya and human-fish: 450Mya) (Hedges et al. 
1996). 
Comparative analyses of HSA21q CNCs with the chicken genome revealed that 5-6% of them 
have been conserved for at least 350Mya (Dequéant and Pourquie 2005). In this work, we 
have evaluated the regulatory potential of a subset of these CNCs in the chicken model. More 
specifically, we explored their activity in two early embryonic stages of the chick retina (E3 
and E6). The use of the retina give us the opportunity to investigate a putative function of 
CNCs in a nervous system derived tissue (Chow and Lang 2001); in addition the early 
embryonic stages used for experimental analyses assess the activity of CNCs in 
undifferentiated (stem-cells like) cells (Reh and Fischer 2001; Sidman 1961; Willbold and 
Layer 1992).  
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EXTENDED PHYLOGENETIC CONSERVATION CONTRIBUTES TO THE REGULATORY 
POTENTIAL OF CNCS 
 
Collaborative project with Dr. Jean-Marc Matter and Dr. Florence Chiodini at the 
Department of Biochemistry, University of Geneva, Switzerland. 
Additional contributors are: Christelle Borel, Carine Wyss and Stylianos E. Antonarakis at 
the Department of Genetic Medicine and Development, University of Geneva, Switzerland. 
 
INTRODUCTION 
 
Background  
Conserved Non-Coding sequences (CNCs) are evolutionarily DNA sequences that are under 
purifying selection (Dermitzakis et al. 2004; Drake et al. 2006). Their identification results 
from comparative analyses between different species, such as human, mouse, chicken, fish 
(Boffelli et al. 2004; Shnyreva et al. 2004; Thomas et al. 2003). The combinations of species 
used might delineate different subclasses of CNCs. The function of a majority of CNCs is still 
unknown, but evidence for a regulatory activity has been established for a subset of them 
(Nobrega et al. 2003; Pennacchio et al. 2006; Poulin et al. 2005; Shin et al. 2005; Woolfe et 
al. 2005). A large contribution to the regulatory CNCs pool might be provided by the fraction 
of deeply conserved sequences (i.e. conserved in human-fish alignments); thus extended 
conservation (beyond mammals) might enrich for regulatory function. Supporting this 
hypothesis, the screen of a subset of mammalian CNCs (limited conservation) has suggested 
that only a small fraction of them behaved as regulators (Attanasio et al.).  
 
In December 2004, the genome of Gallus gallus was published (Hillier et al. 2004). The 
human-chicken comparative analysis showed that approximately 2.5% is selectively 
conserved between these two species, with 44% corresponding to protein coding genes, 25% 
to intronic sequences and 33% to intergenic regions. Our comparative analysis of HSA21q 
CNCs with the chicken genome showed that approximately 5-6% of them can be aligned to 
the chicken genome. 
  
At the time this study was undertaken few investigations had shown that human-chicken 
conservation was able to identify regulatory elements associated to genetic loci (Uchikawa et 
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al. 2003; Uchikawa et al. 2004). Following the release of the Gallus gallus genome and the 
identification of a set of HSA21q ‘GalCNCs’, we set out to evaluate the significance of the 
intermediate conservation (compared to mouse and fish), in terms of the regulatory potential, 
using an approach which is closer to the in-vivo situation. 
 
The Chicken as a model system 
The chicken is a major model organism in developmental biology because: i) their embryos 
come conveniently packaged in eggshells, ii) they have a rather short embryonic development 
(21 days, figure II.1) and iii) they can easily be manipulated experimentally. Chick embryos 
are easily accessible from pre-gastrulation stages and throughout organogenesis. Early 
embryos or tissue derived can be cultured (New 1997), but most importantly living embryos 
can be manipulated in ovo and their development can be followed for several days (Brown et 
al. 2003). In addition, although whole-animal transgenesis is still very difficult, in ovo 
electroporation or explanted tissues electroporation has become commonly used methods 
(Itasaki et al. 1999; Ogura 2002; Uchikawa et al. 2003).  
  
In terms of genomics, due to its position in the evolutionary tree between fish and mammals, 
the chicken is expected to provide invaluable information for understanding vertebrate 
genome evolution. Initial comparison of human and chicken genomes have identified 
approximately 5% of conserved sequences (Dequéant and Pourquie 2005), that show 
clustering and preferential mapping far from known genes (Hillier et al. 2004).  
 
 
 
 
Figure II.1. Chick embryonic development. From left to right; stage E5, E6, E10, E12 and E18. Reproduced 
from http://www.microscopy-uk.org.uk/mag/artnov04macro/mlchicken.html.  
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Development and structure of the chick retina 
In the chick embryo, the formation of the eye starts early on the second day of development as 
a result of the evagination of the diencephalon (brain vesicle) that gives rise to the optic 
vesicle. The optic vesicle develops into an optic cup, and ultimately into a neural retina, the 
pigmented epithelium (RPE), the ciliary epithelium and the iris (figure II.2). Although derived 
from the same region of the neural tube, these tissues are quite distinct; for example, the 
mature neural retina is a multilayered structure containing the photoreceptors and neurons 
necessary for vision, while the RPE is a single layer of non-neuronal, pigmented cells that are 
necessary for the support of the retinal photoreceptors. For review see (Adler 2000; Chow and 
Lang 2001; Mey and Thanos 2000).  
 
 
 
Figure II.2. Genesis of the vertebrate eye. Presumptive or differentiated eye tissues are color-coded in the 
following manner: blue, lens/cornea; green, neural retina; yellow, retinal pigmented epithelium (RPE); purple, 
optic stalk; red, ventral forebrain/prechordal mesenchyme; grey, mesenchyme. A) Evagination of the forebrain 
region (arrow) forms the optic pit (OP) that give rise to the optic vesicle. The optic vesicle region is divided into 
dorso-distal region (green), which contains the presumptive neural retina (PNR) and RPE, and the proximo-
ventral region, which gives rise to the presumptive ventral optic stalk (POS).  B) The optic vesicle continues to 
growth till the lens placode (LP) and the presumptive neural retina (NR) come into contact. DOS, dorsal optic 
stalk; VOS, ventral optic stalk. C) The invagination of the optic vesicle results in the formation of the lens 
vesicle (LV) and neural retina (NR). This establishes the overall structure of the eye. C/I, ciliary body and iris. 
D) The mature eye: C, Cornea; LE, lens epithelium; LF, lens fiber cells; I, iris; CB, ciliary body; GCL, ganglion 
cell layer; INL, inner nuclear layer; ONL outer nuclear layer; ON, optic nerve. Reproduced from Chow and 
Lang. (Chow and Lang 2001). 
 
The early developing retina consists of a morphologically homogenous and proliferating 
neuroepithelium that is composed of mitotically active cells (figure II.3A). Proliferation of 
cells persists until embryonic day 6-8 (E6-8)  at which point cells are still mainly 
undifferentiated but are at different phases of the cell cycle with a majority of them being 
postmitotic and organized into layers (figure II.3B). Importantly, cells composing the 
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neuroepithelium of the early developing retina up to the last cell division have been shown to 
be multipotent (Fekete et al. 1994; Holt et al. 1988; Turner et al. 1990; Wetts and Fraser 
1988). At stage E15-E18 retinal cells are extensively differentiated and reassemble the mature 
retina (Adler 2000).  
 
 
 
Figure II.3. Retina at different stages of development. Schematic representation of the structure of the retina 
at E3, E6 and in mature retina. A) At E3 the retina is essentially composed of an homogenous layer of non 
differentiated and proliferative cells. In terms of morphology, cells extend from the basal to the apical surface of 
the retina. B) At E6 most of the cells are still undifferentiated but they are now distributed according to the cell 
cycle phase they have entered. From E6-E8, the proportion of postmitotic cells increases and will start migrate to 
their definitive layer. C) Schematic of the different layers composing the mature retina: grey, ganglions; brown, 
amacrine cells; red, bipolar cells; blue, horizontal cells; yellow, photoreceptors. 
 
The mature chick retina is composed of six major classes of postmitotic differentiated cells 
that occupy defined positions within its laminated structure: 1) rod and cone photoreceptors, 
2) bipolar cells, 3) horizontal cells, 4) amacrine cells, 5) retinal ganglion cells, 6) glial cells of 
Müller (figure II.3C). Most of these cell types can be divided into a number of additional 
subtypes, based on morphological, molecular and functional criteria.  
The role of the retina is to transmit the visual information to the brain; light stimulates 
photoreceptors that will synapse with bipolar, horizontal and amacrine cells. These in turn 
will transmit the information to the retinal ganglion cells that by the use of the optic nerve 
will transmit the information to the various targets in the brain. 
 
 128
In this study, we have used the retina as a model to explore the regulatory activity of a subset 
of ‘GalCNCs’ in an undifferentiated CNS-precursor structure. Our question is related to the 
ability to recognize regulatory CNCs by taking advantage of the extended phylogenetic 
conservation that the chicken provides. Thus, a detailed description of the processes involved 
in retinal differentiation is beyond the scope of this chapter and will not be discussed further. 
For review see (Adler 2000; Livesey and Cepko 2001).  
 
RESULTS 
 
HSA21q CNCs conserved in the chicken 
We have previously reported that human-mouse comparison of HSA21q had resulted in the 
identification of more 2262 CNCs with minimal length of 100bp, and at least 70% identity 
(Dermitzakis et al. 2002). In the current study, we have searched for HSA21q CNCs that were 
also conserved in the chicken genome. The strategy was as follows: i) identification of all 
human-chicken conserved non-coding sequences of at least 100bp and 70% homology were 
retrieved with the GALA browser (http://gala.cse.psu.edu/), ii) overlap of the set of identified 
human-chicken sequences with the 2262 HSA21q CNCs using Galaxy 
(http://main.g2.bx.psu.edu/). A minimal overlap of 50-100bp was arbitrarily chosen to select 
sequences. We found that 5-6% of HSA21q CNCs were also conserved in the chicken 
(n=110-140 sequences) (figure II.4). These human-mouse-chicken CNCs (GalCNCs) have a 
mean length of 198bp, a mean homology between human and chicken of 79.4% and a 1:2.3 
intronic-intergenic ratio (~77% versus ~33%). 
 
Figure II.4. A fraction of HSA21q CNCs are conserved in the chicken. Genome Browser (hg17) view of the 
long arm of the human chromosome 21. In brown the 2262 humna-mouse HSA21q CNCs are depicted, and in 
orange the CNCs conserved in the chicken (5-6%).  
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Regulatory activity of GalCNCs in chick whole-retina 
To evaluate the regulatory potential of these sequences we began by selecting 31 GalCNCs; 
the genomic characteristics of the selected conserved sequences are shown in Table II.1 and 
figure II.5. Briefly GalCNCs have a mean length of 234bp, a mean identity of 86.4% and an 
intronic:intergenic ratio similar to the overall set of conserved sequences (31% and 69% 
respectively).  
 
Table II.1. Coordinates and features of the assayed CNCs 
 
 
Each sequence was cloned upstream of a TK-minimal promoter driving the expression of a 
GFP-reporter gene (pTAL-GFP, modified from pTAL-LUC, Clontech). Out of the 31 CNCs 
selected, 20 were cloned as singleton and 11 in CNCs clusters (1 cluster of 3 CNCs and 4 
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clusters of 2 CNCs). For comparison we randomly selected 19 non-conserved sequences 
specific to the chicken genome (referred as control sequences) with similar mean length and 
intronic:intergenic ratio (figure II.5). Finally, the previously described retina enhancer, SOX2-
N3 (Uchikawa et al. 2003), was also cloned upstream of the GFP reporter vector and was used 
as a positive control for the detection of regulatory elements. 
 
 
 
Figure II. 5. Set of tested chicken CNCs and chicken non-conserved sequences. Genome browser view of the 
syntenic region of HSA21 on GGA1. Thirty CNCs (orange) and 20 conserved non-coding (green) sequences 
were cloned upstream a minimal promoter driving the expression of the GFP reporter gene.  The regulatory 
potential of these 50 sequences was assessed by whole retina electroporation and transient transfection in 
dissociated retina cells.  
 
The regulatory potential of each sequence (CNCs and controls) was assayed in the chick 
retina. We choose this model, because the retina provides the opportunity to investigate the 
function of CNCs in the development a nervous-derived tissue. In addition, we focused on 
two embryonic stages; E3 and E6 (see figure II.6). At these stages the retina is composed 
essentially of undifferentiated cells that undergo mitotic divisions. This also gives the 
opportunity of evaluating CNCs in a system of non-differentiated cells, i.e. stem cells like. 
This is an aspect of conserved sequences that to our knowledge has not been explored so far. 
 
The procedure used is explained in detail in the material and method section. Briefly, retinas 
at E3 or E6 were dissected and electroporated with each one of the constructs, along with an 
electroporation control vector (CMV-RFP). Retinas were subsequently cultured for 24hr 
before confocal microscopy analysis. Controls such as electroporation of the GFP-reporter 
vector showed that only a basal activity from the TK minimal promoter was detected thus the 
background level of GFP activity was low. The positive control SOX2-N3 enhancer, on the 
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other hand, confirmed the efficiency of the method for detecting regulatory activity (figure 
II.6).  
Each construct was tested at least twice in independent electroporation experiments.  
 
 
Figure II.6. Microscopy images of electroporated chick retinas. A CMV-RFP reporter vector is 
electroporated along with the experimental GFP vector to ascertain the efficiency of the electroporation. In the 
left image, the empty vector pTAL-GFP has been electroporated, despite a good efficiency, only a basal level of 
GFP can be observed driven by the TK minimal promoter. On the right panel, the positive control, SOX2-N3 
strongly drives the transcription of the GFP reporter gene.  
 
Our results we are summarized in Table II.2. Mainly, three profiles could be observed; i) 
strong GFP activation, ii) detection of GFP but only in a few cells and iii) no signal (figure 
II.7). Qualitative quantification suggests that 41% (E3) to 59% (E6) of the CNCs conserved in 
the chicken can strongly drive the transcription of the reporter gene; this is significantly 
higher than we observed in our previous study using the luciferase assay (less than 20% 
showed regulatory potential). An additional set of CNCs, 32% in E3 and 36% in E6, activates 
GFP in few cells and thus could also act as positive transcriptional regulators. Currently it is 
difficult to determine if the reduced activation is due to i) a specific expression of CNCs in a 
targeted population of cells (figure II.7D), ii) TK promoter background activity. Overall, a 
substantial proportion of CNCs conserved in the chicken behave as transcriptional activators, 
especially in E3 where there was a marked difference in reporter gene activation rates 
between conserved and non conserved sequences (41% in CNCs vs. 21% of non-conserved 
controls). At the E6 stage the results were less convincing as 59% of CNCs were positive vs. 
50% of control sequences. Intriguingly, however, the CNCs showed a markedly higher 
intensity of signal compared to controls (figure II.7E,F), this could suggest that TK 
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background activity is increased at E6, and thus we should use more stringent parameters to 
call the positives at this stage.  
 
 
Table II.2. Regulatory potential of CNCs in E3 and E6 retinas 
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Figure II.7. Profile of GFP expression in E3 and E6 retinas. A) & C) show a strong GFP activation in E3 and 
E6 retina respectively. B) and D) illustrate more moderate activation of GFP. This could either result of a 
reduced transcriptional activation of GFP, or it reflects the specific expression of GFP in certain subtype of cells. 
E) and F) are two examples of the profile of GFP activation by the majority of the control sequences. Although 
GFP is activated the level of expression is significantly reduced compared to CNCs signal.  
 
Quantification of CNCs regulatory activity in retina dissociated cells 
The use of GFP-reporter vectors in whole-retina cells has the important advantage of 
providing information on the spatio-temporal activity of the tested sequences. Alternatively, 
one can also measure GFP expression levels in isolated retina cells using FACS. This 
approach has the advantage of being more quantitative although the spatial information is lost.  
To obtain quantitative information, complementary to the whole-retina results, E6 chick 
retinas were dissected and cells were dissociated as described in (Matter-Sadzinski et al. 
1992) (for details see Material and methods). Briefly, 2x106 chick retinal cells were 
transfected with each one of the constructs (i.e. 25 CNCs-constructs, 19 controls and 1 
positive construct), cultured for 24hr and the activity of GFP was quantified by FACS 
analysis. Each construct has been tested in at least three biological replicates. The results 
obtained are represented in figure II.8. The bar graph depicted shows the GFP fold activation 
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driven by each of the cloned sequences, and suggests that the distribution of the CNCs and 
non-conserved sequences are different (P-Value=0.027). Overall, CNCs as a group drive 
higher GFP expression levels than the control sequences. 
 
 
 
Figure II.8. Enhancer assay in retina dissociated cells. The bar graph shows the GFP fold activation driven by 
each construct compared to the empty vector. Red, SOX2 N3 enhancer; green; 25 conserved regions, blue; 19 
controls sequences. Mann-Withney U test on the set of conserved versus non-conserved sequences suggests that 
the two groups have significant different effect on the activation of transcription of GFP (P-Value=0.027). 
 
The results on the dissociated cells confirm the microscopy results although there is not a 
clear one to one correspondence for the positive constructs in the two experiments. This could 
be due to (i) selection of specific cells during dissociation, (ii) differential survival of different 
cell types after trypsinisation and transfection (iii) Cell differentiation as they grow in culture 
(Reh and Kljavin 1989). It is thus likely that slightly different cell populations are being 
analysed in both experiments. 
 
DISCUSSION 
 
In this study we have assessed the significance of extended phylogenetic conservation of 
CNCs on their probability to behave as a regulatory element. We used two complementary 
approaches to study the regulatory potential of CNCs in developing retina:  
Enhancer assay in explanted chick retina at E3 and E6 stages, and enhancer assay in E6 retinal 
dissociated cells. Both methods showed that a substantial proportion of CNCs can act as 
activators in the early development of retina, as compared to non conserved controls. Some of 
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the CNCs showed activation levels comparable to the SOX enhancer showing that they are 
likely to be important regulators.  
Further support to the contribution of phylogenetic conservation to regulatory function is 
provided by reanalysis of the whole set of CNCs that have been assayed in chapter I 
(Attanasio et al.). Out of the 117 CNCs (original, TFBS and DHS CNCs) analysed we have 
found that 22% (26/117) of the previously mammalian-specific CNCs are also found in the 
chicken. It is however striking that about 50% of them are CNCs for which either TFBS or 
DHS had been reported. This further supports that extended conservation in non-mammalian 
amniotes favors a transcriptional role.  
 
We have found that 40%-60% of GalCNCs behave as transcription regulators. To date no 
correlation between specific CNCs and genes has been established; the study of conserved 
blocks of synteny between human, mouse and chicken (Ahituv et al. 2005) would however 
help reducing the number of candidates genes that could be controlled by CNCs. Subsequent 
experiments such as RT-PCR analysis on the expression of HSA21 homologue genes in the 
chick retina could already give insights in the transcriptional activity of putative target genes. 
Additional strategies such as Chromosomal Conformation Capture (3C) (Dekker et al. 2002) 
or RNA TRAP (Carter et al. 2002) could be further used to test a direct interaction between 
the regulatory CNCs and the genes lying in the same block of synteny.  
 
The results we obtained show that CNCs can be active in non-differentiated neural tissue. 
However, we cannot specify yet if the function of those CNCs is specific to neural 
transcription factors or to the multipotent state of cells. Additional investigations such as 
electroporation of differentiated retinas or other tissues would help answering that question; 
the limitation is however that electroporation of differentiated tissues is less efficient.  
In a first attempt to shade light on this, we have dissected and dissociated retina cells from 
E12 embryos. The FACS results we obtained following transfections of the differentiated 
cells revealed a loss of activation of GFP by almost all CNCs (data not shown). These 
preliminary results should be taken with care since the efficiency of transfection was less than 
1% and that no markers of different cell types were used to verify the cell population that was 
analyzed.  
Other strategies would be to test the regulatory potential of CNCs in stem cells from other 
species. 
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Finally further microscopic analyses on electroporated retinas might reveal preferential 
activation of GFP by CNCs in specific regions of the retina. This could help in understanding 
the role of CNCs in chick non-differentiated retinas.  
 
In conclusion our data support that extended conservation of human-mouse CNCs to the 
chicken is efficient at detecting a substantial fraction of conserved regulatory elements.  
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MATERIAL AND METHODS 
 
GFP-Reporter Constructs. pTAL-GFP vector: GFP was PCR amplified from a GFP-vector 
with HindIII and XbaI primers overhangs, purified and cloned into the pTAL-luc vector from 
which the luciferase gene was removed following HindIII-XbaI digestion. The resulting 
pTAL-GFP was verified by sequencing and assayed for GFP basal expression in cells and 
chick retina. In both systems GFP was detected at basal levels.  
Experimental GFP constructs: The 25 conserved regions, 19 controls and Sox2-N3 sequence 
were PCR amplified from chicken gDNA with primers with SalI overhangs. Digested and 
purified PCR products were then cloned into an XhoI pTAL-GFP vector. Each construct was 
verified by direct sequencing.   
 
Dissection and retina Electroporation (figure II.9). Eyes from E3 and E6 chick embryos 
were dissected in Ca2+ and Mg2+-free Hank’s balanced Salt Solution (HBSS, Invitrogen) and 
the pigmented epithelium (RPE, non neuronal cells) was removed. Single whole retinas were 
immersed at room temperature in about 100 !l of phosphate-buffered saline (PBS) containing 
a CMV-RFP reporter plasmid (0.05!g/ul) and experimental-GFP vectors (0.5 !g/!l). Tissues 
were set between two electrodes (0.5 cm apart) and submitted to five 8-10V pulses of 50- to 
80-ms duration spaced 1 s apart. The electroporated tissues were cultured as floating explants 
for 24 h at 37°C in DMEM supplemented with 10%FCS and 1% streptomycin-penicillin 
(Skowronska-Krawczyk et al. 2005). Electroporation efficiency was monitored by RFP-
positive cells. 
Each construct was tested at least in 3 independent experiments.  
 
 
 
Figure II. 9. Retina dissection and electroporation. Schematic view of the procedure. 
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Microscopy analysis. Following the 24hr incubation of the electroporated retinas, the 
medium was removed and retinas were washed once with PBS. Retinas were then fixed by 
addition of approximately 800!l of Paraformaldehyde 4% (PAF) for 20 minutes at RT. PAF 
was removed and fixed tissues were washed three times with PBS. Retinas were kept in PBS 
at 4oC till setting up on a microscopic slide. Microscopy analyses were done by confocal 
microscopy with a Leica TCS SP2 AOBS microscope.  
 
Dissociated retinal cells and transient transfections. Modified from (Matter-Sadzinski et al. 
1992). Chicken eyes were dissected in Ca2+ and Mg2+ -free HBSS, the pigmented epithelium, 
the lens and the vitreous humour are removed. The retinas were transferred into 0.05% 
trypsin, torn into pieces and incubated at 37oC (for 18 retinas at E6, 7ml of trypsin 0.05% is 
used). Visual checking and preparation ‘shaking’ was necessary to avoid aggregates. Time of 
incubation into trypsin varied with number of retinas and embryonic stage. To prevent 
aggregation DNAseI was added shortly after incubation into trypsin at final concentration of 
30ug/ml. When cells were dissociated, trypsin was stopped by addition of fetal calf serum 
(FCS) to 5%. Cells were then pelleted, rinse with Opti-MEM (invitroge) and resuspended into 
10ml of Opit-MEM. Cells were counted and distributed into 12-well PORN coated plates at a 
density of 2-2.5x106 cells/well. 
Transfections were performed as follow: 5!g of experimental vector and 0.3ug CMV-RFP 
transfection control vector were mixed with 250!l of OptiMEM. Plasmid DNA mixture was 
then mixed with 20!l of Lipofectamine previously incubated into 250!l OptiMEM. The 
resulting transfection mixes were added to the plated cells. After 4hr incubation at 37oC, 
transfection were stopped by adding 1ml of DMEM 20%FCS. Cells were cultured overnight 
and the medium was replaced on the following morning. Cells were incubated at 37oC in 
humidified 5% CO2 atmosphere for 24hr.  
For settings purpose the following mixes were prepared for each experiments: i) pTAL-GFP, 
ii) CMV-RPF, iii) pTAL-GFP + CMV-RFP, iv) SOX2-N3 GFP + CMV-RFO.  In addition 
each experimental construct has been tested in three independent experiments.  
 
FACS analyses. Following the 24hr of incubation, cells were washed with PBS, and 
recovered by trypsinisation. They were pelleted and resuspended into 250!l of PBS 
supplemented with 0.5% of FCS (to avoid aggregation). Cells were analysed with FACSfitc. 
Cell debris was eliminated and analysis was performed by gating all cells expressing CMV-
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RFP (transfected cells). GFP was then quantified in the gated population and the mean of its 
expression was used for subsequent analyses.  
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CHAPTER III 
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RATIONALE 
 
The comparative analysis of the human and mouse genomes revealed an unexpectedly large 
number of sequences under selective constraint (Waterston et al. 2002). Their high level of 
conservation among all mammals (including amniotes and/or tetrapods for a fraction of them) 
suggests they have important biological roles. Nucleotide changes within these sequences 
might thus contribute to phenotypic variation among individuals or be responsible for a 
fraction of human disease.  
 
In 2002, when this thesis work was initiated, CNCs had just been discovered and their 
function was almost totally unknown (Dermitzakis et al. 2002; Waterston et al. 2002). It was 
hypothesized that a fraction of them could act as regulatory elements. Nucleotide substitutions 
within an evolutionary conserved sequence could have thus caused the disruption or 
modification of its regulatory activity potentially resulting in a human disease. In 2003, the 
study of Lettice et al. presented such a case through the identification and analysis of 
mutations in a conserved long-range enhancer for the Shh gene. The authors showed that 
mutations in the DNA sequence of the distantly mapped conserved element induced ectopic 
expression of the target gene and resulted in a congenital limb malformation known as 
preaxial polydactyly (Lettice et al. 2003).  
 
Blepharophimosis/ptosis/epicanthus inversus syndrome (BPES) is a dominant monogenic 
disorder that is caused by null mutations in the FOXL2 gene (Crisponi et al. 2001) or nearby 
chromosomal translocations (De Baere et al. 2000; De Baere et al. 1999) as well as 3’ or 5’ 
extragenic deletions (Beysen et al. 2005; Crisponi et al. 2004). A subset of BPES patients 
however was found to be negative for both FOXL2 mutations and gross chromosomal 
abnormalities (translocations and intergenic deletions) within the locus. In order to further 
evaluate the possible contribution of mutations in conserved sequences towards BPES 
occurrence, we decided, in collaboration with Prof. De Baere (Ghent University, Belgium), to 
screen CNCs within the minimal intergenic deletion intervals in this group of patients. 
 
The results of this screen are presented and discussed in the next sections.     
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INVESTIGATION OF 5’FOXL2 INTERGENIC CNCS IN BPES DISEASE 
 
Collaborative project with Dr. Elfride De Baere, Diane Beysen and Barbara D’haene at the 
Department of Medical Genetics, Ghent University Hospital, Belgium. 
Additional contributors are: Marc Friedli, Colette Rossier, Catherine Ucla, Carine Wyss 
and Stylianos E. Antonarakis at the Department of Genetic Medicine and Development, 
University of Geneva, Switzerland. 
 
INTRODUCTION 
 
FOXL2 and BPES Syndrome 
Blepharophimosis/ptosis/epicanthus inversus syndrome (BPES) is an autosomal dominant 
congenital disease (MIM110100) that was first described in 1889 by Vignes et al. (Vignes 
1889). The syndrome is associated with a complex eyelid malformation that includes small 
palpebral fissures (blepharophimosis), drooping eyelids (ptosis) and a tiny skin fold running 
inward and upward from the lower lid (epicanthus inversus) (figure III.1). In addition, eyelid 
dysplasia can be associated (BPES type I) or not (BPES type II) with premature ovarian 
failure. Sex infertility in type I is then specific to females; affected males are fertile but 
transmit the trait to the next generation.  
 
 
 
 
Figure III.1. Blepharophimosis/ptosis/epicanthus inversus syndrome (BPES). (A-B) Pedigrees of a type I 
and type II BPES family. The segregation of the disease supports the autosomal dominant mode of transmission 
in both cases. Pedigrees are drawn by conventional representation; filled symbols represent affected individuals. 
Reproduced from Crisponi et al. (Crisponi et al. 2001) (C) Eyelids malformations of a BPES patient. 
Reproduced from Baron et al. (Baron et al. 2005)  
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The locus responsible for BPES was initially mapped to HSA3q21-24 by linkage analyses on 
type I and type II families (Amati et al. 1995; Amati et al. 1996; Harrar et al. 1995; Small et 
al. 1995). Subsequent case report studies also demonstrated that chromosomal translocation 
breakpoints at HSA3q22-23 were resulting in BPES (De Baere et al. 1999; Lawson et al. 
1995; Praphanphoj et al. 2000). In 2000, De Baere et al. took advantage of one of these 
patients to refine the translocation breakpoint and map putative disrupted genes (De Baere et 
al. 2000). BPESC1 was identified as a candidate gene leading to BPES, however subsequent 
mutation search in affected families did not support a major contribution to the disease. In 
2001, taking advantage of new translocation patients, Crisponi et al. refined the position of 
the causative gene (Crisponi et al. 2001). Their positional cloning pinpointed two candidates 
genes; FOXL2 and C3orf5 (renamed MRPSS). Mutation search in affected families of both 
type I and type II identified coding mutations resulting in premature stop codons or extended 
protein in FOXL2. No mutations were found in C3orf5. The specific expression pattern of 
FOXL2 in the developing eyelids and fetal / adult ovaries further support its role in the BPES 
syndrome (Cocquet et al. 2003; Cocquet et al. 2002; Crisponi et al. 2001) (figure III.2).  
 
Since the identification of FOXL2 as the gene responsible for BPES, more than 135 intragenic 
FOXL2 mutations have been described in BPES patients (Beysen et al. 2004). Interestingly, a 
genotype-phenotype correlation is usually observed; nonsense FOXL2 mutations lead to 
BPES type I and extended proteins lead to type II (Crisponi et al. 2001; De Baere et al. 2001). 
Recently however, this rule has been challenged by the identification of an intra- and inter-
familial phenotypic variability: in the first case, the nonsense mutation Y274X predicted to 
generate a truncated protein has been correlated with a BPES type II mother and her BPES 
type I daughter. In the second case, two unrelated families one with BPES type I, the other 
with  BPES type II have been shown to carry the same 1041-1042C insertion (De Baere et al. 
2003). This could suggest that modifier genes are also involved in the BPES syndrome. 
 
FOXL2 is a single-exon gene that encodes a 2.7kb transcript. The predicted 376 amino acid 
protein belongs to the forkhead /winged helix transcription factor family that contain a 101-
amino acid DNA-binding forkhead domain and a polyalanine tract of 14 residues. The role of 
the polyalanine tract is not known but might be related to the nuclear and cytoplasmic 
aggregation of the protein (Caburet et al. 2004). Comparative analyses of FOXL2 among 
vertebrates also shows that the gene is under purifying selection which leads to a strong 
protein conservation (Cocquet et al. 2003; Cocquet et al. 2002). 
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The targets of FOXL2 have been involved in mechanisms such as cholesterol metabolism, 
apoptosis or folliculogenesis in vivo (Batista et al. 2007). FOXL2 is, in fact, the first 
autosomal gene identified in the ovarian maintenance process; its disruption provides a 
mechanism for premature ovarian failure in BPES patients (Schmidt et al. 2004; Uda et al. 
2004). 
 
Figure III.2. FOXL2 is expressed in developing eyelids and in ovaries. (A) Left panel: mice whole-mount in 
situ hybridization with a FOXL2 probe reveals mRNA expression in the protruding rides around the cornea that 
will fuse and form the developing eyelids. Right panel: mouse embryo section, enlargement of the eye region. 
FOXL2 is expressed in low level in the lens fibers (lf) in the eye and at higher level in the developing eyelids (el) 
in the mesenchyme (pm) just below the epithelium. (B) FOXL2 is also expressed in mouse adult ovary. mRNA is 
detected in the follicle (f) but not in the stroma tissue (st) or oocytes (o). The right panel is an enlargement of the 
left one. (C) FOXL2 is specifically expressed in ovary tissue as shown by Northern analysis on multiple human 
tissues using a FOXL2 cDNA probe. (D) Immunohistochemistry on a human developing eye using an anti-
FOXL2 Antibody. FOXL2 expression is visible in the primordial mesenchyme of the eyelids. (A-C) Reproduced 
from Crisponi et al.(Crisponi et al. 2001) and (D) Reproduced from Cocquet et al. (Cocquet et al. 2003) 
 
Conserved Non-Coding sequences and BPES 
As discussed until now, BPES results from the disruption of FOXL2 function. However, not 
all patients examined to date carry intragenic mutations. Chromosomal rearrangements such 
as translocations (Beysen et al. 2005; Crisponi et al. 2004) and intergenic deletions lying 
outside of the FOXL2 gene have been shown to disrupt its activity and cause the disease 
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(Beysen et al. 2005). This strongly suggests that FOXL2 regulation is under the control of 
long-range regulatory elements. 
In their study, Beysen et al. reported the identification of new microdeletions outside of 
FOXL2 (Beysen et al. 2005). The shortest region of deletion overlap (SRO) defined by these, 
is a 126kb interval that lies approximately 230kb upstream of FOXL2, telomeric to the 
reported translocation breakpoints (figure III.3a). Comparative analysis on the SRO region 
reveals the presence of several evolutionarily conserved sequences potentially involved in the 
regulation of FOXL2 (figure III.3b). Supporting a critical function of the SRO region, the 
11.7kb deletion of the intergenic orthologuous region in the goat genome leads to the Polled 
Intersex Syndrome (PIS). PIS mutations in goats lead to the absence of horns and to sex 
reversal, the first trait segregate in an autosomal dominant mode, while the second is a 
recessive trait. The causative locus for PIS has been shown to map to the orthologuous region 
of HSA3q23 (Schibler et al. 2000), the responsible locus for BPES. PIS goats are thus 
believed to be an animal model for BPES.    
Interestingly, Beysen et al. also identified a downstream chromosomal rearrangement 
associated with BPES. Overall genomic rearrangements account for approximately 16% of all 
molecular defects found in BPES families (Beysen et al. 2005).  
 
The work discussed in this chapter is related to the identification of the SRO region and to the 
hypothesis that long-range enhancers for FOXL2 could map within it. Deletion/Duplications 
or single point mutations of the conserved non-coding sequences (CNCs) within this region 
might disrupt the expression of FOXL2 and lead to the BPES phenotypes. To explore this 
hypothesis, we took advantage of a set of BPES patients for which: (i) no FOXL2 coding 
mutations, (ii) no gross chromosomal rearrangements, (iii) no deletions of the transcription 
unit and outside the transcription unit have been detected.  
Beysen et al. identified putative ‘causative’ CNCs among the available PhastCons database 
(Siepel et al. 2005).  However our study was initiated before the release of the PhastCons 
conserved regions, instead we used the Genome Alignment and Annotation Database (GALA, 
http://gala.cse.psu.edu/) to identify human-mouse conserved sequences. Our comparative 
analysis identified 25 CNCs in the SRO region. 
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Figure III.3. CNCs map to the SRO region. (A) Genomic organization of FOXL2 upstream region; FOXL2 is 
shown in red, translocation breakpoints mapped in BPES patients are marked by black arrows. The shortest 
region of deletion overlap identified by Beysen et al .(Beysen et al. 2005) is depicted in green and includes the 
11.7kb orthologous deleted region in the PIS goat. Pisrt1 is a transcript that seems to be regulated by the PIS 
deleted region. MRPSS and COP'2 genes are shown in grey and orange respectively. Although translocation 
breakpoints and SRO lie within an MRPSS intron, the gene has been excluded for BPES syndrome (Crisponi et 
al. 2001). Reproduced from Uhlenhaut et al. (Uhlenhaut and Treier 2006) (B) Comparative alignment between 
human-mouse and human-chicken of the SRO region. The VISTA browser shows all conserved sequences found 
in the interval. Depicted in pink are CNCs of "100bp and with "70% identity between the species compared. See 
how the number of CNCs decreases with extended phylogenetic comparison.  
 
RESULTS 
 
CNCs mapping  
The SRO region is located between anonymous microsatellites DB8 (in BAC RP11-657M13) 
and DB3 (in BAC RP11-219D15), that corresponds approximately to the HSA3: 140203171-
140203199 (hg16) interval. Comparative analysis on the human and mouse orthologous 
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regions was carried out with the GALA browser (http://gala.cse.psu.edu/) with the following 
parameters: "100bp and "70% identity and no coding evidence. A total of 25 CNCs were 
identified (figure III.4), their position and features are described in table III.1. Subsequent 
analyses using the UCSC genome browser (multiZ alignment and PhastCons conservation) 
confirmed that all CNCs are conserved among placental mammals (~200Mya) with 7/25 also 
conserved in the chicken genome (~350Mya). In addition 3/7 also have a match in the fugu 
genome (~450Mya).  
 
The comparative analysis was initially performed using the hg16 build, however following 
the release of the hg17 build we performed again the comparative analysis and obtained 
similar results. Two small differences were found; the first is the extended length of CNC1 
and the second is the identification of an additional CNC mapping between CNC16 and 
CNC17. This last conserved element was not included in this study. 
 
 
 
Figure III.4. Overview of the SRO region. The SRO interval and the 25 CNCs mapping in it are shown in a 
UCSC Genome Browser window. Additional tracks are the MultizAlignment and PhastCons that give the pattern 
of conservation of the region across 28 species. The PhastCons Mammals/Vertebrate that map the defined 
conserved regions and give specific lod scores are also shown. The zoom in views, highlight the strong overlap 
between the CNCs detected with GALA by pairwise comparison and conserved sequences detected by the 
PhastCons algorithm. The regulatory potential track highlights the strong probability of the sequences to behave 
as regulators.  
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 Table III.1.  Coordinates and features of CNCs. 
CNCs #chrom Start (hg16) End (hg16) lenght Hs-mm 
identity 
Hs-galGal 
identity 
Other hit 
CNC8 chr3 140222692 140223002 310 82.26 no no 
CNC9 chr3 140225388 140225497 109 87.16 no no 
CNC10 chr3 140228032 140228154 122 76.23 no no 
CNC11 chr3 140242587 140242697 110 71.82 no no 
CNC12 chr3 140253926 140254066 140 80.00 no no 
CNC1 chr3 140268229 140268382 153 84.97 33.33 Fugu hit 
CNC2 chr3 140268577 140268808 231 75.76 50.22 no 
CNC3 chr3 140270186 140270402 216 99.07 93.98 Fugu hit 
CNC13 chr3 140270545 140270644 99 80.81 few bases no 
CNC4 chr3 140273138 140273535 397 94.21 71.54 Fugu hit 
CNC14 chr3 140273973 140274104 131 80.15 no no 
CNC5 chr3 140274414 140274610 196 87.24 61.73 no 
CNC15 chr3 140274685 140274833 148 72.30 no no 
CNC6 chr3 140276494 140276628 134 78.36 75.37 no 
CNC16 chr3 140277000 140277104 104 80.77 no no 
CNC17 chr3 140305431 140305544 113 84.96 no no 
CNC18 chr3 140308128 140308325 197 72.59 no no 
CNC7 chr3 140311501 140311616 115 92.17 no no 
CNC19 chr3 140326668 140326768 100 86.00 no no 
CNC20 chr3 140329687 140329906 219 84.02 no no 
CNC21 chr3 140332318 140332429 111 86.49 no no 
CNC22 chr3 140332531 140332661 130 86.15 no no 
CNC23 chr3 140332694 140332978 284 91.90 no no 
CNC24 chr3 140334894 140335067 173 78.03 no no 
CNC25 chr3 140337773 140337882 109 73.39 no no 
 
Mutation search in BPES patients 
Mutation search in the 25 CNCs was carried out in 33 affected probands for which FOXL2 
sequencing had excluded intragenic mutations and for which no gross chromosomal 
rearrangement had been detected by microsatellites analyses. During the course of this study, 
a 2.9Mb tiling path BAC array for the FOXL2 region was developed in the laboratory of Dr. 
De Baere. The 33 patients were re-checked by hybridization to the array and 1/33 was found 
to actually carry a deletion partially overlapping the SRO region. We have kept this patient in 
our set and will further discuss it in the copy number chapter. In addition to BPES patients, 21 
parents DNA were also available and included in the study. All these patients are spontaneous 
cases; there are no familial BPES cases in this study. 
 
The results obtained for the 53 individuals screened are summarized in figure III.5 and table 
III.2. Overall the CNCs sequence analysis did not reveal a clear link between the disease and 
the assayed conserved regions. Among the 14 nucleotide variants reported, 5 were previously 
identified SNPs (refSNP, NCBI), 5 were nucleotide substitutions within or flanking the CNC, 
with no reference in SNP database. However, their identification in non-affected parents 
makes them unlikely to be involved in the disorder. Finally, 3 nucleotide substitutions (in 
CNC2, 11 and 20) and a 4bp deletion (CNC14) were found exclusively in BPES patients. 
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Since no parents are available for these patients we cannot assert if these are de novo 
substitutions. 
 
Table III.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.5. Sequencing results. The table lists the 24 CNCs analysed (1st line) ordered following their 5’-3’ 
genomic position and the 32 patients along with the 21 parents (in yellow) (1st column). Each set of yellow boxes 
highlights an affected child with his two non-affected parents; note that one affected mother (DNA#9351) and 
her affected child (DNA#10024) are disclosed in the orange box. For each CNC and individual, the results of the 
sequencing are symbolized as follows: (-), no nucleotide variants compared to the reference sequence; black 
character, the nucleotide variant identified is a known SNP (see for example CNC4 in the close up view of figure 
III.4); blue character, the variant is not found in SNP databases but its presence in control samples suggests this 
is not the causative nucleotide change;  red bold character, the variant is not a known SNP and is found 
exclusively in affected samples. Each nucleotide position and reference allele is indicated below the 
corresponding column. Additional features related to specific CNCs are also mentioned at the very bottom of the 
table (‘Comment’ line). Finally CNC8-12 are in a different shade of green to point out that following this study, 
these CNCs might no longer map within the SRO region, this will be discussed in the Copy Number section. 
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Figure III.5. (Legend on the previous) 
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Although these could be candidate for BPES occurrence, comparative analysis indicates that 3 
out of the 4 variants are not at nucleotide position strongly conserved among species (figure 
III.6). In conclusion, only 1 variant (in CNC20) seems to be specific to BPES and map within 
a highly conserved nucleotide. To evaluate the specific link of the 4 variants (particularly the 
CNC20 variant) to the disease, control populations should be sequenced to determine their 
incidence within healthy individuals. However, based on their apparent low frequency (1/106 
chromosomes) a vast cohort of ethnically matched controls would have to be investigated to 
discriminate between rare variants or pathogenic substitutions.  
 
 
 
Figure III.6. Conservation of some (candidate pathogenic) nucleotide variants in CNCs. Multispecies 
alignment (human-mouse-dog-chicken) is displayed for the four conserved sequences shown to bare a putative 
BPES-associated variant. Pink boxes highlight the conservation of these substitutions (CNC2, 11 and 20) and 
deletion (CNC14). Except for CNC20, all other nucleotides do not map at position with strong conservation.    
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Among the 24 CNCs screened, 3 conserved sequences are associated with repeats; CNC3 is 
contiguous to a stretch of Adenine (A16), CNC4 contains one such stretch (A13) and CNC7 is 
contiguous to CA repeats (CA20). The presence of these repeats have precluded the 
sequencing of both strands for these CNCs, but since no ambiguous chromatogram peaks 
within the fragments were observed, this was considered enough to exclude nucleotide 
substitutions. Analysis of repeat number variations was however not possible. Given that 
repeat variations have been already associated to disease appearance (e.g. Huntington chorea 
(Collaborative 1993)) , further analyses should be carried out to assess the stability of these 
repeat stretches in BPES patients.  
 
Copy-Number analysis 
In order to quantify the number of CNC copies (deletion/duplication) in all our BPES patients 
we performed quantitative SybrGreen Real-time PCR. The strategy we used was already 
successfully applied for copy-number analyses in Williams-Beuren patients and is described 
in Howald et al. (Howald et al. 2006) (see Material and Method section too). 
  
The analysis was performed on 20 unrelated control individuals and the same 33 BPES and 
21 parents previously discussed. 
 
Analysis of the 20 control DNAs indicates that the SRO region is not a hotspot for insertion/ 
deletion (indels) polymorphisms (further confirmed by analysis of the parents) (figure III.6E). 
The CNCs copy-number profile we obtained on BPES samples further supported this 
observation: out of 31 patients 20 show a clear 1-copy/haploid genome for each amplicon 
(figure III.7A). Nine exhibit a more variable profile with putative chromosomal 
rearrangements (figure III.7B-C and figure III.8). Interestingly some of the variation observed 
in these patients map similar regions (figure III.7B-C, arrows), suggesting a recurrent 
rearrangement; this should however be repeated and additional assays (for example by 
MLPA) around the putative regions should be designed to validate the presence of a 
chromosomal rearrangement. Finally, during the course of this study one BPES patient 
initially negative for deletion (microsatellites analyses) was shown to carry an overlapping 
deletion with SRO region (CGH BAC array). We decided to use this patient as a positive 
control for our approach. The copy-number analysis demonstrated the validity of SybrGreen 
RT-PCR to identify indels. Interestingly, it also allowed us to fine map the centromeric end of 
the deleted region and show that the shortest region of deletion overlap can still be reduced by 
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about 51kb (figure III.7D). Exclusion of the 5’ end of SRO will reduce the number of putative 
conserved regions involved in BPES syndrome (5 CNCs map outside the new minimal 
deletion region).  
 
In conclusion, the data obtained are still preliminary and should be further investigated. 
However they still suggest that there might be some chromosomal re-arrangements. In 
addition, our data strongly suggest that the minimal SRO region can be further reduced. This 
is important for the mapping of putative functional elements.  
 
 
 
 
 
 
 
 
 
 
 
 158
Figure III.7. CNCs copy-number in BPES patients. Genomic rearrangement (ins/del) over conserved regions 
was assessed by quantitative real-time PCR. Amplicons were designed within CNCs and in long flanking 
regions. All graphs shown here indicate the number of copies (y-axis) of the tested amplicon (x-axis) in a 
specific BPES patient (number above the graph). The unit is the number of copies per haploid genome, 0.5 is 
then indicative of a heterozygous deletion and 1.5 is indicative of a heterozygous duplication. (A) The vast 
majority (>20/33) of the patients tested display a very clean pattern indicative of normal genomic organisation. 
(B-C) In few cases copy number variations are observed in specific amplicons (see CNC17 in panel B) or area 
(lower panel B and C). (D) A patient with a deletion overlapping with SRO was used as positive control. 
Interestingly, in addition to validating our approach it also indicates that the SRO region might be shorter than 
expected. (E) All assays used in this study were first tested in a set of 20 unrelated controls; the mean of all the 
copy numbers obtained for each DNA is shown here, along with the standard deviation. Very little variation was 
observed between individuals.  
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Figure III.8. Number of CNCs copies in 31 patients and 10 parents. Each line represents one amplicon and 
each column list the number of copies of these amplicons in the investigated DNA. Yellow boxes highlight the 
parents with their child; orange box depicts an affected mother and her affected child; red box indicates the 
patient with the known overlapping deletion. Not all amplicons for all DNA have been investigated (grey boxes) 
due to insufficient DNA amount. Two patients (#Mx and #8611 in figure III.5) were removed from the list due 
to degraded DNA and patient #8188 in light grey should be controlled for DNA quality.  Shown in red are 
putative deletions or duplications.   
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In vitro enhancer assay 
The analysis of CNCs in the SRO region is based on the assumption that these evolutionarily 
conserved sequences could act as long-range regulatory elements on FOXL2. In order to test 
this hypothesis, we successfully cloned 18/25 CNCs in a luciferase-reporter vector to evaluate 
their impact on the transcriptional activity of the reporter gene in vitro. The assay was 
performed in 293T cells (human kidney) as described previously (see luciferase assays in 
Chapter I and additional informations in Material and Methods section). 
 
The results we obtained are depicted in figure III.9. On the 18 constructs tested no enhancer 
activity could be detected. Only one element showed a strong effect on the luciferase 
transcription; CNC5 seems to repress its activity and thus might behave as a silencer.  
Although the fold activity is less significant for the other CNCs, almost all of them seem to 
have a general negative impact on the expression of the reporter gene, it would be interesting 
to investigate this further in vivo.   
 
 
Figure III.9. Regulatory activity of CNCs. (A) 18 CNCs were tested in 293T cells. The bar graph shows the 
luciferase fold activation observed for each construct compared to the pTAL-Luc vector only. The overall profile 
suggests a general negative effect of CNCs on transcription. (B) The four putative pathogenic variants discussed 
in the sequencing section, were cloned and assayed for differential luciferase expression along with the ‘wt’ form 
of the sequence. The bar graph shows the normalised luciferase activity driven by each construct normalised to 
the empty vector. No differences could be observed between wt and variant sequences. 
 
In addition to the reference sequences (wt CNCs) we investigated the impact of the four 
putative pathogenic variants discussed previously (sequencing section). All the variants were 
cloned into the same luciferase constructs and tested in 293T cells along with the wt form of 
the sequence. As shown in figure III.7B no significant effect was detected for any of them.  
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DISCUSSION 
 
The study presented in this chapter aimed to correlate conserved non-coding sequences with 
the occurrence of the BPES syndrome. A set of 33 patients were initially investigated for 
FOXL2 mutations and intergenic deletions, but were negative for both. We decided to take 
advantage of this cohort to investigate the role of a previously described upstream minimal 
intergenic deletion named SRO (Beysen et al. 2005). In particular we focused our attention on 
the evolutionarily conserved sequences mapping within the minimal deletion interval. 
Twenty-five CNCs were identified and further sequenced in order to identify mutations, 
chromosomal rearrangements and regulatory activity.  
The results obtained, currently do not convincingly support a functional role for these 
sequences in relationship to BPES however, further analyses will be required for definitive 
conclusions. 
 
Sequence analysis 
14 nucleotide variants were detected by sequence analysis, among the putative pathogenic 
variants only one mapped to a highly conserved nucleotide. Computational analyses did not 
support an impact of these variants on putative transcription factor binding sites (data not 
shown). Thus no evidence strongly supports a link between these variants and the disease.  In 
addition to the variants detected three CNCs are linked to repeats, it would be of interest to 
determine whether a repeat length polymorphism would be associated with BPES.  
 
Chromosomal rearrangements in SRO  
Since no clear pathogenic variants were identified within the candidate CNCs, we tested for 
the presence of small deletions or duplications. Our screen on the copy-number of CNCs in 
affected patients revealed some potentially interesting results that would need to be confirmed 
by an alternative method such as MLPA or high resolution CGH analysis. We identified 2 
patients with potential deletions and 7 with putative duplications that were not observed in the 
control group or in the parents of the affected individuals. One patient with a described 
deletion was clearly detected with our qPCR assays suggesting that the method is adequate to 
detect copy number variants, however the effect of DNA quantity and quality on the results 
obtained remains a concern. Finally, we succeed in refining the SRO region from the 5’ end, 
this reduces its size by approximately 51kb and lead to the exclusion of 5 CNCs (including 
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CNC11 for which a putative pathogenic variant was identified).  It would be interesting to 
design new assays in the 3’end of the known SRO to fine map it.  
 
In vitro reporter assays 
Currently, we have assayed the regulatory potential of 18 CNCs: 1/18 shows a strong silencer 
activity. FOXL2 is a gene that is specifically expressed in the developing eyelids and in 
ovaries. Because we aimed to evaluate the long-range regulatory activity of CNCs on FOXL2, 
experiments with ovary-derived cells (e.g. KGN cell line) or in vivo assays in mouse embryos 
would be required to convincingly verify the putative regulatory role of CNCs. One could 
imagine to first test a BAC construct covering the whole SRO region into which a lacZ 
reporter would have been integrated. If any enhancer activity is detected it would then be 
interesting to further dissect the region to evaluate the contribution of specific conserved 
sequences in this activation. LacZ enhancer assays however are specifically used to detect 
positive regulation, since we show that CNC5 probably act as silencer, other approaches like 
DNaseI hypersensitivity would be informative for non-positive regulatory role (could involve 
silencers, but also insulators and barrier elements).  
 
 
In conclusion, the role of the SRO region in the BPES disease remains elusive, although 
patient data strongly suggests that it must modify the expression of FOXL2. This is further 
supported by the 11.7kb homologous deletion in the goat that has shown to reduce FOXL2 
expression (Pailhoux et al. 2001). In addition, it could also affect the expression of additional 
genes but this is currently unknown. A model that could reconcile the different observations 
(and especially the reduced but not complete absence of expression of FOXL2 in goat) is 
related to the work of Osborne et al. (Osborne et al. 2004) In this study the authors investigate 
the role of the murine Locus Control Region (LCR) of '-globin genes during erythroid 
differentiation. They show that deletion of the LCR severely reduces '-globin gene 
expression, this is in turn a result of the non-re-localisation of the LCR in the interior of the 
nucleus during cell differentiation. FOXL2 is a gene that is expressed at early stages of 
embryogenesis in cells that experience differentiation. It is thus feasible that the FOXL2 SRO 
acts in a similar way to the LCR of the '-globin. It would be interesting to pursue experiments 
in that sense.  
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MATERIAL AND METHODS 
 
CNCs detection. CNCs of "100bp, "70% identity between human and mouse were identified 
in the 126kb SRO region by using the GALA genome browser (http://gala.cse.psu.edu/): 25 
CNCs of average length 165bp and average homology 82.5% were identified. See table III.1 
for coordinates (hg16 build).  
 
BPES Patients.  Samples were collected by the Ghent University Hospital. In each of the 33 
probands, intragenic FOXL2 mutations and chromosomal rearrangements (CGH array, 
microsatellites and MLPA analyses) were excluded. 11 parents DNA were also sent to us. A 
brief clinical report was also provided for each patient. The patients are from various origins, 
and since the mutation causing the disease is not known it is not possible to determine 
specifically if a patient has type I or type II BPES (especially true for young patients and 
males). 
  
DNA sequencing (mutation search). Primers surrounding (minimum 50bp upstream of the 
CNC) each one of the 25 CNCs were designed with Primer3 Browser 
(http://biotools.umassmed.edu/bioapps/primer3_www.cgi) and checked for specific 
amplification. 24/25 pair of primers resulted in specific amplification, since no clean pairs 
could be obtained for CNC19, no mutation search was performed on this conserved sequence. 
CNCs sequences were PCR-amplified with the RedTaq (Jumpstart kit, Sigma) under standard 
touchdown PCR conditions (10cycles 60-50oC, and 25 cycles 50oC). Each DNA amplification 
was checked by analytic gel, purified with QIAquick 96 PCR purification kit, and sequenced 
with and ABI 3130 sequencer in forward and reverse orientation. The Sequencher software 
(Gene Codes Corporation) was used to align and identify nucleotide variants.  
 
Copy-Number Analysis. The number of copies of each CNC was determined by SybrGreen 
RT-PCR. The method used is described in Howald et al. (Howald et al. 2006). Briefly, each 
primer was designed using the PrimerExpress program (Applied Biosystems, Foster City, 
California, USA) with default parameters in every case (primer sequences available upon 
request). A total of 28 amplicons covering all CNCs and some long flanking regions were 
designed and subsequently checked by BLAT against the human genome to ensure specificity. 
Primers efficiency was then tested on a set of 20 control DNAs (collected by the Department 
of Genetic Medicine and Development, University of Geneva), only amplicons with similar 
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efficiency in all samples were retained for further analysis. All RT-PCR reactions were 
carried out in triplicate in 10 µl final volume with concentrations of 25ng DNA, 0.42 µM of 
each primer, and 1xSybrGreen mastermix (Applied Biosystems). Reactions were set up in a 
384 well plate format with a Biomek 2000 automate (Beckman) and run in an ABI 
Prism7900HT (Applied Biosystems) with the following amplification conditions: 50°C for 
two minutes, 95°C for 10 minutes, and 50 cycles of 95°C for 15 seconds/60°C for one minute. 
Raw Ct values were obtained using SDS2.0 (Applied Biosystems). Four control DNA, four 
normalisation assays (mapping to HSA7 and HSA21) and three control amplicons (regions of 
1 copy/haploid genome, mapping to HSA10 and HSA21) were systematically included in 
each run.  
 
Luciferase reporter assay. wtCNC and variant-containing CNCs were amplified by PCR 
from ‘wt’ and ‘variant’ human genomic DNA with the same primers set used for sequencing. 
The amplified product was cloned into a TOPO-TA PCR II vector (Invitrogen) and verified 
by sequencing. Subsequent subcloning into pTAL-Luc vector (Clontech) was achieved by 
SacI-XhoI digestion of both the TOPO-CNC construct and pTAL-luc vector. Reverse 
orientated insertions of the CNCs was then achieved. All constructs were transfected in 293T 
cells (human kidney cells) and assayed for luciferase transcription activity as described in 
Attanasio et al. Submitted (Chapter I of this thesis). 
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I started this project in October 2002, at that time very little was known on CNCs. A few 
studies had suggested that conserved sequences might function as transcriptional regulators, 
but it was clear from that time that higher throughput functional genomics studies were 
required. During these 5 years of PhD, many studies on the evolutionarily properties, origins 
and putative functions of CNCs have been reported. They have shown that several features of 
CNCs contribute to their putative function, although most of these have focused on their role 
as transcriptional activators:  
 
1. Phylogenetic conservation: many reports have shown/suggested that CNCs 
conserved down to fish function as developmental regulators (Bejerano et al. 2004; 
Nobrega et al. 2003; Pennacchio et al. 2006; Woolfe et al. 2005). Recently, alignment 
between closely related species (human-apes) has also been used to investigate species 
specific regulation to evaluate the contribution of CNCs in the determination of 
species-specific features (Boffelli et al. 2003; Wang et al. 2007).  
2. Degree of conservation (core and flanking regions): the degree of conservation 
throughout a CNC is not always homogenous; few reports have highlighted the 
presence of ‘conserved domains’ within the CNCs. More detailed functional 
investigation has shown that the different regions within CNCs could represent 
distinct functional modules (Abbasi et al. 2007; Poulin et al. 2005). These are 
important observations since many of the functional studies performed to date involve 
cloning a defined region (enhancer assays, in-vivo LacZ injections, etc.). Deciding 
precisely which region should be cloned might modify the results, and contribute to 
the important variation in the regulatory potential of CNCs. Ultimately tests which do 
not require cloning steps (for example DNAseI or genomic tiling arrays approaches) 
might provide a more unbiased picture of the role of CNCs. 
3. Genomic position: most studies have investigated the function of CNCs in a gene 
centric view, and have shown that CNCs within a specific genomic locus are often 
their regulators. Large-scale analyses on unbiased regions now suggest that the 
regulatory potential of CNCs varies according to the genomic position, and might be 
less strong in gene desert regions where they could have other functional roles 
(Nobrega et al. 2004; Prabhakar et al. 2006). 
Others investigations have focused on intronic CNCs, and have shown/suggested that 
CNCs could regulate gene expression by inducing alternative splicing (Lareau et al. 
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2007; Sorek and Ast 2003; Voelker and Berglund 2007), or by inducing the utilization 
of alternative first exons (Vavouri et al. 2007). 
4. Sequence composition: among CNCs studies, only few of them have investigated the 
correlation of nucleotidic composition on CNCs function. Experimental and 
bioinformatics analyses has suggested that a fraction of CNCs rich in A+T content 
could function as Matrix Attached regions, that would regulate gene expression by 
physically isolating defined transcriptional domains within the nucleus (Glazko et al. 
2003; Lecine et al. 1996). It would be very interesting to see if such a correlation 
exists in the set of A+T rich CNEs test by Woolfe et al. (Woolfe et al. 2005). This 
could give important clues in the mechanistic of gene regulation by CNCs.  
5. Transcript encoded:  unbiased mapping of transcripts in 1% of the HG suggests that 
only a minority of transcript are under evolutionarily constraint (Consortium 2007). 
The function of intergenic transcripts is still largely unknown, recently insights into 
the function of ncRNA encoded by conserved sequences have been provided by the 
study of Dlx5,6 locus. It has been shown that the ncRNA transcript can act to regulate 
the expression of the nearby genes (cis-regulation) by negative feedback loop (Feng et 
al. 2006). 
 
 
During the thesis we have covered different aspects of the functional characterization of 
CNCs, with the main aims of: (i) exploring the function of HSA21q CNC in gene expression 
regulation, (ii) understanding the factors (as phylogenetic conservation for example) 
contributing to the regulatory potential of CNCs and (iii) evaluating their involvement in 
human diseases. 
 
The results discussed in this thesis contribute to the functional characterisation of CNCs by 
suggesting that: 
 
1. The majority of mammalian CNCs are not obvious gene expression regulators: in 
chapter I, we have described the functional analysis of 71 randomly selected CNCs, 23 
TFBS CNCs, 30 DHS CNCs and 20 non-conserved controls sequences. The two main 
conclusions that we obtained were: i) only a small fraction of mammalian CNCs 
(<20%) behave as regulatory elements in our assays, and ii) CNCs do not seem to be 
enriched in regulatory modules compared to less conserved controls sequences. These 
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conclusions do not agree with the mainstream view of CNCs as regulatory elements, 
but we believe that our unbiased choice of CNCs and the fact that most are 
mammalian specific explains to a large extent our different results. We do not think 
that the use of cell lines instead of in vivo models is the cause of the low level of 
regulatory elements. Several studies on CNCs have used cell lines (see table I, in the 
introduction chapter) in parallel (or not) to in vivo LacZ enhancer assays; studies using 
both in vitro and in vivo assays show that there is good consistency between the two 
systems (Shin et al. 2005; Wang et al. 2007). Recently also, the in-depth analysis of 
the functional elements of 1% of the human genome has been based uniquely on the 
use of cells lines (Consortium 2007). Finally, while in vivo studies (especially reporter 
studies) give the advantage of the spatio-temporal activity of a sequence they mainly 
allow the detection of positive regulators (enhancers). We wanted to study the 
regulatory potential of CNCs at large, i.e. enhancer, silencers, insulators, etc. Cell 
lines are more convenient for large scale analyses and to test a vast panel of activities 
(reporter assays, chromatin-related assays, DNA-FISH, etc.) than embryos are. 
However ultimately a combination of both approaches would be necessary to fully 
understand the function of CNCs.  
2. CNCs conserved up to non-mammalian amniotes are more likely to have 
regulatory potential than mammalian CNCs: In chapter II we have evaluated the 
regulatory potential of 25 chicken conserved regions and 19 non-conserved sequences. 
Our results support a contribution of extended phylogenetic conservation on the 
probability of CNCs having a regulatory function. More than 40% of CNCs identified 
through human-chicken alignments behave as transcriptional regulators. In addition, 
using non-differentiated embryonic stages of the chick retina as a model we show that 
CNCs can function in multipotent cells.  
 
The results we have obtained in the two first chapters suggest that all types of CNCs do 
not necessarily seem to act as regulatory elements. Our data support the hypothesis that 
the depth of phylogenetic conservation in CNCs modifies the probability of being a 
regulatory element. Randomly selected mammalian CNCs have less potential to act as cis-
regulatory elements as compared to human-chicken CNCs. Recently, Prabhakar et al. 
reported that extreme human-rodent conservation was sufficient to identify cis-regulatory 
elements (Prabhakar et al. 2006). We do believe this is not in contradiction with our data 
since we still can identify 20% of regulatory elements and that their experimental success 
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rate varies from 0% to 50% depending of the genomic context (DACH1 locus, within or 
outside of development loci). Furthermore the genomic context is also a factor that should 
be taken into account when evaluating the regulatory potential of CNCs. For example, our 
data show that when CNCs are randomly selected less than 13% (luciferase data) act as 
regulators while a preferential mapping near genes increases the fraction of regulatory 
CNCs to approximately 30% (83% of our TFBS CNCs map within 100kb of a known 
gene compared to 58% for randomly selected CNCs).  
 
In both the first and second chapter, a fraction of non-conserved sequences also behave as 
regulatory elements. This is compatible with the results of a recent study of 1% of the genome 
(Consortium 2007); only 20% of all detected regulatory elements overlap with conserved 
sequences (detailed in (Margulies et al. 2007)). Sequence comparisons of more related species 
(zebrafish-fugu, human-apes) show that ‘less’ conserved sequences can actually identify 
recently evolved regulators that would have been missed by more distantly compared species 
(Boffelli et al. 2003; Fisher et al. 2006; Wang et al. 2007). 
Our laboratory is currently also exploring this question by investigating the regulatory 
potential of a 1.7Mb genomic locus of HSA21 in an unbiased manner. Clones of 
approximately 3kb covering the entire region are being evaluated for their regulatory potential 
in mouse embryos. The results will allow further analyses on the contribution of conserved 
versus non-conserved fragments to gene regulation, and give the opportunity to associate 
features such as phylogenetic conservation, distance to genes and nucleotidic composition to 
the regulatory potential of CNCs (Marc Friedli’s project).  
 
The study described in the second chapter, uses the undifferentiated retina to evaluate the 
regulatory potential of GalCNCs. We show that a substantial fraction of CNCs behave as 
regulators into this system. This is to our knowledge the first report investigating the 
regulatory potential of CNCs in multipotent cells. If this is specific to the undifferentiated 
state of the cells (experiments to test this are described in chapter II), then it would be 
interesting to determine if the results from the first chapter are influenced to a large extent by 
the use of differentiated cell lines. Performing enhancer screens and DNA hypersensitivity 
assays in stem cells would provide very informative data.  
 
3. Contribution of CNCs to human disease: in our last chapter we have evaluated, as an 
example, the contribution of ‘SRO’ CNCs to BPES in patients for which coding 
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mutations or chromosomal rearrangements have not been identified. After sequencing 
candidate CNCs and screening for deletions or duplications, we have identified one 
putative pathogenic variant and 7 putative rearranged chromosomal regions. Although 
we cannot, unambiguously link CNC mutations with the pathogenesis of BPES, other 
studies have reported the involvement of CNCs in human disease (Emison et al. 2005; 
Lettice et al. 2003; Loots et al. 2005; Sabherwal et al. 2007).  
  
The overall contribution of CNCs in human disease is still unknown but the fact they have 
been associated to dysregulation of genes (Emison et al. 2005; Lettice et al. 2003),  suggest 
that additional efforts to determine the function of CNCs and their involvement in disorders 
for which a large fraction of mutations remain to be identified is a worthwhile exercise.  
 
Although there has been significant progress on understanding the biology of CNCs in the last 
5 years, the availability to new high-throughput technologies in the functional genomics field 
offer many possibilities for interesting studies, and exploring new roles for CNCs:  
 
i) Identification of protein complexes bound to CNCs: currently the limitation of 
such investigations is mostly due to technical issues. High throughout 
identification of bound proteins are time consuming (1-hybrid, bandshifts) and 
costly (ChIP-chip). However, recent technical advances such as CsCl gradients  
that allow the isolation of naked or bound DNA could be used to determine which 
CNCs are enriched in the protein-associated fractions in a cell and developmental 
stage specific manner (Schwartz et al. 2005). Also, with the availability of ultra 
high-throughput sequencers unbiased analysis of sequences in the protein-
associated fractions now become possible. Modifications of the CsCl gradient 
protocol might also give the opportunity to focus on the identification of the 
associated protein complexes using mass-spectrometry based approaches (such as 
LC-MS-MS).  
ii) Identification of CNC genomic interactions: large-scale analysis on CNCs 
succeeded in establishing their regulatory potential, however finding the regulated 
gene is still challenging. Several models for long range regulatory elements have 
been proposed i) through modification of the chromatin state by histone 
remodelling complexes, ii) looping of the DNA to place in close contact the CNC 
and its ‘target’ gene in the nucleus. Techniques that could provide insights into this 
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could be ChIP using antibodies for specific histone modifications, and chromatin 
conformation capture (3C, 4C) strategies that will allow detection of cis or trans 
regulated genes (Dekker et al. 2002). In addition, RNA-TRAP could be used to 
specifically correlate the initiation of transcription due to binding with the CNCs 
(Carter et al. 2002).  
iii) Dynamics of CNCs in the nucleus: several observation such as i) preferential 
mapping of CNCs within gene poor regions (Dermitzakis et al. 2002), ii) 
transcription of some CNCs prior to transcription of putative cis-regulated genes 
(Feng et al. 2006; Ghanem et al. 2003), iii) clustering of some classes of CNCs 
(Sandelin et al. 2004), could relate a fraction of CNCs to Locus Control regions 
(LCR). Some insights into the function of such regulatory regions have shown that 
they might mediate the activation of their target genes by repositioning in the 
nucleus and association to transcription factories (Ragoczy et al. 2003). 
Microscopy experiments including DNA- / RNA- FISH could be used to 
investigate putative LCR-like regions of CNCs in such mechanisms.  
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Transcriptional activation by bidirectional RNA
polymerase II elongation over a silent promoter
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Transcriptional interference denotes negative cis effects between
promoters. Here, we show that promoters can also interact
positively. Bidirectional RNA polymerase II (Pol II) elongation
over the silent human endogenous retrovirus (HERV)-K18
promoter (representative of 2.5! 103 similar promoters genome-
wide) activates transcription. In tandem constructs, an upstream
promoter activates HERV-K18 transcription. This is abolished by
inversion of the upstream promoter, or by insertion of a poly(A)
signal between the promoters; transcription is restored by poly(A)
signal mutants. TATA-box mutants in the upstream promoter
reduce HERV-K18 transcription. Experiments with the same
promoters in a convergent orientation produce similar effects.
A small promoter deletion partially restores HERV-K18 activity,
consistent with activation resulting from repressor repulsion by
the elongating Pol II. Transcriptional elongation over this class of
intragenic promoters will generate co-regulated sense–antisense
transcripts, or, alternatively initiating transcripts, thus expanding
the diversity and complexity of the human transcriptome.
Keywords: transcriptional interference; human LTR transposons;
RNA polymerase II; Pol II-regulated transcription; transcriptome
diversity
EMBO reports (2005) 6, 956–960. doi:10.1038/sj.embor.7400502
INTRODUCTION
In eukaryotes, RNA polymerase II (Pol II) transcription produces
messenger RNAs for more than 25,000 protein-coding genes, and
is tightly controlled. Although control was thought to be exerted
by proteins, it can be accomplished by RNA (Wassarman, 2004),
and even by the elongating Pol II itself. Transcriptional inter-
ference—the negative effect of a promoter on an adjacent one
in cis (Shearwin et al, 2005)—has long been recognized (Ward
& Murray, 1979; Adhya & Gottesman, 1982; Proudfoot, 1986;
Elledge & Davis, 1989). In tandem promoters, the elongating Pol II
emanating from the upstream promoter has been identified as the
regulator; Pol II negatively interferes with the binding of an
activator at the downstream promoter (Greger et al, 1998; Martens
et al, 2004). Interference in convergent promoters involves
colliding RNA polymerase complexes (Prescott & Proudfoot,
2002). A ‘sitting-duck’ model, or increased sensitivity to the
collision of Pol II complexes escaping the weak promoter into
productive elongation, was put forward (Callen et al, 2004).
Spacing between promoters is considered important irrespective
of promoter orientation. Indeed, the capacity of elongating
Pol II complexes to read through DNA-bound protein barriers
increases with the number of complexes pushing against the block
(Epshtein et al, 2003).
A large fraction of genomes, up to one-half in humans, is
occupied by transposon-derived interspersed repeats (Smit, 1999).
To minimize the adverse effects of transposition and illicit
recombination, the activity of these elements is restricted. This is
achieved by a variety of means; for instance, inefficient Pol II
elongation (Lorincz et al, 2004), methylation (Khodosevich et al,
2004) and formation of condensed chromatin. In one principal
class of transposons, known as the human endogenous retrovirus
long terminal repeats (HERV LTRs), the as yet unidentified protein
complexes assemble at the promoter and repress Pol II transcrip-
tion in most lineages except the germ line (Domansky et al, 2000).
HERV-K18, the model system used here, belongs to this HERV-K
(HML-2) subgroup (Barbulescu et al, 1999) and represents
about 2.5! 103 similar LTR promoters genomewide (Mager &
Medstrand, 2003). HERV-K18 consists of two LTRs flanking
intervening genes that encode defective structural and enzymatic
activities, and cell-surface glycoproteins (supplementary Fig 1 online).
The HERV-K18 element, located in the CD48 gene on chromosome
1, has been characterized extensively for gene-regulatory features
(Stauffer et al, 2001; Marguerat et al, 2004; Meylan et al, 2005).
RESULTS AND DISCUSSION
Pol II activates silent HERV-K18 in tandem promoters
Analysis of episomal reporter constructs comprising the whole
HERV-K18 element or the nominal LTR promoter alone showed
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no significant amounts of constitutive reporter gene activity
(supplementary Fig 1 online). This reflected the repressed
transcriptional state of the endogenous HERV-K18 element, which
was at background levels, as detected by ribonuclease protection
analysis (RPA) in all cell lineages except the thymus (Stauffer et al,
2001; Meylan et al, 2005). For these reasons, we used 50 LTR
episomal reporter constructs in all further studies analysing HERV-
K18 promoter activity. When the composite simian virus 40
(SV40)-derived SRa promoter, consisting of one TATA-dependent
and a second TATA-less promoter, was placed in tandem
upstream of HERV-K18, it resulted in strong HERV-K18 promoter
activity (Fig 1A). This could be accounted for by the upstream
recruitment at enhancers of factors overriding the repression of
HERV-K18, or, alternatively, by Pol II itself initiating at the
upstream promoter and activating the downstream regulatory
region. To differentiate between these possibilities, we performed
two experiments. First, we inverted the upstream SRa promoter
such that orientation-independent enhancers were still available,
but transcription over the HERV-K18 promoter was completely
eliminated. This extinguished HERV-K18 reporter activity, which
suggests that upstream SRa enhancers alone were not able to
stimulate the LTR promoter. Second, we introduced a minimal,
B0.3 kb SV40 poly(A) signal (Orozco et al, 2002) sufficient for
transcriptional termination between the two promoters. This
similarly abolished HERV-K18 reporter activity. Three single point
mutations in the poly(A) signal sequence (AATAAA to AGTACT)
fully restored activated HERV-K18 transcription, indicating that
Pol II elongation over the HERV-K18 promoter was responsible for
the effect. The approximately 300 extra nucleotides of the poly(A)
signal present in the mutant led to an even stronger signal. This
implied a positive effect of spacing between the two promoters on
transcription (Callen et al, 2004). Consistent with our observation,
the likelihood of displacing a DNA-bound protein barrier was
shown to increase with an increase in the number of Pol
complexes pushing against it (Epshtein et al, 2003). The presence
of several open reading frames and stop codons upstream of the
transcription initiation site made it unlikely that luciferase activity
could be derived from transcripts initiating upstream by cap-
dependent translation. In conclusion, upstream Pol II transcription
elongating over the 50 LTR was sufficient to activate the HERV-K18
promoter activity.
To extend this idea further, we mutated the TATA box in one of
the two known upstream SRa promoters (Fig 1B). Four single point
mutations in the TATA box (TATTTA to TGAATT) were sufficient
to reduce downstream HERV-K18 promoter activity. The SV40-
derived SRa promoter is known to consist of two overlapping
promoters, one containing a TATA box that is active early in the
SV40 life cycle, and a second that is turned on only during late
replication (Buchman et al, 1984). Residual promoter activity of
the second, TATA-independent upstream promoter is probably
responsible for the residual activity that we measure after mutating
the TATA box. Alternatively, TATA box mutations in human
promoters reduce Pol II transcription only to some extent.
Consistent with this second possibility, disruption of the TATA
box in a human disease impairs transcription only partially (Ciotti
et al, 1998). Therefore, this second set of experiments confirms
and extends the idea that Pol II transcription initiating at the
upstream SRa promoter and elongating over the LTR activates
downstream HERV-K18 promoter activity.
We wished to substantiate with transcription assays that
upstream initiation would activate transcription at the HERV-
K18 promoter, and to relate this to activated HERV-K18
transcription in vivo. Transcription was addressed by three
technical approaches—RPA, primer extension (PE) and quantita-
tive reverse transcriptase–polymerase chain reaction (qRT–PCR).
First, RPA was performed on RNA extracted from cells that were
transiently transfected with tandem promoter constructs (Fig 2A).
The probe was positioned over the U3–R boundary of the LTR
comprising the transcription initiation site such that upstream
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Fig 1 | RNA polymerase II transcription elongating over the tandem
human endogenous retrovirus-K18 promoter activates transcription.
(A) Physical distances are indicated on the top panel. The promoter
constructs used in reporter gene assays with episomal vectors are shown
(from top to bottom) as follows: (1) the human endogenous retrovirus
(HERV)-K18 long terminal repeat (LTR); (2) tandem constructs with a
composite simian virus 40 (SV40) promoter (SRa) upstream of the LTR
promoter; (3) an LTR construct with the upstream SRa promoter
inverted; (4) the SV40 polyA (pA) signal separating the two promoters;
and (5) a pA signal carrying the mutation AATAAA to AGTACT.
Reporter gene activity in HeLa cells of constructs 1–5 is shown
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(RSV)-controlled Renilla activity was used as an internal control.
(B) The following promoter constructs were analysed for reporter activity
(from top to bottom): (1) the LTR; (2) tandem constructs with
the composite SRa promoter upstream of the LTR; and (3) the
TATA-dependent promoter of the two upstream SRa promoters
carrying the mutation TATTTA to TGAATT (average71 s.d. of three
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transcription could be discriminated from HERV-K18-derived
transcription (Fig 2). Both—transcription initiating upstream in
the SRa promoter (upper arrow) and transcription emanating from
the HERV-K18 LTR—were detected (lower arrow). The biological
relevance of the lower band initiating within HERV-K18 is
corroborated by findings showing that interferon-a (IFN-a)-
activated HERV-K18 transcription in vivo in primary cells (PBL)
of three independent individuals produces a protected band
migrating at exactly the same size as the one resulting from
tandem promoter fusions. This experiment validates and extends
the results of reporter assays to naturally activated HERV-K18
transcription in vivo. Second, PE experiments were carried out on
RNA extracted from the luciferase assays shown in Fig 1A. As can
be seen in Fig 2B, a PE product of 195 nt expected for transcripts
initiating in the LTR precisely at the U3–R boundary was detected
essentially only in conditions that gave rise to consistent reporter
gene activity, namely, for the SRa-poly(A) (pA) mutant and the
SRa-LTR constructs. These findings were supported by results from
a second independent experiment including a further PE probe in
the LTR placed 117 nt from initiation (not shown). Third, qRT–PCR
corroborated the RPA and PE results (Fig 2C,D). Significant
transcription over the LTR was identified exclusively for the two
conditions that give rise to strong luciferase activity. As also shown
by RPA, the signal intensity of transcription emanating from the
LTR is stronger than that detected upstream of the LTR initiation
site (compare (4) and (5) in Fig 2C). Conversely, constructs that do
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not produce reporter activity lack detectable transcription over the
LTR (Fig 2C,D). A second independent experiment yielding similar
results is shown in supplementary Fig 2 online. In conclusion, the
perfect consistency of reporter and transcription assays indeed
shows that Pol II is the transcriptional activator of HERV-K18.
Convergent transcription activates HERV-K18
In its genomic setting, HERV-K18 is arranged in a convergent
orientation with respect to the CD48 promoter (Fig 3). We therefore
examined the same promoter couple used in previous experiments
in a convergent orientation. Surprisingly, even face to face, the
SRa promoter was able to activate HERV-K18 transcription (Fig 3).
A poly(A) signal between SRa and HERV-K18 abolished the
effect, showing that Pol II elongating over the HERV-K18 LTR was
required. These experiments show that Pol II, even when elongating
transcription opposite to HERV-K18, is still able to activate the LTR
promoter. The smaller amplitude of LTR activation as compared
with the tandem arrangement probably reflects the susceptibility of
transcription complexes forming at HERV-K18 to Pol II collision,
once the putative repressor is dislodged by the first incoming
complexes that have initiated at the SV40 promoter (Prescott &
Proudfoot, 2002; Callen et al, 2004).
HERV-K18 is repressed by unidentified proteins
Previous experiments have shown that as yet unidentified protein
complexes assembling at single HERV-K LTRs repress transcription
(Domansky et al, 2000). Although HERV-K18 is nominally a
member of the same subgroup of HERV-K LTRs, we confirmed
that it behaved similarly in this respect. Deletion of 70 nt in the
30 end of the U5 moiety of the LTR restored promoter activity
significantly, as described for other members of this class of HERV-
K LTRs (Fig 4; Domansky et al, 2000). This effect was weaker,
however, than transcriptional activation achieved by Pol II, which
could result from concomitant removal of activator binding sites,
and/or by repressor binding sites elsewhere on the promoter.
Collectively, we conclude that the HERV-K18 promoter is actively
repressed, and that Pol II complexes elongating bidirectionally
over the promoter are responsible for relieving repression. We
propose repressor repulsion as the mechanism accounting for
transcriptional activation by bidirectional Pol II elongation over
the HERV-K18 promoter.
HERV-K18 is not silenced post-transcriptionally
Some repressors function by recruitment of cofactors that induce
repressive chromatin modifications. Chromatin immunoprecipita-
tion experiments were performed in primary cells in which
HERV-K18 and CD48 are differentially expressed (supplementary
Fig 3 online). Marks of active chromatin were found over
actively transcribing (thymus) CD48 and HERV-K18 regions, but
not silent ones (epithelial cells). Post-transcriptional silencing by
heterochromatin formation, as reported for other transposons
(Lorincz et al, 2004; Novina & Sharp, 2004), does not seem to
have an important role with respect to HERV-K18, because
repressive chromatin modifications, such as di- and trimethylated
lysine 9 and heterochromatin protein 1, were localized to the
silent CD48 promoter, rather than to HERV-K18. In conclusion,
repression at the LTR by as yet unidentified negative regulatory
factors seems to be the predominant mechanism in place to
silence HERV-K18 promoter activity in vivo.
The presence of about 2.5! 103 similar LTRs genomewide may
have significant functional consequences because the elongating
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Pol II activates transcription at these promoters. Several testable
predictions can be made for LTRs in convergent or tandem
orientation to cellular promoters. For instance, when Pol II
activates transcription from an LTR face to face, double-stranded
RNA will be produced (Novina & Sharp, 2004). Such Pol II-
regulated antisense transcription may have a regulatory role
(Lavorgna et al, 2004). At least 20,000 sense–antisense transcrip-
tional units have been described in humans, with a sizable
fraction of noncoding RNAs (Kampa et al, 2004).
For LTRs in tandem with cellular promoters, alternatively
initiating transcripts will be generated after Pol II crosses the LTRs.
This provides an alternative mechanism to splicing for increasing
the coding diversity of individual transcriptional units (Levine &
Tjian, 2003). The proof of principle for this has already been
provided (van de Lagemaat et al, 2003). Transposable elements,
and particularly LTRs, have been identified to a significant extent
among the 50 termini of cellular transcripts involved in rapidly
evolving functions. Given the considerable differences among
species and individuals in nature and the composition of LTR
transposons, our findings extend the number of mechanisms that are
responsible for transcriptome diversity and complexity in humans.
METHODS
Constructs. Oligonucleotide sequences are indicated in the
supplementary information online. The episomal reporter con-
structs were generated by PCR on the basis of pREP4-Luc and
pREP7-Rluc (Liu et al, 2001). The SRa promoter was from pCDL
(Takebe et al, 1988) and the SV40 early poly(A) was from pREP4-Luc.
Reporter assays. See the supplementary information online.
Ribonuclease protection analysis. 3T3 mouse fibroblasts were
transiently transfected with Fugene (T. Hoffmann–La Roche Ltd,
Basel, Switzerland), using the SRa-LTR tandem promoter construct
in a pBSK backbone. RPA was performed on total RNA with a
probe spanning the U3–R region of the LTR. The probe was
generated by PCR (see the supplementary information online).
The 259 nt probe was generated with T3 polymerase on SpeI-
linearized plasmid templates.
Primer extension and quantitative reverse transcriptase–polymerase
chain reaction. See the supplementary information online.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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Suppl5 Fig 8! The HERV-K18 promoter is silent or only weakly active in all tissues 
examined. (A) Reporter gene assays were performed with the whole HERV-K18 element 
in which the envelope was replaced by the luciferase gene (1), with the isolated LTR 
promoter (2), with the multimerized ISRE (interferon stimulated response element) from 
the 9-27 promoter (Ackrill et al., 1991) (3), and with the natural 9-27 promoter (4). 
Experiments were performed in the fibrosarcoma cell line 2fTGH and HeLa, which were 
or not treated with interferon-( (IFN-() for 16h before analysis. The use of episomal 
reporter constructs is indicated by the suffix “e”. For all other assays pGL3 based reporter 
constructs (Promega) were used. The natural 9-27 promoter is not constitutively active, 
but strongly IFN-( inducible. (B) Reporter gene assays were carried out in the 
lymphoblastoid cell line Ramos, which was or not treated with interferon-( (IFN-() for 
16h before analysis, using the following episomal constructs; (1), a subgenomic HERV-
K18 construct lacking a portion of the polymerase gene, (2), a HERV-K18 construct with 
most of the gag gene deleted, (3), with the HERV-K18 LTR, and (4), the natural 9-27 
promoter. The subgenomic HERV-K18 constructs were generated such that luciferase 
can be synthesized from spliced subgenomic mRNAs. 
 
Suppl5 Fig :! Consistency between transcription and reporter assays shows that RNA 
Pol II is the HERV-K18 transcriptional activator. A second qRT-PCR experiment 
identical to that in Fig 2C-D is shown. qRT-PCR was performed with RNAs extracted 
from reporter assays shown in Fig 1A. Shown are absolute values of triplicates for each 
point, obtained after subtraction of RT- from RT+ numbers. The approximate position of 
the amplification product is indicated on top of the panel, and constructs are shown on the 
right; (A) shows values obtained over the LTR, (B) values spread over the complete 
construct length. (C) Shown are relative values after normalization for the first data point. 
 
Suppl5 Fig <! Chromatin immunprecipitation (ChIP) experiments at the natural HERV-
K18/CD48 locus reveal marks of active chromatin. (A) The organization of the HERV-
K18/CD48 locus is depicted. (B) HERV-K18 is transcribed to a significant extent only in 
thymocytes, while CD48 is expressed in all haematopoietic lineages, but not in epithelial 
cells. (C-E) Chromatin from the indicated conditions was formaldehyde fixed in living 
cells, shared by sonication, immunoprecipitated with the antibodies indicated, and 
subsequently amplified by real-time quantitative PCR using the primers at the positions 
depicted in A. Chromatin from thymocytes (black bar), mature T cells (white bar), and 
HeLa cells (gray bar), immunoprecipitated with antibodies against dimethylated lysine 4 
of histone 3 (H3) (C), trimethylated lysine 4 of H3 (%), and acetylated lysine 9 of H3 (E). 
The signals obtained by quantitative PCR for the primer locations depicted in A are 
expressed as percentages of signals generated by the input chromatin. (F-H) Chromatin 
from thymocytes (black bar), mature T cells (white bar), and HeLa cells (gray bar), was 
immunoprecipitated with antibodies against trimethylated lysine 9 of H3 (F), 
dimethylated lysine 9 of H3 (#), and HP1-( (H). The signals obtained by quantitative 
PCR for the primer locations depicted in (A) are expressed as percentages of signals 
generated by the input chromatin. 
 
 
Suppl5 to METHO%S 
Constructs5 Tandem promoter constructs were generated based on pREP4-Luc. pREP4-
LTR-Luc was generated by subcloning the 5’ HERV-K18.1 LTR SpeI-SalI into the NheI-
XhoI linarized pREP-Luc. All downstream constructs based on pREP4-LTR-Luc were 
made by PCR using oligonucleotides and terminal sites indicated. The convergent 
promoter constructs LTR-Luc-SR( and LTR-Luc-pA-SR( were generated by subcloning 
the respective fragments into the unique SalI site of pREP4-LTR located 3’ of the 
luciferase polyA signal. 
Oligonucleotides 
1. pREP4 SR(-LTR-Luc 
5’AGG ACC AGA TCT CTA GTA AGC TTG GCT GTG G 3’ 
5’ AGG CTT GAA TTC TCT AGA CT A TAG TGA GTC GTA TTA AGT GC 3’ 
2. pREP4 (RS-LTR-Luc 
5’ GTA CCA ACT AGT TCT AGA CTA GTA AGC TTG GCT GTG G 3’ 
5’ TCG TTA AGA TCT GTC GAC CT ATA GTG AGT CGT ATT AAG TGC 3’ 
3. pREP4 SR(-pA-LTR-Luc 
5’ AGG CTT GAA TTC CTA GAG TCG GGG CGG CCG 3’ 
5’ TCA TTA TCT AGA CTT ATC GAT TTT ACC ACA TTT GTA GAG G 3’ 
4. pREP4 SR(-pAmutant-LTR-Luc  
5’ A GCT GCA GTA CTC AAG TTA ACA ACA ACA ATT GC 3’ 
5’ TAA CTT GAG TAC TGC AGC TTA TAA TGG TTA C 3’ 
5. pREP4 SR(TATAmutant-LTR-Luc 
5’ TTT TTT TGA ATT CGC AGA GGC CGA GGC CGC CT 3’ 
5’ TCT GCG AAT TCA AAA AAA ATT AGT CAG 3’ 
 
Reporter Assays5 For the adherent cell lines 2fTGH and HeLa, 105 cells were plated in 
2ml DMEM 10% FCS in 6 well plates 16h before transfection. Plasmid DNA, 1)g of 
luciferase constructs and 0.2)g of renilla constructs, was incubated with 3.6)l Fugene 
(Roche) in 100)l serum-free DMEM for 30 minutes at room temperature, before adding 
to individual wells. Transfection efficiencies were monitored by FACS analysis of EGFP 
fluorescence, and were in the order of 30-60%. After 24h and 48h, 5)l of cytosolic 
extracts were assayed for luciferase and renilla activity according to instructions 
(Promega), except that 20)l each of LARII and Stop and Glow were used, on a TD-20/20 
luminometer (Turner Design). Two independent measurements were taken for single 
experiments, which were performed on at least three independent occasions. The 
lymphoblastoid cell line Ramos was transfected by electroporation. Efficiencies as 
determined by FACS analysis were between 5 and 10%.  
 
Ribonuclease Protection Analysis IRPAJ5 RPA was performed on total RNA with a 
probe spanning the U3-R region of the LTR. The probe was generated by PCR on 
HERV-K18.1 DNA using primers 5’ TTA AGA TCT CAC ACT AGT GAA CTG GGC 
AAT GGA ATG TCT CGG 3’, and 5’ TTA GCG GCC GCT TAG TCG ACA AGA 
GGG AGA TGT GTC AGG GTC 3’, and was cloned SpeI-NotI into pBSK. The 259 nt 
probe was generated with T3 polymerase on SpeI-linearized plasmid templates.  
 
Primer extension IPEJ5 The oligonucleotides 5’ GTC AGG GTC ACA AGA CAA TAG 
TGG 3’, positioned 195 nt from the LTR initiation site was 5’end-labeled, and used for 
PE experiments on RNA extracted from 7*105 HeLa cells (RNeasy Mini Kit, QIAGEN). 
The sequence of the second primer positioned at 146 nt from LTR initiation was 5’ GA 
ACA AAG GTC TTT GCA TCA TAG ACA AGG 3’. 10)g of quality controlled RNA 
(Agilent 2100 Bioanalyzer, Agilent Technologies) was used as template in RT reactions 
(Primer Extension System-AMV Reverse Transcriptase, Promega). The final products 
were precipitated, resuspended in a final volume of 10)l, and analysed by 8% denaturing 
polyacrylamide gel electrophoresis.  
 
Real-time MRT-PCR5 Total RNA was extracted from 6*105 HeLa cells, 24h after 
transfection, and DNAse I treated (RNeasy Mini Kit, QIAGEN). RNA was reverse 
transcribed using oligo-d(T) primed SuperScript II RNaseH (Invitrogen). For each pool 
of transfected cells, 5µg total RNA was converted to cDNA, and diluted 1:5. SYBR green 
assays were designed using PrimerExpress (Applied Biosystems), with default 
parameters. Efficiencies of all primer pairs were tested in cDNA dilution series (Livak 
and Schmittgen, 2001). Oligonucleotides were used at a final concentration of 300nM. 
Assays were run for RT- and RT+ reactions; PCR amplifications for RT-samples were 
reaching threshold at least 5-10 cycles later as compared to RT+ reactions (QuantiTect 
SYBR Green PCR Kit, QIAGEN). PCR reactions were set up on a Biomek 2000 robot 
(Beckman), in a 10µL volume in 384 well plates with three replicates per sample. 
Reactions were run on an ABI 7900 Sequence Detection System (Applied Biosystems), 
with the following conditions, 50°C for 2 min, 95°C for 10 min, and 50 cycles of 95°C 15 
sec/60°C for 1 min, a final dissociation curve step was also performed. Raw threshold Ct 
values were obtained using SDS 2.0 (Applied Biosystems). Assay efficiency calculations 
and measurements of relative expression were carried out in Excel (Microsoft). 
Normalization was performed by dividing all values with the one obtained with primer 
couple one, positioned upstream of the SR( promoter (suppl. Fig 2C). 
Primer sequences 
Position 1 
5’ AGT TCC GCC CAT TCT CCG 3’ 
5’ TGC ATA AAT AAA AAA AAT TAG TCA GCC AT 3’ 
Position 2 
5’ TGA CCC TGC TTG CTC AAC TCT 3’ 
5’ GGC GCA GAA CAG AAA ACG AA 3’ 
Position 3 
5’ CAT GAT AAG ATA CAT TGA TGA GTT TGG A 3’ 
5’ CAC TGC ATT CTA GTT GTG GTT TGT C 3’ 
Position 4 
5’ ATT AAG GGC GGT GCA AGA TGT 3’ 
5’ TGC TGC CTT CAA GCA TCT GTT 3’ 
Position 5 
5’ GGA CAT GCA GGC AGC AAT ACT 3’ 
5’ ACA CAT AAA CAT CTC AAT GCT TTA CAA A 3’ 
Position 6 
5’ CCT CTC CCC ACT ATT GTC TTG TG 3’ 
5’ TTT CTC CGA GAG GGA GAT GTG T 3’ 
 
Chromatin immunoprecipitation ICh1PJ5 ChIP experiments were performed as 
described (Masternak et al., 2000). The ChIP antibodies were from upstate, the anti-di- 
and trimethyl H9 (Lysine 9) antibodies were raised against 2*branched synthetic peptides 
(upstate, cell signaling solutions). PCR reagents and cybergreen were from Eurogentec 
(qPCR core kit, Eurogentec-Belgium). The reactions were run in duplicate 20)l each, in 
96 well plates on an ABI prism 7700 (Applied Biosystems). Amplifications were 
individually standardized to function at efficiencies close to 100%, and the results are 
expressed based on a standard curve generated on dilutions of input chromatin. Primer 
sequences are available upon request.  
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